@misc{sulis_lavoine_sederoff_jiang_marques_lan_cofre-vega_barrangou_wang_2025, title={Advances in lignocellulosic feedstocks for bioenergy and bioproducts}, volume={16}, ISSN={["2041-1723"]}, url={https://doi.org/10.1038/s41467-025-56472-y}, DOI={10.1038/s41467-025-56472-y}, abstractNote={Lignocellulose, an abundant renewable resource, presents a promising alternative for sustainable energy and industrial applications. However, large-scale adoption of lignocellulosic feedstocks faces considerable obstacles, including scalability, bioprocessing efficiency, and resilience to climate change. This Review examines current efforts and future opportunities for leveraging lignocellulosic feedstocks in bio-based energy and products, with a focus on enhancing conversion efficiency and scalability. It also explores emerging biotechnologies such as CRISPR-based genome editing informed by machine learning, aimed at improving feedstock traits and reducing the environmental impact of fossil fuel dependence. Lignocellulose is a promising feedstock to produce bioenergy and biomaterials. Here, the authors review current efforts, including genome editing informed by machine learning, for lignocellulosic feedstock-based bioenergy and biomaterials production and provide outlook for improving feedstock traits.}, number={1}, journal={NATURE COMMUNICATIONS}, author={Sulis, Daniel B. and Lavoine, Nathalie and Sederoff, Heike and Jiang, Xiao and Marques, Barbara M. and Lan, Kai and Cofre-Vega, Carlos and Barrangou, Rodolphe and Wang, Jack P.}, year={2025}, month={Feb} } @article{adler_al-shimary_patel_armbruster_colognori_charles_miller_lahiri_cui_oromi-bosch_et al._2025, title={CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d}, volume={2}, ISSN={["2058-5276"]}, DOI={10.1038/s41564-025-01935-7}, abstractNote={Abstract Bacteriophages constitute one of the largest reservoirs of genes of unknown function in the biosphere. Even in well-characterized phages, the functions of most genes remain unknown. Experimental approaches to study phage gene fitness and function at genome scale are lacking, partly because phages subvert many modern functional genomics tools. Here we leverage RNA-targeting dCas13d to selectively interfere with protein translation and to measure phage gene fitness at a transcriptome-wide scale. We find CRISPR Interference through Antisense RNA-Targeting (CRISPRi-ART) to be effective across phage phylogeny, from model ssRNA, ssDNA and dsDNA phages to nucleus-forming jumbo phages. Using CRISPRi-ART, we determine a conserved role of diverse rII homologues in subverting phage Lambda RexAB-mediated immunity to superinfection and identify genes critical for phage fitness. CRISPRi-ART establishes a broad-spectrum phage functional genomics platform, revealing more than 90 previously unknown genes important for phage fitness.}, journal={NATURE MICROBIOLOGY}, author={Adler, Benjamin A. and Al-Shimary, Muntathar J. and Patel, Jaymin R. and Armbruster, Emily G. and Colognori, David and Charles, Emeric J. and Miller, Kate V. and Lahiri, Arushi and Cui, Michael L. and Oromi-Bosch, Agnes and et al.}, year={2025}, month={Feb} } @article{butterfield_rohm_roberts_nethery_rizzo_morone_garnier_iglesias_barrangou_gersbach_2025, title={Characterization of diverse Cas9 orthologs for genome and epigenome editing}, url={https://doi.org/10.1073/pnas.2417674122}, DOI={10.1073/pnas.2417674122}, abstractNote={CRISPR-Cas9 systems have revolutionized biotechnology, creating diverse new opportunities for biomedical research and therapeutic genome and epigenome editing. Despite the abundance of bacterial CRISPR-Cas9 systems, relatively few are effective in human cells, limiting the overall potential of CRISPR technology. To expand the CRISPR-Cas toolbox, we characterized a set of type II CRISPR-Cas9 systems from select bacterial genera and species encoding diverse Cas9s. Four systems demonstrated robust and specific gene repression in human cells when used as nuclease-null dCas9s fused with a KRAB domain and were also highly active nucleases in human cells. These systems have distinct protospacer adjacent motifs (PAMs), including AT-rich motifs and sgRNA features orthogonal to the commonly used Staphylococcus aureus and Streptococcus pyogenes Cas9s. Additionally, we assessed gene activation when fused with the p300 catalytic domain. Notably, S. uberis Cas9 performed competitively against benchmarks with promising repression, activation, nuclease, and base editing activity. This study expands the CRISPR-Cas9 repertoire, enabling effective genome and epigenome editing for diverse applications.}, journal={Proceedings of the National Academy of Sciences}, author={Butterfield, Gabriel L. and Rohm, Dahlia and Roberts, Avery and Nethery, Matthew A. and Rizzo, Anthony J. and Morone, Daniel J. and Garnier, Lisa and Iglesias, Nahid and Barrangou, Rodolphe and Gersbach, Charles A.}, year={2025}, month={Mar} } @article{barrangou_2025, title={Managing Expectations for CRISPR in a Volatile World}, volume={1}, ISSN={["2573-1602"]}, url={https://doi.org/10.1089/crispr.2025.0006}, DOI={10.1089/crispr.2025.0006}, journal={CRISPR JOURNAL}, author={Barrangou, Rodolphe}, year={2025}, month={Jan} } @article{pan_o'flaherty_hibberd_gerdes_morovic_barrangou_2025, title={The curated Lactobacillus acidophilus NCFM genome provides insights into strain specificity and microevolution}, volume={26}, ISSN={["1471-2164"]}, DOI={10.1186/s12864-024-11177-2}, number={1}, journal={BMC GENOMICS}, author={Pan, Meichen and O'Flaherty, Sarah and Hibberd, Ashley and Gerdes, Svetlana and Morovic, Wesley and Barrangou, Rodolphe}, year={2025}, month={Jan} } @article{barrangou_2024, title={'Tis the Season: CRISPR Products All Around}, volume={12}, ISSN={["2573-1602"]}, url={https://doi.org/10.1089/crispr.2024.0094}, DOI={10.1089/crispr.2024.0094}, journal={CRISPR JOURNAL}, author={Barrangou, Rodolphe}, year={2024}, month={Dec} } @article{barrangou_2024, title={AI and SynBio Meet CRISPR Heralding a New Genome Editing Era}, url={https://doi.org/10.1089/crispr.2024.0063}, DOI={10.1089/crispr.2024.0063}, journal={The CRISPR Journal}, author={Barrangou, Rodolphe}, year={2024}, month={Aug} } @article{roberts_spang_sanozky-dawes_nethery_barrangou_2024, title={Characterization of Ligilactobacillus salivarius CRISPR-Cas systems}, volume={7}, ISSN={["2379-5042"]}, url={https://doi.org/10.1128/msphere.00171-24}, DOI={10.1128/msphere.00171-24}, abstractNote={is a diverse genus among lactobacilli with phenotypes that reflect adaptation to various hosts. CRISPR-Cas systems are highly prevalent within lactobacilli, and}, journal={MSPHERE}, author={Roberts, Avery and Spang, Daniel and Sanozky-Dawes, Rosemary and Nethery, Matthew A. and Barrangou, Rodolphe}, editor={Ellermeier, Craig D.Editor}, year={2024}, month={Jul} } @article{davies_philippidis_barrangou_2024, title={Five Years of Progress in CRISPR Clinical Trials (2019-2024)}, volume={7}, ISSN={["2573-1602"]}, url={https://doi.org/10.1089/crispr.2024.0081}, DOI={10.1089/crispr.2024.0081}, abstractNote={In July 2019, Victoria Gray became the first patient with sickle cell disease to receive a CRISPR-based cell therapy as a volunteer in the exa-cel clinical trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. Barely four years later, the ensuing therapy, branded as Casgevy, received approval from regulatory agencies in Europe, the United States, and the Middle East, ushering in a new era of CRISPR-based medicines. During this period, scores of other clinical trials have been launched, including many actively recruiting patients across phase 1, phase 2, and phase 3 clinical trials around the world. In this brief Perspective, we collate the latest information on therapeutic clinical trials featuring CRISPR, base and prime editing, across a range of both}, number={5}, journal={CRISPR JOURNAL}, author={Davies, Kevin and Philippidis, Alex and Barrangou, Rodolphe}, year={2024}, month={Oct}, pages={227–230} } @article{barrangou_2024, title={Surveying the State of CRISPR and Gene Editing}, volume={7}, ISSN={["2573-1602"]}, url={https://doi.org/10.1089/crispr.2024.0045}, DOI={10.1089/crispr.2024.0045}, number={3}, journal={CRISPR JOURNAL}, author={Barrangou, Rodolphe}, year={2024}, month={Jun}, pages={133–134} } @article{qaim_barrangou_ronald_2024, title={Sustainability of animal-sourced foods and plant-based alternatives}, volume={121}, ISSN={["1091-6490"]}, url={https://doi.org/10.1073/pnas.2400495121}, DOI={10.1073/pnas.2400495121}, number={50}, journal={PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA}, author={Qaim, Matin and Barrangou, Rodolphe and Ronald, Pamela C.}, year={2024}, month={Dec} } @article{gilfillan_vilander_pan_goh_o'flaherty_feng_fox_lang_greenberg_abdo_et al._2023, title={Lactobacillus acidophilus Expressing Murine Rotavirus VP8 and Mucosal Adjuvants Induce Virus-Specific Immune Responses}, volume={11}, ISSN={["2076-393X"]}, url={https://www.mdpi.com/2076-393X/11/12/1774}, DOI={10.3390/vaccines11121774}, abstractNote={Rotavirus diarrhea-associated illness remains a major cause of global death in children under five, attributable in part to discrepancies in vaccine performance between high- and low-middle-income countries. Next-generation probiotic vaccines could help bridge this efficacy gap. We developed a novel recombinant Lactobacillus acidophilus (rLA) vaccine expressing rotavirus antigens of the VP8* domain from the rotavirus EDIM VP4 capsid protein along with the adjuvants FimH and FliC. The upp-based counterselective gene-replacement system was used to chromosomally integrate FimH, VP8Pep (10 amino acid epitope), and VP8-1 (206 amino acid protein) into the L. acidophilus genome, with FliC expressed from a plasmid. VP8 antigen and adjuvant expression were confirmed by flow cytometry and Western blot. Rotavirus naïve adult BALB/cJ mice were orally immunized followed by murine rotavirus strain ECWT viral challenge. Antirotavirus serum IgG and antigen-specific antibody-secreting cell responses were detected in rLA-vaccinated mice. A day after the oral rotavirus challenge, fecal antigen shedding was significantly decreased in the rLA group. These results indicate that novel rLA constructs expressing VP8 can be successfully constructed and used to generate modest homotypic protection from rotavirus challenge in an adult murine model, indicating the potential for a probiotic next-generation vaccine construct against human rotavirus.}, number={12}, journal={VACCINES}, author={Gilfillan, Darby and Vilander, Allison C. and Pan, Meichen and Goh, Yong Jun and O'Flaherty, Sarah and Feng, Ningguo and Fox, Bridget E. and Lang, Callie and Greenberg, Harry B. and Abdo, Zaid and et al.}, year={2023}, month={Dec} } @article{foley_walker_stewart_o'flaherty_gentry_patel_beaty_allen_pan_simpson_et al._2023, title={Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut}, volume={3}, ISSN={["2058-5276"]}, DOI={10.1038/s41564-023-01337-7}, abstractNote={Abstract Bile acids (BAs) mediate the crosstalk between human and microbial cells and influence diseases including Clostridioides difficile infection (CDI). While bile salt hydrolases (BSHs) shape the BA pool by deconjugating conjugated BAs, the basis for their substrate selectivity and impact on C. difficile remain elusive. Here we survey the diversity of BSHs in the gut commensals Lactobacillaceae, which are commonly used as probiotics, and other members of the human gut microbiome. We structurally pinpoint a loop that predicts BSH preferences for either glycine or taurine substrates. BSHs with varying specificities were shown to restrict C. difficile spore germination and growth in vitro and colonization in pre-clinical in vivo models of CDI. Furthermore, BSHs reshape the pool of microbial conjugated bile acids (MCBAs) in the murine gut, and these MCBAs can further restrict C. difficile virulence in vitro. The recognition of conjugated BAs by BSHs defines the resulting BA pool, including the expansive MCBAs. This work provides insights into the structural basis of BSH mechanisms that shape the BA landscape and promote colonization resistance against C. difficile .}, journal={NATURE MICROBIOLOGY}, author={Foley, Matthew H. and Walker, Morgan E. and Stewart, Allison K. and O'Flaherty, Sarah and Gentry, Emily C. and Patel, Shakshi and Beaty, Violet V. and Allen, Garrison and Pan, Meichen and Simpson, Joshua B. and et al.}, year={2023}, month={Mar} } @article{barrangou_2023, title={CRISPR Technology and its Many Applications with Select Examples Related to Animal Agriculture}, volume={101}, ISSN={["1525-3163"]}, DOI={10.1093/jas/skad068.001}, abstractNote={Abstract Dr. Barrangou’s research focuses on the biology and genetics of CRISPR-Cas immune systems in bacteria. Using microbiology, molecular biology and genomics approaches, he investigates the use of CRISPR-Cas systems to generate novel tools for the manipulation of industrially relevant organisms for food and biotechnological applications. Dr. Barrangou talk will be an update on CRISPR technology and its many applications with select examples related to animal agriculture.}, journal={JOURNAL OF ANIMAL SCIENCE}, author={Barrangou, Rodolphe}, year={2023}, month={May} } @article{adler_trinidad_bellieny-rabelo_zhang_karp_skopintsev_thornton_weissman_yoon_chen_et al._2023, title={CasPEDIA Database: a functional classification system for class 2 CRISPR-Cas enzymes}, volume={10}, ISSN={["1362-4962"]}, url={https://doi.org/10.1093/nar/gkad890}, DOI={10.1093/nar/gkad890}, abstractNote={Abstract CRISPR-Cas enzymes enable RNA-guided bacterial immunity and are widely used for biotechnological applications including genome editing. In particular, the Class 2 CRISPR-associated enzymes (Cas9, Cas12 and Cas13 families), have been deployed for numerous research, clinical and agricultural applications. However, the immense genetic and biochemical diversity of these proteins in the public domain poses a barrier for researchers seeking to leverage their activities. We present CasPEDIA (http://caspedia.org), the Cas Protein Effector Database of Information and Assessment, a curated encyclopedia that integrates enzymatic classification for hundreds of different Cas enzymes across 27 phylogenetic groups spanning the Cas9, Cas12 and Cas13 families, as well as evolutionarily related IscB and TnpB proteins. All enzymes in CasPEDIA were annotated with a standard workflow based on their primary nuclease activity, target requirements and guide-RNA design constraints. Our functional classification scheme, CasID, is described alongside current phylogenetic classification, allowing users to search related orthologs by enzymatic function and sequence similarity. CasPEDIA is a comprehensive data portal that summarizes and contextualizes enzymatic properties of widely used Cas enzymes, equipping users with valuable resources to foster biotechnological development. CasPEDIA complements phylogenetic Cas nomenclature and enables researchers to leverage the multi-faceted nucleic-acid targeting rules of diverse Class 2 Cas enzymes.}, journal={NUCLEIC ACIDS RESEARCH}, author={Adler, Benjamin A. and Trinidad, Marena I and Bellieny-Rabelo, Daniel and Zhang, Elaine and Karp, Hannah M. and Skopintsev, Petr and Thornton, Brittney W. and Weissman, Rachel F. and Yoon, Peter H. and Chen, Linxing and et al.}, year={2023}, month={Oct} } @article{page_perez-diaz_pan_barrangou_2023, title={Genome-Wide Comparative Analysis of Lactiplantibacillus pentosus Isolates Autochthonous to Cucumber Fermentation Reveals Subclades of Divergent Ancestry}, volume={12}, ISSN={["2304-8158"]}, url={https://doi.org/10.3390/foods12132455}, DOI={10.3390/foods12132455}, abstractNote={Lactiplantibacillus pentosus, commonly isolated from commercial cucumber fermentation, is a promising candidate for starter culture formulation due to its ability to achieve complete sugar utilization to an end pH of 3.3. In this study, we conducted a comparative genomic analysis encompassing 24 L. pentosus and 3 Lactiplantibacillus plantarum isolates autochthonous to commercial cucumber fermentation and 47 lactobacillales reference genomes to determine species specificity and provide insights into niche adaptation. Results showed that metrics such as average nucleotide identity score, emulated Rep-PCR-(GTG)5, computed multi-locus sequence typing (MLST), and multiple open reading frame (ORF)-based phylogenetic trees can robustly and consistently distinguish the two closely related species. Phylogenetic trees based on the alignment of 587 common ORFs separated the L. pentosus autochthonous cucumber isolates from olive fermentation isolates into clade A and B, respectively. The L. pentosus autochthonous clade partitions into subclades A.I, A.II, and A.III, suggesting substantial intraspecies diversity in the cucumber fermentation habitat. The hypervariable sequences within CRISPR arrays revealed recent evolutionary history, which aligns with the L. pentosus subclades identified in the phylogenetic trees constructed. While L. plantarum autochthonous to cucumber fermentation only encode for Type II-A CRISPR arrays, autochthonous L. pentosus clade B codes for Type I-E and L. pentosus clade A hosts both types of arrays. L. pentosus 7.8.2, for which phylogeny could not be defined using the varied methods employed, was found to uniquely encode for four distinct Type I-E CRISPR arrays and a Type II-A array. Prophage sequences in varied isolates evidence the presence of adaptive immunity in the candidate starter cultures isolated from vegetable fermentation as observed in dairy counterparts. This study provides insight into the genomic features of industrial Lactiplantibacillus species, the level of species differentiation in a vegetable fermentation habitat, and diversity profile of relevance in the selection of functional starter cultures.}, number={13}, journal={FOODS}, author={Page, Clinton A. and Perez-Diaz, Ilenys M. and Pan, Meichen and Barrangou, Rodolphe}, year={2023}, month={Jul} } @article{o'flaherty_cobian_barrangou_2023, title={Impact of Pomegranate on Probiotic Growth, Viability, Transcriptome and Metabolism}, volume={11}, ISSN={["2076-2607"]}, url={https://doi.org/10.3390/microorganisms11020404}, DOI={10.3390/microorganisms11020404}, abstractNote={Despite rising interest in understanding intestinal bacterial survival in situ, relatively little attention has been devoted to deciphering the interaction between bacteria and functional food ingredients. Here, we examined the interplay between diverse beneficial Lactobacillaceae species and a pomegranate (POM) extract and determined the impact of this functional ingredient on bacterial growth, cell survival, transcription and target metabolite genesis. Three commercially available probiotic strains (Lactobacillus acidophilus NCFM, Lacticaseibacillus rhamnosus GG and Lactiplantibacillus plantarum Lp-115) were used in growth assays and flow cytometry analysis, indicating differential responses to the presence of POM extract across the three strains. The inclusion of POM extract in the growth medium had the greatest impact on L. acidophilus cell counts. LIVE/DEAD staining determined significantly fewer dead cells when L. acidophilus was grown with POM extract compared to the control with no POM (1.23% versus 7.23%). Whole-transcriptome analysis following exposure to POM extract showed markedly different global transcriptome responses, with 15.88% of the L. acidophilus transcriptome, 19.32% of the L. rhamnosus transcriptome and only 2.37% of the L. plantarum transcriptome differentially expressed. We also noted strain-dependent metabolite concentrations in the medium with POM extract compared to the control medium for punicalagin, ellagic acid and gallic acid. Overall, the results show that POM extract triggers species-specific responses by probiotic strains and substantiates the rising interest in using POM as a prebiotic compound.}, number={2}, journal={MICROORGANISMS}, author={O'Flaherty, Sarah and Cobian, Natalia and Barrangou, Rodolphe}, year={2023}, month={Feb} } @article{raftopoulou_barrangou_2023, title={Mining microbial organisms to discover and characterize novel CRISPR-Cas systems}, volume={27}, ISSN={["2468-4511"]}, url={https://doi.org/10.1016/j.cobme.2023.100469}, DOI={10.1016/j.cobme.2023.100469}, abstractNote={The need for new genome manipulation tools is leading the way for the continued discovery of novel clustered regularly interspaced short palindromic repeats— CRISPR associated sequences (CRISPR-Cas) systems. Researchers have been analyzing the genomes of prokaryotes and more recently metagenomic sequencing data to find novel and diverse CRISPR-Cas systems and their associated genome editing effectors. In this review, we provide an overview of in silico, in vitro, and in vivo analyses performed to characterize key elements of CRISPR-Cas systems, encompassing the CRISPR array, Cas proteins, guide ribonucleic acid (RNAs), and protospacer-adjacent motif (PAM) which defines targeting. We also highlight subsequent in vitro and in vivo assays employed to validate CRISPR function and Cas effector activity in the context of genome editing in various cellular contexts.}, journal={CURRENT OPINION IN BIOMEDICAL ENGINEERING}, author={Raftopoulou, Ourania and Barrangou, Rodolphe}, year={2023}, month={Sep} } @article{sulis_jiang_yang_marques_matthews_miller_lan_cofre-vega_liu_sun_et al._2023, title={Multiplex CRISPR editing of wood for sustainable fiber production}, volume={381}, ISSN={["1095-9203"]}, url={http://europepmc.org/abstract/med/37440632}, DOI={10.1126/science.add4514}, abstractNote={The domestication of forest trees for a more sustainable fiber bioeconomy has long been hindered by the complexity and plasticity of lignin, a biopolymer in wood that is recalcitrant to chemical and enzymatic degradation. Here, we show that multiplex CRISPR editing enables precise woody feedstock design for combinatorial improvement of lignin composition and wood properties. By assessing every possible combination of 69,123 multigenic editing strategies for 21 lignin biosynthesis genes, we deduced seven different genome editing strategies targeting the concurrent alteration of up to six genes and produced 174 edited poplar variants. CRISPR editing increased the wood carbohydrate-to-lignin ratio up to 228% that of wild type, leading to more-efficient fiber pulping. The edited wood alleviates a major fiber-production bottleneck regardless of changes in tree growth rate and could bring unprecedented operational efficiencies, bioeconomic opportunities, and environmental benefits.}, number={6654}, journal={SCIENCE}, author={Sulis, Daniel B. and Jiang, Xiao and Yang, Chenmin and Marques, Barbara M. and Matthews, Megan L. and Miller, Zachary and Lan, Kai and Cofre-Vega, Carlos and Liu, Baoguang and Sun, Runkun and et al.}, year={2023}, month={Jul}, pages={216-+} } @article{pyhtila_kasowitz_leeson_barrangou_2023, title={The Expanding Dissemination and Distribution Patterns of Diverse CRISPR Plasmids by Addgene}, volume={11}, ISSN={["2573-1602"]}, url={https://doi.org/10.1089/crispr.2023.0059}, DOI={10.1089/crispr.2023.0059}, abstractNote={CRISPR-based technologies have rapidly enabled the democratization of genome editing in academic institutions through distribution by Addgene over the past decade. Recently, several distribution milestones have been reached, with a collection of >15,000 plasmids deposited by >1,000 laboratories spanning ∼40 countries now shipped 300,000 times to ∼5,000 organizations traversing ∼100 countries. Yet, both deposits of and requests for CRISPR plasmids continue to rise for this disruptive technology. Distribution patterns revealed robust demand for three distinct classes of CRISPR effectors, namely nucleases (e.g., Cas9 and Cas12), modulators (deactivated CRISPR nucleases fused to transcriptional regulators and epigenome modifiers), and chimeric effectors (Cas proteins fused to enzymes carrying out other activities such as deamination, reverse transcription, transposition, and integration). Yearly deposits over the past decade are requested in near-even proportions, reflecting continuous technological development and requests for novel constructs. Though it is unclear whether the slowing rate of requests is inherent to a pandemic operational lag or a transition from emerging to mature technology, it is noteworthy that the relative proportion of requests from plasmids deposited in the previous year remains stable, suggesting robust development of novel tools concurrent with continued adoption of editing, base editing, prime editing, and more. Predictably, most requested plasmids are designed for mammalian genome manipulation, presumably for medical research and human health pursuits, reflecting investments in therapeutic applications. Concurrently, requests for plant and microbial constructs are on the rise, especially in regions of the world more reliant on local agricultural inputs and focused on food and feed applications, illustrating continued diversification of genome editing applications.}, journal={CRISPR JOURNAL}, author={Pyhtila, Brook and Kasowitz, Seth and Leeson, Rachel and Barrangou, Rodolphe}, year={2023}, month={Nov} } @article{adler_hessler_cress_lahiri_mutalik_barrangou_banfield_doudna_2022, title={Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing}, volume={10}, ISSN={["2058-5276"]}, url={https://doi.org/10.1038/s41564-022-01258-x}, DOI={10.1038/s41564-022-01258-x}, abstractNote={Abstract CRISPR-Cas13 proteins are RNA-guided RNA nucleases that defend against incoming RNA and DNA phages by binding to complementary target phage transcripts followed by general, non-specific RNA degradation. Here we analysed the defensive capabilities of LbuCas13a from Leptotrichia buccalis and found it to have robust antiviral activity unaffected by target phage gene essentiality, gene expression timing or target sequence location. Furthermore, we find LbuCas13a antiviral activity to be broadly effective against a wide range of phages by challenging LbuCas13a against nine E. coli phages from diverse phylogenetic groups. Leveraging the versatility and potency enabled by LbuCas13a targeting, we applied LbuCas13a towards broad-spectrum phage editing. Using a two-step phage-editing and enrichment method, we achieved seven markerless genome edits in three diverse phages with 100% efficiency, including edits as large as multi-gene deletions and as small as replacing a single codon. Cas13a can be applied as a generalizable tool for editing the most abundant and diverse biological entities on Earth.}, journal={NATURE MICROBIOLOGY}, author={Adler, Benjamin A. and Hessler, Tomas and Cress, Brady F. and Lahiri, Arushi and Mutalik, Vivek K. and Barrangou, Rodolphe and Banfield, Jillian and Doudna, Jennifer A.}, year={2022}, month={Oct} } @article{nethery_hidalgo-cantabrana_roberts_barrangou_2022, title={CRISPR-based engineering of phages for in situ bacterial base editing}, volume={119}, ISSN={["1091-6490"]}, url={https://doi.org/10.1073/pnas.2206744119}, DOI={10.1073/pnas.2206744119}, abstractNote={Investigation of microbial gene function is essential to the elucidation of ecological roles and complex genetic interactions that take place in microbial communities. While microbiome studies have increased in prevalence, the lack of viable in situ editing strategies impedes experimental progress, rendering genetic knowledge and manipulation of microbial communities largely inaccessible. Here, we demonstrate the utility of phage-delivered CRISPR-Cas payloads to perform targeted genetic manipulation within a community context, deploying a fabricated ecosystem (EcoFAB) as an analog for the soil microbiome. First, we detail the engineering of two classical phages for community editing using recombination to replace nonessential genes through Cas9-based selection. We show efficient engineering of T7, then demonstrate the expression of antibiotic resistance and fluorescent genes from an engineered λ prophage within an Escherichia coli host. Next, we modify λ to express an APOBEC-1-based cytosine base editor (CBE), which we leverage to perform C-to-T point mutations guided by a modified Cas9 containing only a single active nucleolytic domain (nCas9). We strategically introduce these base substitutions to create premature stop codons in-frame, inactivating both chromosomal ( lacZ ) and plasmid-encoded genes (mCherry and ampicillin resistance) without perturbation of the surrounding genomic regions. Furthermore, using a multigenera synthetic soil community, we employ phage-assisted base editing to induce host-specific phenotypic alterations in a community context both in vitro and within the EcoFAB, observing editing efficiencies from 10 to 28% across the bacterial population. The concurrent use of a synthetic microbial community, soil matrix, and EcoFAB device provides a controlled and reproducible model to more closely approximate in situ editing of the soil microbiome.}, number={46}, journal={PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA}, author={Nethery, Matthew A. and Hidalgo-Cantabrana, Claudio and Roberts, Avery and Barrangou, Rodolphe}, year={2022}, month={Nov} } @article{monte_nethery_berman_keelara_lincopan_fedorka-cray_barrangou_landgraf_2022, title={Clustered Regularly Interspaced Short Palindromic Repeats Genotyping of Multidrug-Resistant Salmonella Heidelberg Strains Isolated From the Poultry Production Chain Across Brazil}, volume={13}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2022.867278}, abstractNote={Salmonella enterica subsp. enterica serovar Heidelberg has been associated with a broad host range, such as poultry, dairy calves, swine, wild birds, environment, and humans. The continuous evolution of S . Heidelberg raises a public health concern since there is a global dispersal of lineages harboring a wide resistome and virulome on a global scale. Here, we characterized the resistome, phylogenetic structure and clustered regularly interspaced short palindromic repeats (CRISPR) array composition of 81 S . Heidelberg strains isolated from broiler farms ( n = 16), transport and lairage ( n = 5), slaughterhouse ( n = 22), and retail market ( n = 38) of the poultry production chain in Brazil, between 2015 and 2016 using high-resolution approaches including whole-genome sequencing (WGS) and WGS-derived CRISPR genotyping. More than 91% of the S . Heidelberg strains were multidrug-resistant. The total antimicrobial resistance (AMR) gene abundances did not vary significantly across regions and sources suggesting the widespread distribution of antibiotic-resistant strains from farm to market. The highest AMR gene abundance was observed for fosA7 , aac(6′)-Iaa , sul2 , tet(A) , gyrA , and parC for 100% of the isolates, followed by 88.8% for bla CMY –2 . The β-lactam resistance was essentially driven by the presence of the plasmid-mediated AmpC (pAmpC) bla CMY –2 gene, given the isolates which did not carry this gene were susceptible to cefoxitin (FOX). Most S . Heidelberg strains were classified within international lineages, which were phylogenetically nested with Salmonella strains from European countries; while CRISPR genotyping analysis revealed that the spacer content was overall highly conserved, but distributed into 13 distinct groups. In summary, our findings underscore the potential role of S . Heidelberg as a key pathogen disseminated from farm to fork in Brazil and reinforce the importance of CRISPR-based genotyping for salmonellae. Hence, we emphasized the need for continuous mitigation programs to monitor the dissemination of this high-priority pathogen.}, journal={FRONTIERS IN MICROBIOLOGY}, author={Monte, Daniel F. M. and Nethery, Matthew A. and Berman, Hanna and Keelara, Shivaramu and Lincopan, Nilton and Fedorka-Cray, Paula J. and Barrangou, Rodolphe and Landgraf, Mariza}, year={2022}, month={Jun} } @article{roberts_nethery_barrangou_2022, title={Functional characterization of diverse type I-F CRISPR-associated transposons}, volume={11}, ISSN={["1362-4962"]}, url={https://doi.org/10.1093/nar/gkac985}, DOI={10.1093/nar/gkac985}, abstractNote={CRISPR-Cas systems generally provide adaptive immunity in prokaryotes through RNA-guided degradation of foreign genetic elements like bacteriophages and plasmids. Recently, however, transposon-encoded and nuclease-deficient CRISPR-Cas systems were characterized and shown to be co-opted by Tn7-like transposons for CRISPR RNA-guided DNA transposition. As a genome engineering tool, these CRISPR-Cas systems and their associated transposon proteins can be deployed for programmable, site-specific integration of sizable cargo DNA, circumventing the need for DNA cleavage and homology-directed repair involving endogenous repair machinery. Here, we selected a diverse set of type I-F3 CRISPR-associated transposon systems derived from Gammaproteobacteria, predicted all components essential for transposition activity, and deployed them for functionality testing within Escherichia coli. Our results demonstrate that these systems possess a significant range of integration efficiencies with regards to temperature, transposon size, and flexible PAM requirements. Additionally, our findings support the categorization of these systems into functional compatibility groups for efficient and orthogonal RNA-guided DNA integration. This work expands the CRISPR-based toolbox with new CRISPR RNA-guided DNA integrases that can be applied to complex and extensive genome engineering efforts.}, journal={NUCLEIC ACIDS RESEARCH}, author={Roberts, Avery and Nethery, Matthew A. and Barrangou, Rodolphe}, year={2022}, month={Nov} } @article{pan_morovic_hidalgo-cantabrana_roberts_walden_goh_barrangou_2022, title={Genomic and epigenetic landscapes drive CRISPR-based genome editing in Bifidobacterium}, volume={119}, ISSN={["1091-6490"]}, url={https://doi.org/10.1073/pnas.2205068119}, DOI={10.1073/pnas.2205068119}, abstractNote={Bifidobacterium is a commensal bacterial genus ubiquitous in the human gastrointestinal tract, which is associated with a range of health benefits. The advent of CRISPR-based genome editing technologies provides opportunities to investigate the genetics of important bacteria and transcend the lack of genetic tools in bifidobacteria to study the basis for their health-promoting attributes. Here, we repurpose the endogenous type I-G CRISPR-Cas system and adopt an exogenous CRISPR base editor for genome engineering in B. animalis subsp. lactis, demonstrating that both genomic and epigenetic contexts drive editing outcomes across strains. We reprogrammed the endogenous type I-G system to screen for naturally occurring large deletions up to 27 kb and to generate a 500-bp deletion in tetW to abolish tetracycline resistance. A CRISPR-cytosine base editor was optimized to install C•G-to-T•A amber mutations to resensitize multiple B. lactis strains to tetracycline. Remarkably, we uncovered epigenetic patterns that are distributed unevenly among B. lactis strains, despite their genomic homogeneity, that may contribute to editing efficiency variability. Insights were also expanded to Bifidobacterium longum subsp. infantis to emphasize the broad relevance of these findings. This study highlights the need to develop individualized CRISPR-based genome engineering approaches for distinct bacterial strains and opens avenues for engineering of next generation probiotics.}, number={30}, journal={PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA}, author={Pan, Meichen and Morovic, Wesley and Hidalgo-Cantabrana, Claudio and Roberts, Avery and Walden, Kimberly K. O. and Goh, Yong Jun and Barrangou, Rodolphe}, year={2022}, month={Jul} } @article{chamberlain_o'flaherty_cobian_barrangou_2022, title={Metabolomic Analysis of Lactobacillus acidophilus, L. gasseri, L. crispatus, and Lacticaseibacillus rhamnosus Strains in the Presence of Pomegranate Extract}, volume={13}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2022.863228}, abstractNote={Lactobacillus species are prominent inhabitants of the human gastrointestinal tract that contribute to maintaining a balanced microbial environment that positively influences host health. These bacterial populations can be altered through use of probiotic supplements or via dietary changes which in turn affect the host health. Utilizing polyphenolic compounds to selectively stimulate the growth of commensal bacteria can have a positive effect on the host through the production of numerous metabolites that are biologically active. Four Lactobacillus strains were grown in the presence of pomegranate (POM) extract. Two strains, namely, L. acidophilus NCFM and L. rhamnosus GG, are commonly used probiotics, while the other two strains, namely, L. crispatus NCK1351 and L. gasseri NCK1342, exhibit probiotic potential. To compare and contrast the impact of POM on the strains' metabolic capacity, we investigated the growth of the strains with and without the presence of POM and identified their carbohydrate utilization and enzyme activity profiles. To further investigate the differences between strains, an untargeted metabolomic approach was utilized to quantitatively and qualitatively define the metabolite profiles of these strains. Several metabolites were produced significantly and/or exclusively in some of the strains, including mevalonate, glutamine, 5-aminoimidazole-4-carboxamide, phenyllactate, and fumarate. The production of numerous discrete compounds illustrates the unique characteristics of and diversity between strains. Unraveling these differences is essential to understand the probiotic function and help inform strain selection for commercial product formulation.}, journal={FRONTIERS IN MICROBIOLOGY}, author={Chamberlain, MaryClaire and O'Flaherty, Sarah and Cobian, Natalia and Barrangou, Rodolphe}, year={2022}, month={May} } @article{barrangou_2022, title={Next-Generation Foods and CRISPR Engineering}, url={https://doi.org/10.52750/106366}, DOI={10.52750/106366}, abstractNote={The advent of CRISPR-based technologies has revolutionized our ability to manipulate the genomes of virtually every entity across the tree of life.Besides the tremendous progress in the medical applications of CRISPR technologies for gene therapies and cell engineering in the clinic, there are tremendous opportunities to exploit genome editing for food and agriculture.Indeed, breeding of crops and livestock can address grand challenges for our food supply chain and revolutionize agriculture at a time when resources are scarce and sustainability is crucial.Rodolphe Barrangou, Ph.D., discusses how genome editing is opening new avenues for a more sustainable agriculture.Barrangou is the T.R. Klaenhammer Distinguished professor at NC State.He is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria.Barrangou spent nine years in research and development, and mergers and acquisitions at Danisco and DuPont.}, author={Barrangou, Rodolphe}, year={2022}, month={Aug} } @article{adler_hessler_cress_mutalik_barrangou_banfield_doudna_2022, title={RNA-targeting CRISPR-Cas13 Provides Broad-spectrum Phage Immunity}, volume={3}, url={https://doi.org/10.1101/2022.03.25.485874}, DOI={10.1101/2022.03.25.485874}, abstractNote={Abstract CRISPR-Cas13 proteins are RNA-guided RNA nucleases that defend against invasive phages through general, non-specific RNA degradation upon complementary target transcript binding. Despite being RNA nucleases, Cas13 effectors are capable of inhibiting the infection of dsDNA phages but have only been investigated across a relatively small sampling of phage diversity. Here, we employ a systematic, phage-centric approach to determine the anti-phage capacity of Cas13 and find LbuCas13a to be a remarkably potent phage inhibitor. LbuCas13a confers robust, consistent antiviral activity regardless of gene essentiality, gene expression timing or target sequence location. Furthermore, after challenging LbuCas13a with eight diverse E. coli phages distributed across E. coli phage phylogenetic groups, we find no apparent phage-encoded limits to its potent antiviral activity. In contrast to other Class 2 CRISPR-Cas proteins, these results suggest that DNA phages are generally vulnerable to Cas13a targeting. Leveraging this effective anti-phage activity, LbuCas13a can be used seamlessly as a counter-selection agent for broad-spectrum phage editing. Using a two-step phage editing and enrichment approach, we show that LbuCas13a enables markerless genome edits in phages with exceptionally high efficiency and precision, including edits as small as a single codon. By taking advantage of the broad vulnerability of RNA during viral infection, Cas13a enables a generalizable strategy for editing the most abundant and diverse biological entities on Earth.}, publisher={Cold Spring Harbor Laboratory}, author={Adler, Benjamin A. and Hessler, Tomas and Cress, Brady F and Mutalik, Vivek K. and Barrangou, Rodolphe and Banfield, Jillian and Doudna, Jennifer A}, year={2022}, month={Mar} } @article{barrangou_marraffini_2022, title={Turning CRISPR on with antibiotics}, volume={30}, ISSN={["1934-6069"]}, DOI={10.1016/j.chom.2021.12.013}, abstractNote={CRISPR-Cas systems have the ability to integrate invasive DNA sequences to build adaptive immunity in bacteria. In this issue Dimitriu et al. show bacteriostatic antibiotics prompt CRISPR acquisition events, illustrating how environmental conditions affect complex dynamics between host and virus and the corresponding biological and genetic arms race.}, number={1}, journal={CELL HOST & MICROBE}, author={Barrangou, Rodolphe and Marraffini, Luciano A.}, year={2022}, month={Jan}, pages={12–14} } @article{kuiken_barrangou_grieger_2021, title={(Broken) Promises of Sustainable Food and Agriculture through New Biotechnologies: The CRISPR Case}, volume={4}, ISSN={["2573-1602"]}, DOI={10.1089/crispr.2020.0098}, abstractNote={In recent years, the development of diverse CRISPR-based technologies has revolutionized genome manipulation and enabled a broad scientific community in industry, academia, and beyond to redefine research and development for biotechnology products encompassing food, agriculture, and medicine. CRISPR-based genome editing affords tremendous opportunities in agriculture for the breeding of crops and livestock across the food supply chain that could benefit larger portions of the population compared to CRISPR applications in medicine, for example by helping to feed a growing global population, reach sustainability goals, and possibly mitigate the effects of climate change. These promises come alongside concerns of risks and adverse impacts associated with CRISPR-based genome editing and concerns that governance systems that are ill equipped or not well suited to evaluate these risks. The international community will continue to gather, in multiple venues, in the coming years to discuss these concerns. At the same time, responsible research and innovation paradigms also promise to evaluate the risks and benefits better while incorporating broad stakeholder engagement across the research and development process. The CRISPR community therefore must actively engage with these international deliberations, society, and national governance systems that have promised to build better agricultural systems and provide better food products to achieve equitable outcomes while protecting the environment. Without this active engagement, the promises discussed in this paper are sure to be broken.}, number={1}, journal={CRISPR JOURNAL}, author={Kuiken, Todd and Barrangou, Rodolphe and Grieger, Khara}, year={2021}, month={Feb}, pages={25–31} } @article{mcclements_barrangou_hill_kokini_lila_meyer_yu_2021, title={Building a Resilient, Sustainable, and Healthier Food Supply Through Innovation and Technology}, volume={12}, ISSN={["1941-1421"]}, DOI={10.1146/annurev-food-092220-030824}, abstractNote={The modern food supply faces many challenges. The global population continues to grow and people are becoming wealthier, so the food production system must respond by creating enough high-quality food to feed everyone with minimal damage to our environment. The number of people suffering or dying from diet-related chronic diseases, such as obesity, diabetes, heart disease, stroke, and cancer, continues to rise, which is partly linked to overconsumption of highly processed foods, especially high-calorie or rapidly digestible foods. After falling for many years, the number of people suffering from starvation or malnutrition is rising, and thishas been exacerbated by the global COVID-19 pandemic. The highly integrated food supply chains that spread around the world are susceptible to disruptions due to policy changes, economic stresses, and natural disasters, as highlighted by the recent pandemic. In this perspective article, written by members of the Editorial Committee of the Annual Review of Food Science and Technology, we highlight some of the major challenges confronting the modern food supply chain as well as how innovations in policy and technology can be used to address them. Pertinent technological innovations include robotics, machine learning, artificial intelligence, advanced diagnostics, nanotechnology, biotechnology, gene editing, vertical farming, and soft matter physics. Many of these technologies are already being employed across the food chain by farmers, distributors, manufacturers, and consumers to improve the quality, nutrition, safety, and sustainability of the food supply. These innovations are required to stimulate the development and implementation of new technologies to ensure a more equitable, resilient, and efficient food production system. Where appropriate, these technologies should be carefully tested before widespread implementation so that proper risk–benefit analyses can be carried out. They can then be employed without causing unforeseen adverse consequences. Finally, it is important to actively engage all stakeholders involved in the food supply chain throughout the development and testing of these new technologies to support their adoption if proven safe and effective.}, journal={ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 12, 2021}, author={McClements, David Julian and Barrangou, Rodolphe and Hill, Colin and Kokini, Jozef L. and Lila, Mary Ann and Meyer, Anne S. and Yu, Liangli}, year={2021}, pages={1–28} } @article{nethery_korvink_makarova_wolf_v. koonin_barrangou_2021, title={CRISPRclassify: Repeat-Based Classification of CRISPR Loci}, volume={4}, ISSN={["2573-1602"]}, DOI={10.1089/crispr.2021.0021}, abstractNote={Detection and classification of CRISPR-Cas systems in metagenomic data have become increasingly prevalent in recent years due to their potential for diverse applications in genome editing. Traditionally, CRISPR-Cas systems are classified through reference-based identification of proximate cas genes. Here, we present a machine learning approach for the detection and classification of CRISPR loci using repeat sequences in a cas-independent context, enabling identification of unclassified loci missed by traditional cas-based approaches. Using biological attributes of the CRISPR repeat, the core element in CRISPR arrays, and leveraging methods from natural language processing, we developed a machine learning model capable of accurate classification of CRISPR loci in an extensive set of metagenomes, resulting in an F1 measure of 0.82 across all predictions and an F1 measure of 0.97 when limiting to classifications with probabilities >0.85. Furthermore, assessing performance on novel repeats yielded an F1 measure of 0.96. Although the performance of cas-based identification will exceed that of a repeat-based approach in many cases, CRISPRclassify provides an efficient approach to classification of CRISPR loci for cases in which cas gene information is unavailable, such as metagenomes and fragmented genome assemblies.}, number={4}, journal={CRISPR JOURNAL}, author={Nethery, Matthew A. and Korvink, Michael and Makarova, Kira S. and Wolf, Yuri I. and V. Koonin, Eugene and Barrangou, Rodolphe}, year={2021}, month={Aug}, pages={558–574} } @article{cobian_garlet_hidalgo-cantabrana_barrangou_2021, title={Comparative Genomic Analyses and CRISPR-Cas Characterization of Cutibacterium acnes Provide Insights Into Genetic Diversity and Typing Applications}, volume={12}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2021.758749}, abstractNote={is an important member of the human skin microbiome and plays a critical role in skin health and disease.}, journal={FRONTIERS IN MICROBIOLOGY}, author={Cobian, Natalia and Garlet, Allison and Hidalgo-Cantabrana, Claudio and Barrangou, Rodolphe}, year={2021}, month={Nov} } @article{goh_barrangou_klaenhammer_2021, title={In Vivo Transcriptome of Lactobacillus acidophilus and Colonization Impact on Murine Host Intestinal Gene Expression}, volume={12}, ISSN={["2150-7511"]}, url={https://doi.org/10.1128/mBio.03399-20}, DOI={10.1128/mBio.03399-20}, abstractNote={Lactobacillus acidophilus NCFM is a probiotic strain commonly used in dairy products and dietary supplements. Postgenome in vitro studies of NCFM thus far have linked potential key genotypes to its probiotic-relevant attributes, including gut survival, prebiotic utilization, host interactions, and immunomodulatory activities. To corroborate and extend beyond previous in vivo and in vitro functional studies, we employed a dual RNA sequencing (RNA-seq) transcriptomic approach to identify genes potentially driving the gut fitness and activities of L. acidophilus NCFM in vivo, and in parallel, examine the ileal transcriptional response of its murine hosts during monocolonization. Spatial expression profiling of NCFM from the ileum through the colon revealed a set of 134 core genes that were consistently overexpressed during gut transit. These in vivo core genes are predominantly involved in the metabolism of carbohydrates, amino acids, and nucleotides, along with mucus-binding proteins and adhesion factors, confirming their functionally important roles in nutrient acquisition and gut retention. Functional characterization of the highly expressed major S-layer-encoding gene established its indispensable role as a cell shape determinant and maintenance of cell surface integrity, essential for viability and probiotic attributes. Host colonization by L. acidophilus resulted in significant downregulation of several proinflammatory cytokines and tight junction proteins. Genes related to redox signaling, mucin glycosylation, and circadian rhythm modulation were induced, suggesting impacts on intestinal development and immune functions. Metagenomic analysis of NCFM populations postcolonization demonstrated the genomic stability of L. acidophilus as a gut transient and further established its safety as a probiotic and biotherapeutic delivery platform.IMPORTANCE To date, our basis for comprehending the probiotic mechanisms of Lactobacillus acidophilus, one of the most widely consumed probiotic microbes, was largely limited to in vitro functional genomic studies. Using a germfree murine colonization model, in vivo-based transcriptional studies provided the first view of how L. acidophilus survives in the mammalian gut environment, including gene expression patterns linked to survival, efficient nutrient acquisition, stress adaptation, and host interactions. Examination of the host ileal transcriptional response, the primary effector site of L. acidophilus, has also shed light into the mechanistic roles of this probiotic microbe in promoting anti-inflammatory responses, maintaining intestinal epithelial homeostasis and modulation of the circadian-metabolic axis in its host.}, number={1}, journal={MBIO}, publisher={American Society for Microbiology}, author={Goh, Yong Jun and Barrangou, Rodolphe and Klaenhammer, Todd R.}, editor={Huffnagle, Gary B.Editor}, year={2021} } @article{foley_o'flaherty_allen_rivera_stewart_barrangou_theriot_2021, title={Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization}, volume={118}, ISSN={["1091-6490"]}, url={https://doi.org/10.1073/pnas.2017709118}, DOI={10.1073/pnas.2017709118}, abstractNote={Significance The transformation of bile acids (BAs) by the gut microbiota is increasingly recognized as an important factor shaping host health. The prerequisite step of BA metabolism is carried out by bile salt hydrolases (BSHs), which are encoded by select gut and probiotic bacteria. Despite their prevalence, the utility of harboring a bsh is unclear. Here, we investigate the role of BSHs encoded by Lactobacillus acidophilus and Lactobacillus gasseri . We show that BA type and BSH substrate preferences affect in vitro and in vivo growth of both species. These findings contribute to a mechanistic understanding of bacterial survival in various BA-rich niches and inform future efforts to leverage BSHs as a therapeutic tool for manipulating the gut microbiota.}, number={6}, journal={PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA}, publisher={Proceedings of the National Academy of Sciences}, author={Foley, Matthew H. and O'Flaherty, Sarah and Allen, Garrison and Rivera, Alissa J. and Stewart, Allison K. and Barrangou, Rodolphe and Theriot, Casey M.}, year={2021}, month={Feb} } @article{goh_barrangou_2021, title={Portable CRISPR-Cas9(N) System for Flexible Genome Engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei}, volume={87}, ISSN={["1098-5336"]}, url={https://doi.org/10.1128/AEM.02669-20}, DOI={10.1128/AEM.02669-20}, abstractNote={This work describes the development of a lactobacillus CRISPR-based editing system for genome manipulations in three Lactobacillus species belonging to the lactic acid bacteria (LAB), which are commonly known for their long history of use in food fermentations and as indigenous members of healthy microbiotas and for their emerging roles in human and animal commercial health-promoting applications. We exploited the established CRISPR-SpyCas9 nickase for flexible and precise genome editing applications in Lactobacillus acidophilus and further demonstrated the efficacy of this universal system in two distantly related Lactobacillus species.}, number={6}, journal={APPLIED AND ENVIRONMENTAL MICROBIOLOGY}, publisher={American Society for Microbiology}, author={Goh, Yong Jun and Barrangou, Rodolphe}, editor={Dudley, Edward G.Editor}, year={2021}, month={Mar} } @article{rubin_diamond_cress_crits-christoph_lou_borges_shivram_he_xu_zhou_et al._2021, title={Species- and site-specific genome editing in complex bacterial communities}, volume={12}, ISSN={["2058-5276"]}, DOI={10.1038/s41564-021-01014-7}, abstractNote={Understanding microbial gene functions relies on the application of experimental genetics in cultured microorganisms. However, the vast majority of bacteria and archaea remain uncultured, precluding the application of traditional genetic methods to these organisms and their interactions. Here, we characterize and validate a generalizable strategy for editing the genomes of specific organisms in microbial communities. We apply environmental transformation sequencing (ET-seq), in which nontargeted transposon insertions are mapped and quantified following delivery to a microbial community, to identify genetically tractable constituents. Next, DNA-editing all-in-one RNA-guided CRISPR-Cas transposase (DART) systems for targeted DNA insertion into organisms identified as tractable by ET-seq are used to enable organism- and locus-specific genetic manipulation in a community context. Using a combination of ET-seq and DART in soil and infant gut microbiota, we conduct species- and site-specific edits in several bacteria, measure gene fitness in a nonmodel bacterium and enrich targeted species. These tools enable editing of microbial communities for understanding and control.}, journal={NATURE MICROBIOLOGY}, author={Rubin, Benjamin E. and Diamond, Spencer and Cress, Brady F. and Crits-Christoph, Alexander and Lou, Yue Clare and Borges, Adair L. and Shivram, Haridha and He, Christine and Xu, Michael and Zhou, Zeyi and et al.}, year={2021}, month={Dec} } @article{barrangou_hill_2021, title={Todd R. Klaenhammer, an inspirational food microbiologist who leaves a lasting legacy}, volume={118}, ISSN={["0027-8424"]}, url={https://doi.org/10.1073/pnas.2107754118}, DOI={10.1073/pnas.2107754118}, abstractNote={Pesticidal proteins from bacteria, such as Bacillus thuringiensis and Lysinibacillus sphaericus, are widely used as biocontrol agents against various mosquito vectors of human disease. Tpp49Aa1/Cry48Aa1 from L. sphaericus are required as a ...The Lysinibacillus sphaericus proteins Tpp49Aa1 and Cry48Aa1 can together act as a toxin toward the mosquito Culex quinquefasciatus and have potential use in biocontrol. Given that proteins with sequence homology to the individual proteins can have ...}, number={22}, journal={PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA}, publisher={Proceedings of the National Academy of Sciences}, author={Barrangou, Rodolphe and Hill, Colin}, year={2021}, month={Jun} } @article{yu_xue_barrangou_chen_huang_2021, title={Toward inclusive global governance of human genome editing}, volume={118}, ISSN={["1091-6490"]}, url={https://doi.org/10.1073/pnas.2118540118}, DOI={10.1073/pnas.2118540118}, abstractNote={Pesticidal proteins from bacteria, such as Bacillus thuringiensis and Lysinibacillus sphaericus, are widely used as biocontrol agents against various mosquito vectors of human disease. Tpp49Aa1/Cry48Aa1 from L. sphaericus are required as a ...The Lysinibacillus sphaericus proteins Tpp49Aa1 and Cry48Aa1 can together act as a toxin toward the mosquito Culex quinquefasciatus and have potential use in biocontrol. Given that proteins with sequence homology to the individual proteins can have ...}, number={47}, journal={PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA}, author={Yu, Hanzhi and Xue, Lan and Barrangou, Rodolphe and Chen, Shaowei and Huang, Ying}, year={2021}, month={Nov} } @article{monte_nethery_barrangou_landgraf_fedorka-cray_2021, title={Whole-genome sequencing analysis and CRISPR genotyping of rare antibiotic-resistant Salmonella enterica serovars isolated from food and related sources}, volume={93}, ISSN={["1095-9998"]}, DOI={10.1016/j.fm.2020.103601}, abstractNote={For decades, Salmonella Typhimurium and Salmonella Enteritidis have prevailed in several countries as agents of salmonellosis outbreaks. In Brazil, the largest exporter of poultry meat, relatively little attention has been paid to infrequent serovars. Here, we report the emergence and characterization of rare serovars isolated from food and related sources collected between 2014 and 2016 in Brazil. Twenty-two Salmonella enterica isolates were analyzed through the use of whole-genome sequencing (WGS) and clustered regularly interspaced short palindromic repeats (CRISPR) genotyping. These isolates were classified into 10 infrequent serovars, including S. Abony, S. Isangi, S. Rochdale, S. Saphra, S. Orion, S. Ouakam, S. Grumpensis, S. Carrau, S. Abaetetuba, and S. Idikan. The presence of six antimicrobial resistance (AMR) genes, qnrB19, blaCMY-2, tetA, aac(6')-Iaa, sul2 and fosA7, which encode resistance to quinolones, third-generation cephalosporin, tetracycline, aminoglycoside, sulfonamide and fosfomycin, respectively, were confirmed by WGS. All S. Isangi harbored qnrB19 with conserved genomic context across strains, while S. Abony harbored blaCMY-2. Twelve (54.5%) strains displayed chromosomal mutations in parC (Thr57→Ser). Most serovars were classified as independent lineages, except S. Abony and S. Abaetetuba, which phylogenetically nested with Salmonella strains from different countries. CRISPR analysis revealed that the spacer content was strongly correlated with serovar and multi-locus sequence type for all strains, independently confirming the observed phylogenetic patterns, and highlighting the value of CRISPR-based genotyping for Salmonella. These findings add valuable information to the epidemiology of S. enterica in Brazil, where the emergency of antibiotic-resistant Salmonella continues to evolve.}, journal={FOOD MICROBIOLOGY}, author={Monte, Daniel F. M. and Nethery, Matthew A. and Barrangou, Rodolphe and Landgraf, Mariza and Fedorka-Cray, Paula J.}, year={2021}, month={Feb} } @article{brandt_barrangou_2020, title={Adaptive response to iterative passages of five Lactobacillus species in simulated vaginal fluid}, volume={20}, url={https://doi.org/10.1186/s12866-020-02027-8}, DOI={10.1186/s12866-020-02027-8}, abstractNote={Abstract Background Microbiome and metagenomic studies have given rise to a new understanding of microbial colonization of various human tissues and their ability to impact our health. One human microbiome growing in notoriety, the vaginal microbiome, stands out given its importance for women’s health, and is peculiar in terms of its relative bacterial composition, including its simplicity and typical domination by a small number of Lactobacillus species. The loss of Lactobacillus dominance is associated with disorders such as bacterial vaginosis, and efforts are now underway to understand the ability of Lactobacillus species to colonize the vaginal tract and adapt to this dynamic and acidic environment. Here, we investigate how various Lactobacillus species often isolated from the vaginal and intestinal cavities genomically and transcriptionally respond to iterative growth in simulated vaginal fluid. Results We determined the genomes and transcriptomes of L. acidophilus, L. crispatus, L. fermentum, L. gasseri, and L. jensenii and compared profiles after 50, 100, 500, and 1000 generations of iterative passages in synthetic vaginal fluid. In general, we identified relatively few genetic changes consisting of single nucleotide polymorphisms, with higher counts occurring more frequently in non-vaginal isolated species. Transcriptional profiles were more impacted over time and tended to be more extensive for species that typically do not dominate the vaginal tract, reflecting a more extensive need to adapt to a less familiar environment. Conclusions This study provides insights into how vaginal and non-vaginal Lactobacillus species respond and adapt to a simulated vaginal environment. Overall, trends indicate high genomic stability for all species involved, with more variability in the transcriptome especially for non-dominant species of the vaginal tract.}, number={1}, journal={BMC Microbiology}, publisher={Springer Science and Business Media LLC}, author={Brandt, Katelyn and Barrangou, Rodolphe}, year={2020}, month={Dec} } @article{roberts_barrangou_2020, title={Applications of CRISPR-Cas systems in lactic acid bacteria}, volume={44}, url={https://doi.org/10.1093/femsre/fuaa016}, DOI={10.1093/femsre/fuaa016}, abstractNote={ABSTRACT As a phenotypically and phylogenetically diverse group, lactic acid bacteria are found in a variety of natural environments and occupy important roles in medicine, biotechnology, food and agriculture. The widespread use of lactic acid bacteria across these industries fuels the need for new and functionally diverse strains that may be utilized as starter cultures or probiotics. Originally characterized in lactic acid bacteria, CRISPR-Cas systems and derived molecular machines can be used natively or exogenously to engineer new strains with enhanced functional attributes. Research on CRISPR-Cas biology and its applications has exploded over the past decade with studies spanning from the initial characterization of CRISPR-Cas immunity in Streptococcus thermophilus to the use of CRISPR-Cas for clinical gene therapies. Here, we discuss CRISPR-Cas classification, overview CRISPR biology and mechanism of action, and discuss current and future applications in lactic acid bacteria, opening new avenues for their industrial exploitation and manipulation of microbiomes.}, number={5}, journal={FEMS Microbiology Reviews}, publisher={Oxford University Press (OUP)}, author={Roberts, Avery and Barrangou, Rodolphe}, year={2020}, month={Sep}, pages={523–537} } @article{barrangou_sontheimer_2020, title={CRISPR Shields: Fending Off Diverse Cas Nucleases with Nucleus-like Structures}, volume={77}, ISSN={["1097-4164"]}, DOI={10.1016/j.molcel.2020.02.015}, abstractNote={Two recent studies have uncovered a novel means by which bacteriophages thwart host immunity. Mendoza et al., 2020Mendoza S.D. Nieweglowska E.S. Govindarajan S. Leon L.M. Berry J.D. Tiwari A. Chaikeeratisak V. Pogliano J. Agard D.A. Bondy-Denomy J. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.Nature. 2020; 577: 244-248Crossref PubMed Scopus (71) Google Scholar and Malone et al., 2020Malone L.M. Warring S.L. Jackson S.A. Warnecke C. Gardner P.P. Gumy L.F. Fineran P.C. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.Nat. Microbiol. 2020; 5: 48-55Crossref PubMed Scopus (69) Google Scholar demonstrate that a nucleus-like proteinaceous structure shields phage DNA from CRISPR-associated nucleases encompassing Cascade-Cas3, Cas9, and Cas12. Two recent studies have uncovered a novel means by which bacteriophages thwart host immunity. Mendoza et al., 2020Mendoza S.D. Nieweglowska E.S. Govindarajan S. Leon L.M. Berry J.D. Tiwari A. Chaikeeratisak V. Pogliano J. Agard D.A. Bondy-Denomy J. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.Nature. 2020; 577: 244-248Crossref PubMed Scopus (71) Google Scholar and Malone et al., 2020Malone L.M. Warring S.L. Jackson S.A. Warnecke C. Gardner P.P. Gumy L.F. Fineran P.C. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.Nat. Microbiol. 2020; 5: 48-55Crossref PubMed Scopus (69) Google Scholar demonstrate that a nucleus-like proteinaceous structure shields phage DNA from CRISPR-associated nucleases encompassing Cascade-Cas3, Cas9, and Cas12. The dynamic arms race between prokaryotic hosts and viruses is well chronicled (Hampton et al., 2020Hampton H.G. Watson B.N.J. Fineran P.C. The arms race between bacteria and their phage foes.Nature. 2020; 577: 327-336Crossref PubMed Scopus (240) Google Scholar), especially with the recent addition of CRISPR-Cas adaptive immune systems (Makarova et al., 2020Makarova K.S. Wolf Y.I. Iranzo J. Shmakov S.A. Alkhnbashi O.S. Brouns S.J.J. Charpentier E. Cheng D. Haft D.H. Horvath P. et al.Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants..Nat. Rev. Microbiol. 2020; 18: 435-448Crossref Scopus (733) Google Scholar) and the subsequent discovery that bacteriophages deploy countermeasures enabling CRISPR escape or evasion (Hampton et al., 2020Hampton H.G. Watson B.N.J. Fineran P.C. The arms race between bacteria and their phage foes.Nature. 2020; 577: 327-336Crossref PubMed Scopus (240) Google Scholar, Stanley and Maxwell, 2018Stanley S.Y. Maxwell K.L. Phage-Encoded Anti-CRISPR Defenses.Annu. Rev. Genet. 2018; 52: 445-464Crossref PubMed Scopus (83) Google Scholar). The broad and diverse CRISPR-Cas arsenal featured in many bacteria and most archaea reflects the evolutionary value of this adaptive immune system, especially in protecting against widespread lytic bacteriophages. To cope with the range of CRISPR defense systems, several studies have revealed a plethora of bacteriophage escape mechanisms, encompassing anti-CRISPR inhibitors, recombination between genetically distinct genomes, and specific mutations at Cas nuclease binding and targeting sites. Now, expanding the CRISPR evasion menu, two studies (Mendoza et al., 2020Mendoza S.D. Nieweglowska E.S. Govindarajan S. Leon L.M. Berry J.D. Tiwari A. Chaikeeratisak V. Pogliano J. Agard D.A. Bondy-Denomy J. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.Nature. 2020; 577: 244-248Crossref PubMed Scopus (71) Google Scholar, Malone et al., 2020Malone L.M. Warring S.L. Jackson S.A. Warnecke C. Gardner P.P. Gumy L.F. Fineran P.C. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.Nat. Microbiol. 2020; 5: 48-55Crossref PubMed Scopus (69) Google Scholar) show that some phages with unusually large genomes, "jumbophages," can form nucleus-like shells that physically shield viral DNA from CRISPR-Cas effectors, as well as from restriction endonucleases that also defend against phage predation (Figure 1). Furthermore, the subset of CRISPR-Cas systems that degrade RNA (in addition to, or instead of, phage DNA) retain their efficacy in the face of these nucleus-like jumbophage shells, partially explaining the evolutionary pressures driving the emergence and spread of RNA-targeting CRISPR-Cas machineries. Bondy-Denomy et al., 2013Bondy-Denomy J. Pawluk A. Maxwell K.L. Davidson A.R. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.Nature. 2013; 493: 429-432Crossref PubMed Scopus (501) Google Scholar had previously used Pseudomonas aeruginosa and its phages to discover anti-CRISPR proteins, which are now known to be widespread (Stanley and Maxwell, 2018Stanley S.Y. Maxwell K.L. Phage-Encoded Anti-CRISPR Defenses.Annu. Rev. Genet. 2018; 52: 445-464Crossref PubMed Scopus (83) Google Scholar). Most anti-CRISPRs bind CRISPR-Cas effectors and prevent target nucleic acid recognition or degradation. Working again in P. aeruginosa, Bondy-Denomy and colleagues began their more recent study (Mendoza et al., 2020Mendoza S.D. Nieweglowska E.S. Govindarajan S. Leon L.M. Berry J.D. Tiwari A. Chaikeeratisak V. Pogliano J. Agard D.A. Bondy-Denomy J. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.Nature. 2020; 577: 244-248Crossref PubMed Scopus (71) Google Scholar) with a successful search for phages that can circumvent the immunity conferred by type I-C CRISPR-Cas systems that are native to some strains of this opportunistic pathogen. A jumbophage called φKZ successfully counteracted type I-C CRISPR-Cas immunity, making it a potential source of anti-CRISPRs specific for this subtype. Surprisingly, however, infections of control strains revealed φKZ to be similarly impervious to endogenous type I-F CRISPR-Cas defenses, as well as heterologous type II-A and type V-A CRISPR-Cas machineries and even restriction enzymes. The range of nucleases encompassed here spans the CRISPR-Cas effectors Cascade-Cas3, Cas9, and Cas12, as well as "classical" type I and type II restriction enzymes (EcoRI, HsdRMS), illustrating how widely effective this "pan-resistance" mechanism may be. More importantly, the unprecedented mechanistic and phylogenetic breadth of inhibition would be difficult to explain for a conventional anti-CRISPR protein, leading Mendoza et al. to seek other explanations for such impressive resilience against diverse host immunity. Intriguingly, certain jumbophages that infect P. aeruginosa had been shown previously to form an intracellular, proteinaceous shell that surrounds the phage genome during lytic growth and DNA replication (Chaikeeratisak et al., 2017Chaikeeratisak V. Nguyen K. Khanna K. Brilot A.F. Erb M.L. Coker J.K. Vavilina A. Newton G.L. Buschauer R. Pogliano K. et al.Assembly of a nucleus-like structure during viral replication in bacteria.Science. 2017; 355: 194-197Crossref PubMed Scopus (110) Google Scholar). Mechanistically, this nucleus-like structure is a multimeric assembly of a single protein unit and is localized to the cell center by PhuZ, a phage-encoded tubulin homolog. This physically defined shell-like structural feature has the potential to protect phage φKZ DNA by providing a shield preventing exposure to nucleases. This structure houses only the phage (and not the host) DNA, and the barrier mechanism is somewhat selective, allowing entry of important enzymes critical for viral DNA replication and progeny particle assembly, yet excluding many others (Chaikeeratisak et al., 2017Chaikeeratisak V. Nguyen K. Khanna K. Brilot A.F. Erb M.L. Coker J.K. Vavilina A. Newton G.L. Buschauer R. Pogliano K. et al.Assembly of a nucleus-like structure during viral replication in bacteria.Science. 2017; 355: 194-197Crossref PubMed Scopus (110) Google Scholar). Mendoza et al. demonstrated that fluorescently tagged CRISPR-Cas effectors and restriction endonucleases are likewise excluded from the shell's interior, suggesting physical sequestration of phage DNA as the broadly effective anti-immunity mechanism. Furthermore, extracted phage DNA was found to be susceptible to Cas9 and restriction endonuclease cleavage in vitro, demonstrating that shell-encased DNA is not intrinsically resistant to enzymatic digestion, e.g., via chemical modification. To establish a causal role for genome sequestration as an anti-immunity countermeasure, the authors sent a restriction enzyme (EcoRI) "under the radar" by fusing it to a phage recombinase (ORF152, encoding a RecA homolog) shown previously to be shell-permeable. Whereas EcoRI alone was excluded from the shell and ineffective in host defense, the EcoRI-ORF152 chimera trafficked into the nucleus-like structure and conferred substantial host immunity. The finding that intra-shell transport of a DNA-targeting immune effector negates the φKZ countermeasures clearly implicates physical DNA sequestration as the jumbophage's anti-immunity mechanism. Nonetheless, the ORF152 fusion approach proved unsuccessful when applied to the larger Cas9 nuclease, suggesting size limits to active shell permeability. Similarly, Fineran and colleagues (Malone et al., 2020Malone L.M. Warring S.L. Jackson S.A. Warnecke C. Gardner P.P. Gumy L.F. Fineran P.C. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.Nat. Microbiol. 2020; 5: 48-55Crossref PubMed Scopus (69) Google Scholar) explored phage resistance to CRISPR-Cas immunity in a strain from the genus Serratia and identified a jumbophage that encodes a tubulin homolog, forms a microscopically visible shell, and escapes CRISPR targeting by the Cascade-Cas3 effectors of endogenous type I-E and I-F systems. These results further implicate nucleus-like shells in negating CRISPR-Cas immunity and extend this strategy beyond P. aeruginosa jumbophages. Future studies will be needed to determine how this physical structure is assembled, how its barrier function is gated, and how widespread this mechanism is. Mechanistic explorations of CRISPR-Cas immunity have revealed some systems (type III) that augment the DNA-cleaving activity of their Cas10 effectors with separate ribonuclease activities and others (type VI) that rely solely on RNA cleavage by Cas13, without benefit of DNA degradation activity (Makarova et al., 2020Makarova K.S. Wolf Y.I. Iranzo J. Shmakov S.A. Alkhnbashi O.S. Brouns S.J.J. Charpentier E. Cheng D. Haft D.H. Horvath P. et al.Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants..Nat. Rev. Microbiol. 2020; 18: 435-448Crossref Scopus (733) Google Scholar). Intriguingly, although jumbophage DNA replication and transcription are thought to occur inside the shell, phage-derived mRNAs must escape the shell for translation, as ribosomes do not appear to be imported (Chaikeeratisak et al., 2017Chaikeeratisak V. Nguyen K. Khanna K. Brilot A.F. Erb M.L. Coker J.K. Vavilina A. Newton G.L. Buschauer R. Pogliano K. et al.Assembly of a nucleus-like structure during viral replication in bacteria.Science. 2017; 355: 194-197Crossref PubMed Scopus (110) Google Scholar). Might this imply that RNA-targeting systems provide hosts with immune systems that nucleus-like shells cannot circumvent? Using a heterologous Cas13 effector and an endogenous Cas10-based system, respectively, Mendoza et al. and Malone et al. demonstrate that the answer to this question is yes: in both cases, CRISPR-Cas immunity based on RNA degradation persists during jumbophage infection. This observation provides a compelling rationale for the evolution of RNA-targeting CRISPR-Cas systems, alongside their capacity to induce altruistic dormancy responses via host transcript targeting (Meeske et al., 2019Meeske A.J. Nakandakari-Higa S. Marraffini L.A. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.Nature. 2019; 570: 241-245Crossref PubMed Scopus (112) Google Scholar, Rostøl and Marraffini, 2019Rostøl J.T. Marraffini L.A. Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity.Nat. Microbiol. 2019; 4: 656-662Crossref PubMed Scopus (76) Google Scholar). These studies further illustrate how the interplay between bacteria and predatory bacteriophages continues to provide insights into the dynamic arms race playing out globally between various microbiomes and viromes that shape the composition and biology of most habitats on the planet. Furthermore, they open new avenues for the understanding of CRISPR-Cas systems and their impact on phage-host dynamics, and also illustrate how much potential lies in the continued exploration of new hosts, wild phages, and recently discovered defense systems (Doron et al., 2018Doron S. Melamed S. Ofir G. Leavitt A. Lopatina A. Keren M. Amitai G. Sorek R. Systematic discovery of antiphage defense systems in the microbial pangenome.Science. 2018; 359: eaar4120Crossref PubMed Scopus (393) Google Scholar). R.B. acknowledges support from NC State University, and E.J.S. acknowledges funding from the NIH (GM125797). The authors also acknowledge graphical support from Avery Roberts in the CRISPR lab. R.B. is a shareholder of Caribou Biosciences, Intellia Therapeutics, Locus Biosciences, Inari Ag, and TreeCo. E.J.S. is a shareholder of Intellia Therapeutics.}, number={5}, journal={MOLECULAR CELL}, author={Barrangou, Rodolphe and Sontheimer, Erik J.}, year={2020}, month={Mar}, pages={934–936} } @article{hidalgo-cantabrana_barrangou_2020, title={Characterization and applications of Type I CRISPR-Cas systems}, volume={48}, url={https://doi.org/10.1042/BST20190119}, DOI={10.1042/BST20190119}, abstractNote={CRISPR-Cas constitutes the adaptive immune system of bacteria and archaea. This RNA-mediated sequence-specific recognition and targeting machinery has been used broadly for diverse applications in a wide range of organisms across the tree of life. The compact class 2 systems, that hinge on a single Cas effector nuclease have been harnessed for genome editing, transcriptional regulation, detection, imaging and other applications, in different research areas. However, most of the CRISPR-Cas systems belong to class 1, and the molecular machinery of the most widespread and diverse Type I systems afford tremendous opportunities for a broad range of applications. These highly abundant systems rely on a multi-protein effector complex, the CRISPR associated complex for antiviral defense (Cascade), which drives DNA targeting and cleavage. The complexity of these systems has somewhat hindered their widespread usage, but the pool of thousands of diverse Type I CRISPR-Cas systems opens new avenues for CRISPR-based applications in bacteria, archaea and eukaryotes. Here, we describe the features and mechanism of action of Type I CRISPR-Cas systems, illustrate how endogenous systems can be reprogrammed to target the host genome and perform genome editing and transcriptional regulation by co-delivering a minimal CRISPR array together with a repair template. Moreover, we discuss how these systems can also be used in eukaryotes. This review provides a framework for expanding the CRISPR toolbox, and repurposing the most abundant CRISPR-Cas systems for a wide range of applications.}, number={1}, journal={Biochemical Society Transactions}, publisher={Portland Press Ltd.}, author={Hidalgo-Cantabrana, Claudio and Barrangou, Rodolphe}, year={2020}, month={Feb}, pages={15–23} } @misc{pan_barrangou_2020, title={Combining omics technologies with CRISPR-based genome editing to study food microbes}, volume={61}, ISSN={["1879-0429"]}, DOI={10.1016/j.copbio.2019.12.027}, abstractNote={The implementation of omics technologies such as genomics, proteomics and transcriptomics has revolutionized our understanding of microbiomes, and shed light on the functional attributes and mechanisms of action underlying the ability of probiotics to impact host health and starter cultures to drive food fermentation. Recently, molecular machines from CRISPR-Cas systems have redefined the gene editing toolbox and democritized our ability to alter the genome of food microorganisms. An integrated approach in which CRISPR-based genome editing is informed by omics studies is poised to enable the engineering of microorganisms and the formulation of microbiomes impacting the food supply chain. Here, we highlight the current applications of omics technologies in food microorganisms and CRISPR-based genome editing technologies in bacteria, and discuss how this integrated approach enables effective engineering of food microbes to generate enhanced probiotic strains, develop novel biotherapeutics and alter microbial communities in food matrices.}, journal={CURRENT OPINION IN BIOTECHNOLOGY}, author={Pan, Meichen and Barrangou, Rodolphe}, year={2020}, month={Feb}, pages={198–208} } @article{pan_hidalgo-cantabrana_goh_sanozky-dawes_barrangou_2020, title={Comparative Analysis of Lactobacillus gasseri and Lactobacillus crispatus Isolated From Human Urogenital and Gastrointestinal Tracts}, volume={10}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2019.03146}, abstractNote={Lactobacillus crispatus and Lactobacillus gasseri are two of the main Lactobacillus species found in the healthy vaginal microbiome and have also previously been identified and isolated from the human gastrointestinal (GI) tract. These two ecological niches are fundamentally different, notably with regards to the epithelial cell type, nutrient availability, environmental conditions, pH, and microbiome composition. Given the dramatic differences between these two environments, we characterized strains within the same Lactobacillus species isolated from either the vaginal or intestinal tract to assess whether they are phenotypically and genetically different. We compared the genomes of the Lactobacillus strains selected in this study for genetic features of interest, and performed a series of comparative phenotypic assays including small intestinal juice and acid resistance, carbohydrate fermentation profiles, lactic acid production, and host interaction with intestinal Caco-2 and vaginal VK2 cell lines. We also developed a simulated vaginal fluid (SVF) to study bacterial growth in a proxy vaginal environment and conducted differential transcriptomic analysis between SVF and standard laboratory MRS medium. Overall, our results show that although strain-specific variation is observed, some phenotypic differences seem associated with the isolation source. We encourage future probiotic formulation to include isolation source and take into consideration genetic and phenotypic features for use at various body sites.}, journal={FRONTIERS IN MICROBIOLOGY}, author={Pan, Meichen and Hidalgo-Cantabrana, Claudio and Goh, Yong Jun and Sanozky-Dawes, Rosemary and Barrangou, Rodolphe}, year={2020}, month={Jan} } @article{o'flaherty_foley_rivera_theriot_barrangou_2020, title={Complete Genome Sequence of Lactobacillus johnsonii NCK2677, Isolated from Mice}, volume={9}, url={https://doi.org/10.1128/MRA.00918-20}, DOI={10.1128/MRA.00918-20}, abstractNote={We report the closed genome sequence of a Lactobacillus johnsonii strain (NCK2677) that was isolated from a cefoperazone-treated mouse model designed for the study of Clostridioides difficile infection. Illumina and Nanopore sequencing reads were assembled into a circular 1,951,416-bp chromosome with a G+C content of 34.7%, containing 1,865 genes.}, number={43}, journal={Microbiology Resource Announcements}, publisher={American Society for Microbiology}, author={O'Flaherty, Sarah and Foley, Matthew H. and Rivera, Alissa J. and Theriot, Casey M. and Barrangou, Rodolphe}, editor={Rasko, DavidEditor}, year={2020}, month={Oct} } @article{pan_nethery_hidalgo-cantabrana_barrangou_2020, title={Comprehensive Mining and Characterization of CRISPR-Cas Systems in Bifidobacterium}, volume={8}, url={https://doi.org/10.3390/microorganisms8050720}, DOI={10.3390/microorganisms8050720}, abstractNote={The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-associated cas) systems constitute the adaptive immune system in prokaryotes, which provides resistance against bacteriophages and invasive genetic elements. The landscape of applications in bacteria and eukaryotes relies on a few Cas effector proteins that have been characterized in detail. However, there is a lack of comprehensive studies on naturally occurring CRISPR-Cas systems in beneficial bacteria, such as human gut commensal Bifidobacterium species. In this study, we mined 954 publicly available Bifidobacterium genomes and identified CRIPSR-Cas systems in 57% of these strains. A total of five CRISPR-Cas subtypes were identified as follows: Type I-E, I-C, I-G, II-A, and II-C. Among the subtypes, Type I-C was the most abundant (23%). We further characterized the CRISPR RNA (crRNA), tracrRNA, and PAM sequences to provide a molecular basis for the development of new genome editing tools for a variety of applications. Moreover, we investigated the evolutionary history of certain Bifidobacterium strains through visualization of acquired spacer sequences and demonstrated how these hypervariable CRISPR regions can be used as genotyping markers. This extensive characterization will enable the repurposing of endogenous CRISPR-Cas systems in Bifidobacteria for genome engineering, transcriptional regulation, genotyping, and screening of rare variants.}, number={5}, journal={Microorganisms}, publisher={MDPI AG}, author={Pan, Meichen and Nethery, Matthew A. and Hidalgo-Cantabrana, Claudio and Barrangou, Rodolphe}, year={2020}, month={May}, pages={720} } @article{klotz_goh_o'flaherty_johnson_barrangou_2020, title={Deletion of S-Layer Associated Ig-Like Domain Protein Disrupts the Lactobacillus acidophilus Cell Surface}, volume={11}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2020.00345}, abstractNote={Bacterial surface-layers (S-layers) are crystalline arrays of repeating proteinaceous subunits that coat the exterior of many cell envelopes. S-layers have demonstrated diverse functions in growth and survival, maintenance of cell integrity, and mediation of host interactions. Additionally, S-layers can act as scaffolds for the outward display of auxiliary proteins and glycoproteins. These non-covalently bound S-layer associated proteins (SLAPs) have characterized roles in cell division, adherence to intestinal cells, and modulation of the host immune response. Recently, IgdA (LBA0695), a Lactobacillus acidophilus SLAP that possesses a Group 3 immunoglobulin (Ig)-like domain and GW (Gly-Tryp) dipeptide surface anchor, was recognized for its high conservation among S-layer-forming lactobacilli, constitutive expression, and surface localization. These findings prompted its selection for examination within the present study. Although IgdA and corresponding orthologs were shown to be unique to host-adapted lactobacilli, the Ig domain itself was specific to vertebrate-adapted species suggesting a role in vertebrate adaptation. Using a counterselective gene replacement system, igdA was deleted from the L. acidophilus NCFM chromosome. The resultant mutant, NCK2532, exhibited a visibly disrupted cell surface which likely contributed to its higher salt sensitivity, severely reduced adhesive capacity, and altered immunogenicity profile. Transcriptomic analyses revealed the induction of several stress response genes and secondary surface proteins. Due to the broad impact of IgdA on the cellular physiology and probiotic attributes of L. acidophilus, identification of similar proteins in alternative bacterial species may help pinpoint next-generation host-adapted probiotic candidates.}, journal={FRONTIERS IN MICROBIOLOGY}, author={Klotz, Courtney and Goh, Yong Jun and O'Flaherty, Sarah and Johnson, Brant and Barrangou, Rodolphe}, year={2020}, month={Mar} } @misc{makarova_wolf_iranzo_shmakov_alkhnbashi_brouns_charpentier_cheng_haft_horvath_et al._2020, title={Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants}, volume={18}, ISSN={["1740-1534"]}, DOI={10.1038/s41579-019-0299-x}, abstractNote={The number and diversity of known CRISPR-Cas systems have substantially increased in recent years. Here, we provide an updated evolutionary classification of CRISPR-Cas systems and cas genes, with an emphasis on the major developments that have occurred since the publication of the latest classification, in 2015. The new classification includes 2 classes, 6 types and 33 subtypes, compared with 5 types and 16 subtypes in 2015. A key development is the ongoing discovery of multiple, novel class 2 CRISPR-Cas systems, which now include 3 types and 17 subtypes. A second major novelty is the discovery of numerous derived CRISPR-Cas variants, often associated with mobile genetic elements that lack the nucleases required for interference. Some of these variants are involved in RNA-guided transposition, whereas others are predicted to perform functions distinct from adaptive immunity that remain to be characterized experimentally. The third highlight is the discovery of numerous families of ancillary CRISPR-linked genes, often implicated in signal transduction. Together, these findings substantially clarify the functional diversity and evolutionary history of CRISPR-Cas.}, number={2}, journal={NATURE REVIEWS MICROBIOLOGY}, author={Makarova, Kira S. and Wolf, Yuri I and Iranzo, Jaime and Shmakov, Sergey A. and Alkhnbashi, Omer S. and Brouns, Stan J. J. and Charpentier, Emmanuelle and Cheng, David and Haft, Daniel H. and Horvath, Philippe and et al.}, year={2020}, month={Feb}, pages={67–83} } @article{brandt_nethery_sarah_barrangou_2020, title={Genomic characterization of Lactobacillus fermentum DSM 20052}, volume={21}, url={https://doi.org/10.1186/s12864-020-6740-8}, DOI={10.1186/s12864-020-6740-8}, abstractNote={Lactobacillus fermentum, a member of the lactic acid bacteria complex, has recently garnered increased attention due to documented antagonistic properties and interest in assessing the probiotic potential of select strains that may provide human health benefits. Here, we genomically characterize L. fermentum using the type strain DSM 20052 as a canonical representative of this species.We determined the polished whole genome sequence of this type strain and compared it to 37 available genome sequences within this species. Results reveal genetic diversity across nine clades, with variable content encompassing mobile genetic elements, CRISPR-Cas immune systems and genomic islands, as well as numerous genome rearrangements. Interestingly, we determined a high frequency of occurrence of diverse Type I, II, and III CRISPR-Cas systems in 72% of the genomes, with a high level of strain hypervariability.These findings provide a basis for the genetic characterization of L. fermentum strains of scientific and commercial interest. Furthermore, our study enables genomic-informed selection of strains with specific traits for commercial product formulation, and establishes a framework for the functional characterization of features of interest.}, number={1}, journal={BMC Genomics}, publisher={Springer Science and Business Media LLC}, author={Brandt, Katelyn and Nethery, Matthew A. and Sarah, O’Flaherty and Barrangou, Rodolphe}, year={2020}, month={Dec} } @article{pan_hidalgo-cantabrana_barrangou_2020, title={Host and body site-specific adaptation of Lactobacillus crispatus genomes}, volume={2}, url={https://doi.org/10.1093/nargab/lqaa001}, DOI={10.1093/nargab/lqaa001}, abstractNote={Abstract Lactobacillus crispatus is a common inhabitant of both healthy poultry gut and human vaginal tract, and the absence of this species has been associated with a higher risk of developing infectious diseases. In this study, we analyzed 105 L. crispatus genomes isolated from a variety of ecological niches, including the human vaginal tract, human gut, chicken gut and turkey gut, to shed light on the genetic and functional features that drive evolution and adaptation of this important species. We performed in silico analyses to identify the pan and core genomes of L. crispatus, and to reveal the genomic differences and similarities associated with their origins of isolation. Our results demonstrated that, although a significant portion of the genomic content is conserved, human and poultry L. crispatus isolates evolved to encompass different genomic features (e.g. carbohydrate usage, CRISPR–Cas immune systems, prophage occurrence) in order to thrive in different environmental niches. We also observed that chicken and turkey L. crispatus isolates can be differentiated based on their genomic information, suggesting significant differences may exist between these two poultry gut niches. These results provide insights into host and niche-specific adaptation patterns in species of human and animal importance.}, number={1}, journal={NAR Genomics and Bioinformatics}, publisher={Oxford University Press (OUP)}, author={Pan, Meichen and Hidalgo-Cantabrana, Claudio and Barrangou, Rodolphe}, year={2020}, month={Mar} } @article{selle_fletcher_tuson_schmitt_mcmillan_vridhambal_rivera_montgomery_fortier_barrangou_et al._2020, title={In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials}, volume={11}, url={https://doi.org/10.1128/mBio.00019-20}, DOI={10.1128/mBio.00019-20}, abstractNote={Clostridioides difficile is a bacterial pathogen responsible for significant morbidity and mortality across the globe. Current therapies based on broad-spectrum antibiotics have some clinical success, but approximately 30% of patients have relapses, presumably due to the continued perturbation to the gut microbiota. Here, we show that phages can be engineered with type I CRISPR-Cas systems and modified to reduce lysogeny and to enable the specific and efficient targeting and killing of C. difficile in vitro and in vivo. Additional genetic engineering to disrupt phage modulation of toxin expression by lysogeny or other mechanisms would be required to advance a CRISPR-enhanced phage antimicrobial for C. difficile toward clinical application. These findings provide evidence into how phage can be combined with CRISPR-based targeting to develop novel therapies and modulate microbiomes associated with health and disease.}, number={2}, journal={mBio}, publisher={American Society for Microbiology}, author={Selle, Kurt and Fletcher, Joshua R. and Tuson, Hannah and Schmitt, Daniel S. and McMillan, Lana and Vridhambal, Gowrinarayani S. and Rivera, Alissa J. and Montgomery, Stephanie A. and Fortier, Louis-Charles and Barrangou, Rodolphe and et al.}, editor={Ballard, Jimmy D.Editor}, year={2020}, month={Apr} } @article{angrist_barrangou_baylis_brokowski_burgio_caplan_chapman_church_cook-deegan_cwik_et al._2020, title={Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing}, volume={3}, ISSN={["2573-1602"]}, DOI={10.1089/crispr.2020.29106.man}, abstractNote={In September 2020, a detailed report on Heritable Human Genome Editing was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In this perspective, some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.}, number={5}, journal={CRISPR JOURNAL}, author={Angrist, Misha and Barrangou, Rodolphe and Baylis, Francoise and Brokowski, Carolyn and Burgio, Gaetan and Caplan, Arthur and Chapman, Carolyn Riley and Church, George M. and Cook-Deegan, Robert and Cwik, Bryan and et al.}, year={2020}, month={Oct}, pages={332–349} } @article{klotz_goh_sarah_barrangou_2020, title={S-layer associated proteins contribute to the adhesive and immunomodulatory properties of Lactobacillus acidophilus NCFM}, volume={20}, url={https://doi.org/10.1186/s12866-020-01908-2}, DOI={10.1186/s12866-020-01908-2}, abstractNote={Abstract Background Surface layers (S-layers) are two-dimensional crystalline arrays of repeating proteinaceous subunits that form the outermost layer of many bacterial cell envelopes. Within the Lactobacillus genus, S-layer presence is frequently associated with probiotic-relevant properties such as improved adherence to host epithelial cells and modulation of the immune response. However, recent studies have demonstrated that certain S-layer functions may be supplemented by a novel subset of proteins embedded within its lattice, termed S-layer associated proteins (SLAPs). In the following study, four Lactobacillus acidophilus NCFM SLAPs (LBA0046, LBA0864, LBA1426, and LBA1539) were selected for in silico and phenotypic assessment. Results Despite lacking any sequence similarity or catalytic domains that may indicate function, the genes encoding the four proteins of interest were shown to be unique to S-layer-forming, host-adapted lactobacilli species. Likewise, their corresponding deletion mutants exhibited broad, host-relevant phenotypes including decreased inflammatory profiles and reduced adherence to Caco-2 intestinal cells, extracellular matrices, and mucin in vitro. Conclusions Overall, the data presented in this study collectively links several previously uncharacterized extracellular proteins to roles in the underlying host adaptive mechanisms of L. acidophilus .}, number={1}, journal={BMC Microbiology}, publisher={Springer Science and Business Media LLC}, author={Klotz, Courtney and Goh, Yong Jun and Sarah, O’Flaherty and Barrangou, Rodolphe}, year={2020}, month={Dec} } @article{lamanna_pyhtila_barrangou_2020, title={Sharing the CRISPR Toolbox with an Expanding Community}, volume={3}, ISSN={["2573-1602"]}, DOI={10.1089/crispr.2020.0075}, abstractNote={Over the past 8 years, the widespread adoption of CRISPR-based technologies has fueled the global genome editing revolution. This platform is based on Cas molecular machines such as Cas9, Cas12, Cas13, as well as other CRISPR effector proteins that are able to alter the genome, transcriptome, and epigenome of virtually any species. Technological improvements have rendered these tools more efficient and precise, and enabled functional diversification and specialization, as recently illustrated by the rise of base editing and the quickly growing demand for prime editing constructs. Here, we discuss the continued adoption of CRISPR tools and constructs distributed by the nonprofit organization Addgene, highlight the trends in the global demand for the CRISPR toolbox, and consider the widespread attitude changes around open sharing that are having a transformative effect on speeding up science.}, number={4}, journal={CRISPR JOURNAL}, author={LaManna, Caroline M. and Pyhtila, Brook and Barrangou, Rodolphe}, year={2020}, month={Aug}, pages={248–252} } @article{barrangou_sontheimer_2020, title={Shutting down RNA-targeting CRISPR}, volume={369}, ISSN={["1095-9203"]}, DOI={10.1126/science.abc8243}, abstractNote={The discovery of an anti-CRISPR reveals viral escape from CRISPR immunity}, number={6499}, journal={SCIENCE}, author={Barrangou, Rodolphe and Sontheimer, Erik J.}, year={2020}, month={Jul}, pages={31–32} } @article{reed_nethery_stewart_barrangou_theriot_2020, title={Strain-Dependent Inhibition of Clostridioides difficile by Commensal Clostridia Carrying the Bile Acid-Inducible ( bai ) Operon}, volume={202}, url={https://doi.org/10.1128/JB.00039-20}, DOI={10.1128/JB.00039-20}, abstractNote={Commensal Clostridia carrying the bai operon, such as C. scindens, have been associated with protection against CDI; however, the mechanism for this protection is unknown. Herein, we show four commensal Clostridia that carry the bai operon and affect C. difficile growth in a strain-dependent manner, with and without the addition of cholate. Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production. Competition studies also revealed that C. difficile was able to outcompete the commensals in an in vitro coculture system. These studies are instrumental in understanding the relationship between commensal Clostridia and C. difficile in the gut, which is vital for designing targeted bacterial therapeutics.}, number={11}, journal={Journal of Bacteriology}, publisher={American Society for Microbiology}, author={Reed, A. D. and Nethery, M. A. and Stewart, A. and Barrangou, R. and Theriot, C. M.}, editor={Comstock, Laurie E.Editor}, year={2020}, month={May} } @article{reed_nethery_stewart_barrangou_theriot_2020, title={Strain-dependent inhibition ofClostridioides difficileby commensalClostridiaencoding the bile acid inducible(bai)operon}, url={https://doi.org/10.1101/2020.01.22.916304}, DOI={10.1101/2020.01.22.916304}, abstractNote={Abstract Clostridioides difficile is one of the leading causes of antibiotic-associated diarrhea. Gut microbiota-derived secondary bile acids and commensal Clostridia that encode the bile acid inducible ( bai ) operon are associated with protection from C. difficile infection (CDI), although the mechanism is not known. In this study we hypothesized that commensal Clostridia are important for providing colonization resistance against C. difficile due to their ability to produce secondary bile acids, as well as potentially competing against C. difficile for similar nutrients. To test this hypothesis, we examined the ability of four commensal Clostridia encoding the bai operon ( C. scindens VPI 12708, C. scindens ATCC 35704, C. hiranonis , and C. hylemonae ) to convert CA to DCA in vitro , and if the amount of DCA produced was sufficient to inhibit growth of a clinically relevant C. difficile strain. We also investigated the competitive relationship between these commensals and C. difficile using an in vitro co-culture system. We found that inhibition of C. difficile growth by commensal Clostridia supplemented with CA was strain-dependent, correlated with the production of ∼2 mM DCA, and increased expression of bai operon genes. We also found that C. difficile was able to outcompete all four commensal Clostridia in an in vitro co-culture system. These studies are instrumental in understanding the relationship between commensal Clostridia and C. difficile in the gut, which is vital for designing targeted bacterial therapeutics. Future studies dissecting the regulation of the bai operon in vitro and in vivo and how this affects CDI will be important. Importance Commensal Clostridia encoding the bai operon such as C. scindens have been associated with protection against CDI, however the mechanism for this protection is unknown. Herein, we show four commensal Clostridia that encode the bai operon effect C. difficile growth in a strain-dependent manner, with and without the addition of cholate. Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production. Competition studies also revealed that C. difficile was able to outcompete the commensals in an in vitro co-culture system. These studies are instrumental in understanding the relationship between commensal Clostridia and C. difficile in the gut, which is vital for designing targeted bacterial therapeutics.}, author={Reed, A.D. and Nethery, M.A. and Stewart, A. and Barrangou, R. and Theriot, C.M.}, year={2020}, month={Jan} } @article{brandt_barrangou_2019, title={Applications of CRISPR Technologies Across the Food Supply Chain}, volume={10}, ISSN={["1941-1413"]}, DOI={10.1146/annurev-food-032818-121204}, abstractNote={The food industry faces a 2050 deadline for the advancement and expansion of the food supply chain to support the world's growing population. Improvements are needed across crops, livestock, and microbes to achieve this goal. Since 2005, researchers have been attempting to make the necessary strides to reach this milestone, but attempts have fallen short. With the introduction of clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins, the food production field is now able to achieve some of its most exciting advancements since the Green Revolution. This review introduces the concept of applying CRISPR-Cas technology as a genome-editing tool for use in the food supply chain, focusing on its implementation to date in crop, livestock, and microbe production, advancement of products to market, and regulatory and societal hurdles that need to be overcome.}, number={1}, journal={ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 10}, publisher={Annual Reviews}, author={Brandt, Katelyn and Barrangou, Rodolphe}, year={2019}, pages={133–150} } @article{foley_o'flaherty_barrangou_theriot_2019, title={Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract}, volume={15}, ISSN={["1553-7374"]}, url={https://doi.org/10.1371/journal.ppat.1007581}, DOI={10.1371/journal.ppat.1007581}, abstractNote={Research on bile acids has increased dramatically due to recent studies demonstrating their ability to significantly impact the host, microbiome, and various disease states [1–3]. Although these liver-synthesized molecules assist in the absorption and digestion of dietary fat in the intestine, their reabsorption and recirculation also gives them access to peripheral organs [4] (Fig 1A). Bile acids serve as substrates for bile acid receptors (BARs) found throughout the body that control critical regulatory and metabolic processes and therefore represent an important class of bioactive molecules [5]. Despite the importance of bile acids to host health, there remain gaps in our knowledge about the bacterial enzymes driving their composition and modification. Open in a separate window Fig 1 Bile salt hydrolases act on circulating conjugated bile acids in the gut-liver axis. (A) Bile acids synthesized in the liver and stored in the gall bladder enter the small intestine through the duodenum where they reach millimolar concentrations. The majority of bile acids (95%) are reabsorbed in the ileum and recirculate to the liver through the portal vein. The remaining population transit to the colon as they continue to be reabsorbed, and a small (<5%) amount exit through the feces. Recirculating bile acids access host tissues outside the intestines to impart systemic effects on host physiology. (B) BSHs cleave the amide bond in conjugated bile acids to open up the bile acid pool to increased complexity. The gut microbiota performs additional chemistry on deconjugated bile acids to generate the secondary bile acid pool, which can undergo enterohepatic circulation and be reconjugated in the liver. These transformations are illustrated to the right as conjugated CA is deconjugated, subjected to 7 α-dehydroxylation to become DCA, and subsequently reconjugated. (C) Monomeric BSH overlay from Bifidobacterium longum (PDB ID 2HEZ), Enteroccocus faecalis (PDB ID 4WL3), Lactobacillus salivarius (PDB ID 5HKE), and Clostridium perfringens (PDB ID 2BJF). Hydrolyzed TDCA in the CpBSH active site is coordinated by several loops that contain the most variation in the peptide backbone compared to the other structures. BSH, bile salt hydrolase; CA, cholic acid; CpBSH, C. perfringens BSH; DCA,; TDCA, taurodeoxycholic acid; PDB ID, Protein Data Bank ID.}, number={3}, journal={PLOS PATHOGENS}, author={Foley, Matthew H. and O'Flaherty, Sarah and Barrangou, Rodolphe and Theriot, Casey M.}, editor={Knoll, Laura J.Editor}, year={2019}, month={Mar} } @article{barrangou_2019, title={Bringing CRISPR to the Cinema}, volume={2}, DOI={10.1089/crispr.2019.29070.rba}, abstractNote={The CRISPR JournalVol. 2, No. 4 EditorialBringing CRISPR to the CinemaRodolphe BarrangouRodolphe BarrangouEditor in Chief, The CRISPR Journal.Search for more papers by this authorPublished Online:16 Aug 2019https://doi.org/10.1089/crispr.2019.29070.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Bringing CRISPR to the Cinema." The CRISPR Journal, 2(4), p. 187FiguresReferencesRelatedDetails Volume 2Issue 4Aug 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.Bringing CRISPR to the Cinema.The CRISPR Journal.Aug 2019.187-187.http://doi.org/10.1089/crispr.2019.29070.rbaPublished in Volume: 2 Issue 4: August 16, 2019PDF download}, number={4}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, month={Aug}, pages={187–187} } @article{nethery_barrangou_2019, title={CRISPR Visualizer: rapid identification and visualization of CRISPR loci via an automated high-throughput processing pipeline}, volume={16}, ISSN={["1555-8584"]}, url={https://doi.org/10.1080/15476286.2018.1493332}, DOI={10.1080/15476286.2018.1493332}, abstractNote={A CRISPR locus, defined by an array of repeat and spacer elements, constitutes a genetic record of the ceaseless battle between bacteria and viruses, showcasing the genomic integration of spacers acquired from invasive DNA. In particular, iterative spacer acquisitions represent unique evolutionary histories and are often useful for high-resolution bacterial genotyping, including comparative analysis of closely related organisms, clonal lineages, and clinical isolates. Current spacer visualization methods are typically tedious and can require manual data manipulation and curation, including spacer extraction at each CRISPR locus from genomes of interest. Here, we constructed a high-throughput extraction pipeline coupled with a local web-based visualization tool which enables CRISPR spacer and repeat extraction, rapid visualization, graphical comparison, and progressive multiple sequence alignment. We present the bioinformatic pipeline and investigate the loci of reference CRISPR-Cas systems and model organisms in 4 well-characterized subtypes. We illustrate how this analysis uncovers the evolutionary tracks and homology shared between various organisms through visual comparison of CRISPR spacers and repeats, driven through progressive alignments. Due to the ability to process unannotated genome files with minimal preparation and curation, this pipeline can be implemented promptly. Overall, this efficient high-throughput solution supports accelerated analysis of genomic data sets and enables and expedites genotyping efforts based on CRISPR loci.}, number={4}, journal={RNA BIOLOGY}, publisher={Informa UK Limited}, author={Nethery, Matthew A. and Barrangou, Rodolphe}, year={2019}, month={Apr}, pages={577–584} } @article{barrangou_2019, title={CRISPR on the Move in 2019}, volume={2}, DOI={10.1089/crispr.2019.29043.rba}, abstractNote={The CRISPR JournalVol. 2, No. 1 EditorialCRISPR on the Move in 2019Rodolphe BarrangouRodolphe BarrangouDr. Barrangou is a co-founder of Intellia Therapeutics and Locus Biosciences.Editor-in-Chief, The CRISPR JournalSearch for more papers by this authorPublished Online:21 Feb 2019https://doi.org/10.1089/crispr.2019.29043.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"CRISPR on the Move in 2019." The CRISPR Journal, 2(1), pp. 1–2FiguresReferencesRelatedDetails Volume 2Issue 1Feb 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.CRISPR on the Move in 2019.The CRISPR Journal.Feb 2019.1-2.http://doi.org/10.1089/crispr.2019.29043.rbaPublished in Volume: 2 Issue 1: February 21, 2019PDF download}, number={1}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, month={Feb}, pages={1–2} } @misc{barrangou_notebaart_2019, title={CRISPR-Directed Microbiome Manipulation across the Food Supply Chain}, volume={27}, ISSN={["1878-4380"]}, url={https://doi.org/10.1016/j.tim.2019.03.006}, DOI={10.1016/j.tim.2019.03.006}, abstractNote={The advent of CRISPR-based technologies has revolutionized genetics over the past decade, and genome editing is now widely implemented for diverse medical and agricultural applications, such as correcting genetic disorders and improving crop and livestock breeding. CRISPR-based technologies are also of great potential to alter the genetic content of food bacteria in order to control the composition and activity of microbial populations across the food supply chain, from the farm to consumer products. Advancing the food supply chain is of great societal importance as it involves optimizing fermentation processes to enhance taste and sensory properties of food products, as well as improving food quality and safety by controlling spoilage bacteria and pathogens. Here, we discuss the various CRISPR technologies that can alter bacterial functionalities and modulate the composition of microbial communities in foods. We illustrate how these applications can be harnessed along the food supply chain to manipulate microbiomes that encompass spoilage and pathogenic bacteria as well as desirable starter cultures and health-promoting probiotics.}, number={6}, journal={TRENDS IN MICROBIOLOGY}, publisher={Elsevier BV}, author={Barrangou, Rodolphe and Notebaart, Richard A.}, year={2019}, month={Jun}, pages={489–496} } @misc{hidalgo-cantabrana_goh_barrangou_2019, title={Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria}, volume={431}, ISSN={["1089-8638"]}, DOI={10.1016/j.jmb.2018.09.013}, abstractNote={CRISPR–Cas systems constitute the adaptive immune system of bacteria and archaea, as a sequence-specific nucleic acid targeting defense mechanism. The sequence-specific recognition and cleavage of Cas effector complexes has been harnessed to developed CRISPR-based technologies and drive the genome editing revolution underway, due to their efficacy, efficiency, and ease of implementation in a broad range of organisms. CRISPR-based technologies offer a wide variety of opportunities in genome remodeling and transcriptional regulation, opening new avenues for therapeutic and biotechnological applications. To repurpose CRISPR–Cas systems for these applications, the various elements of the system need to be first identified and functionally characterized in their native host. Bioinformatic tools are first used to identify putative CRISPR arrays and their associated genes, followed by a comprehensive characterization of the CRISPR–Cas system, encompassing predictions for guide and target sequences. Subsequently, interference assays and transcriptomic analyses should be performed to probe the functionality of the CRISPR–Cas system. Once an endogenous CRISPR–Cas system is characterized as functional, they can be readily repurposed by delivering an engineered synthetic CRISPR array or a small RNA guide for targeted gene manipulation. Alternatively, developing a plasmid-based system for heterologous expression of the necessary CRISPR components can enable exploitation in other organisms. Altogether, there is a wide diversity of native CRISPR–Cas systems in many bacteria and most archaea that await functional characterization and repurposing for genome editing applications in prokaryotes.}, number={1}, journal={JOURNAL OF MOLECULAR BIOLOGY}, publisher={Elsevier BV}, author={Hidalgo-Cantabrana, Claudio and Goh, Yong Jun and Barrangou, Rodolphe}, year={2019}, month={Jan}, pages={21–33} } @article{huang_porter_zhang_barrangou_2019, title={Collaborative networks in gene editing}, volume={37}, ISSN={["1546-1696"]}, DOI={10.1038/s41587-019-0275-z}, number={10}, journal={NATURE BIOTECHNOLOGY}, publisher={Springer Science and Business Media LLC}, author={Huang, Ying and Porter, Alan and Zhang, Yi and Barrangou, Rodolphe}, year={2019}, month={Oct}, pages={1107–1109} } @article{faure_shmakov_makarova_wolf_crawley_barrangou_koonin_2019, title={Comparative genomics and evolution of trans-activating RNAs in Class 2 CRISPR-Cas systems}, volume={16}, ISSN={["1555-8584"]}, url={https://doi.org/10.1080/15476286.2018.1493331}, DOI={10.1080/15476286.2018.1493331}, abstractNote={Trans-activating CRISPR (tracr) RNA is a distinct RNA species that interacts with the CRISPR (cr) RNA to form the dual guide (g) RNA in type II and subtype V-B CRISPR-Cas systems. The tracrRNA-crRNA interaction is essential for pre-crRNA processing as well as target recognition and cleavage. The tracrRNA consists of an antirepeat, which forms an imperfect hybrid with the repeat in the crRNA, and a distal region containing a Rho-independent terminator. Exhaustive comparative analysis of the sequences and predicted structures of the Class 2 CRISPR guide RNAs shows that all these guide RNAs share distinct structural features, in particular, the nexus stem-loop that separates the repeat-antirepeat hybrid from the distal portion of the tracrRNA and the conserved GU pair at that end of the hybrid. These structural constraints might ensure full exposure of the spacer for target recognition. Reconstruction of tracrRNA evolution for 4 tight bacterial groups demonstrates random drift of repeat-antirepeat complementarity within a window of hybrid stability that is, apparently, maintained by selection. An evolutionary scenario is proposed whereby tracrRNAs evolved on multiple occasions, via rearrangement of a CRISPR array to form the antirepeat in different locations with respect to the array. A functional tracrRNA would form if, in the new location, the antirepeat is flanked by sequences that meet the minimal requirements for a promoter and a Rho-independent terminator. Alternatively, or additionally, the antirepeat sequence could be occasionally 'reset' by recombination with a repeat, restoring the functionality of tracrRNAs that drift beyond the required minimal hybrid stability.}, number={4}, journal={RNA BIOLOGY}, publisher={Informa UK Limited}, author={Faure, Guilhem and Shmakov, Sergey A. and Makarova, Kira S. and Wolf, Yuri I. and Crawley, Alexandra B. and Barrangou, Rodolphe and Koonin, Eugene V.}, year={2019}, month={Apr}, pages={435–448} } @article{nethery_henriksen_daughtry_johanningsmeier_barrangou_2019, title={Comparative genomics of eight Lactobacillus buchneri strains isolated from food spoilage}, volume={20}, ISSN={["1471-2164"]}, url={https://doi.org/10.1186/s12864-019-6274-0}, DOI={10.1186/s12864-019-6274-0}, abstractNote={Abstract Background Lactobacillus buchneri is a lactic acid bacterium frequently associated with food bioprocessing and fermentation and has been found to be either beneficial or detrimental to industrial food processes depending on the application. The ability to metabolize lactic acid into acetic acid and 1,2-propandiol makes L. buchneri invaluable to the ensiling process, however, this metabolic activity leads to spoilage in other applications, and is especially damaging to the cucumber fermentation industry. This study aims to augment our genomic understanding of L. buchneri in order to make better use of the species in a wide range of applicable industrial settings. Results Whole-genome sequencing (WGS) was performed on seven phenotypically diverse strains isolated from spoiled, fermented cucumber and the ATCC type strain for L. buchneri , ATCC 4005. Here, we present our findings from the comparison of eight newly-sequenced and assembled genomes against two publicly available closed reference genomes, L. buchneri CD034 and NRRL B-30929. Overall, we see ~ 50% of all coding sequences are conserved across these ten strains. When these coding sequences are clustered by functional description, the strains appear to be enriched in mobile genetic elements, namely transposons. All isolates harbor at least one CRISPR-Cas system, and many contain putative prophage regions, some of which are targeted by the host’s own DNA-encoded spacer sequences. Conclusions Our findings provide new insights into the genomics of L. buchneri through whole genome sequencing and subsequent characterization of genomic features, building a platform for future studies and identifying elements for potential strain manipulation or engineering.}, number={1}, journal={BMC GENOMICS}, publisher={Springer Science and Business Media LLC}, author={Nethery, Matthew A. and Henriksen, Emily DeCrescenzo and Daughtry, Katheryne V and Johanningsmeier, Suzanne D. and Barrangou, Rodolphe}, year={2019}, month={Nov} } @article{barrangou_2019, title={Foresight is 2020: Ten Bold Predictions for the New CRISPR Year}, volume={2}, DOI={10.1089/crispr.2019.29075.rba}, abstractNote={Whereas most people use the last few days of the year to reflect on the events that shaped the previous 12 months, I have decided to embrace the disruptiveness of CRISPR and pre-emptively offer 10 bold predictions to set the stage for what promises to be yet another eventful, perhaps pivotal, year for genome editing.Rather than offer a linear progression of incremental insights into what is likely to come, I will channel the ability of our field to leap ahead and offer colorful, perhaps contrarian, predictions of what may (hopefully will) happen for CRISPR in the next 12 months.}, number={6}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, pages={341–342} } @article{hidalgo-cantabrana_goh_pan_sanozky-dawes_barrangou_2019, title={Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus}, url={https://doi.org/10.1073/pnas.1905421116}, DOI={10.1073/pnas.1905421116}, abstractNote={CRISPR-Cas systems are now widely used for genome editing and transcriptional regulation in diverse organisms. The compact and portable nature of class 2 single effector nucleases, such as Cas9 or Cas12, has facilitated directed genome modifications in plants, animals, and microbes. However, most CRISPR-Cas systems belong to the more prevalent class 1 category, which hinges on multiprotein effector complexes. In the present study, we detail how the native type I-E CRISPR-Cas system, with a 5′-AAA-3′ protospacer adjacent motif (PAM) and a 61-nucleotide guide CRISPR RNA (crRNA) can be repurposed for efficient chromosomal targeting and genome editing in Lactobacillus crispatus , an important commensal and beneficial microbe in the vaginal and intestinal tracts. Specifically, we generated diverse mutations encompassing a 643-base pair (bp) deletion (100% efficiency), a stop codon insertion (36%), and a single nucleotide substitution (19%) in the exopolysaccharide priming-glycosyl transferase ( p-gtf ). Additional genetic targets included a 308-bp deletion (20%) in the prophage DNA packaging Nu1 and a 730-bp insertion of the green fluorescent protein gene downstream of enolase (23%). This approach enables flexible alteration of the formerly genetically recalcitrant species L. crispatus , with potential for probiotic enhancement, biotherapeutic engineering, and mucosal vaccine delivery. These results also provide a framework for repurposing endogenous CRISPR-Cas systems for flexible genome targeting and editing, while expanding the toolbox to include one of the most abundant and diverse systems found in nature.}, journal={Proceedings of the National Academy of Sciences}, author={Hidalgo-Cantabrana, Claudio and Goh, Yong Jun and Pan, Meichen and Sanozky-Dawes, Rosemary and Barrangou, Rodolphe}, year={2019}, month={Aug} } @misc{goh_barrangou_2019, title={Harnessing CRISPR-Cas systems for precision engineering of designer probiotic lactobacilli}, volume={56}, ISSN={["1879-0429"]}, url={https://doi.org/10.1016/j.copbio.2018.11.009}, DOI={10.1016/j.copbio.2018.11.009}, abstractNote={Our evolving understanding on the mechanisms underlying the health-promoting attributes of probiotic lactobacilli, together with an expanding genome editing toolbox have made this genus an ideal chassis for the development of living therapeutics. The rising adoption of CRISPR-based technologies for prokaryotic engineering has demonstrated precise, efficient and scalable genome editing and tunable transcriptional regulation that can be translated into next-generation development of probiotic lactobacilli with enhanced robustness and designer functionalities. Here, we discuss how these tools in conjunction with the naturally abundant and diverse native CRISPR-Cas systems can be harnessed for Lactobacillus cell surface engineering and the delivery of biotherapeutics.}, journal={CURRENT OPINION IN BIOTECHNOLOGY}, publisher={Elsevier BV}, author={Goh, Yong Jun and Barrangou, Rodolphe}, year={2019}, month={Apr}, pages={163–171} } @article{canez_selle_goh_barrangou_2019, title={Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus}, volume={366}, ISSN={["1574-6968"]}, url={https://doi.org/10.1093/femsle/fnz105}, DOI={10.1093/femsle/fnz105}, abstractNote={ABSTRACT CRISPR-Cas systems provide adaptive immunity against phages in prokaryotes via DNA-encoded, RNA-mediated, nuclease-dependent targeting and cleavage. Due to inefficient and relatively limited DNA repair pathways in bacteria, CRISPR-Cas systems can be repurposed for lethal DNA targeting that selects for sequence variants. In this study, the relative killing efficiencies of endogenous Type I and Type II CRISPR-Cas systems in the model organism Streptococcus thermophilus DGCC7710 were assessed. Additionally, the genetic and phenotypic outcomes of chromosomal targeting by plasmid-programmed Type I-E or Type II-A systems were analyzed. Efficient killing was observed using both systems, in a dose-dependent manner when delivering 0.4–400 ng of plasmid DNA. Targeted PCR screening and genome sequencing were used to determine the genetic basis enabling survival, showing that evasion of Type I-E self-targeting was primarily the result of low-frequency defective plasmids that excised the targeting spacer. The most notable genotype recovered from Type II-A targeting of genomic locus, lacZ, was a 34 kb-deletion derived from homologous recombination (HR) between identical conserved sequences in two separate galE coding regions, resulting in 2% loss of the genome. Collectively, these results suggest that HR contributes to the plasticity and remodeling of bacterial genomes, leading to evasion of genome targeting by CRISPR-Cas systems.}, number={9}, journal={FEMS MICROBIOLOGY LETTERS}, publisher={Oxford University Press (OUP)}, author={Canez, Cassandra and Selle, Kurt and Goh, Yong Jun and Barrangou, Rodolphe}, year={2019}, month={May} } @article{barrangou_2019, title={Partnering with bioRxiv}, volume={2}, DOI={10.1089/crispr.2019.29076.rba}, abstractNote={The CRISPR JournalVol. 2, No. 6 EditorialsPartnering with bioRxivRodolphe BarrangouRodolphe BarrangouSearch for more papers by this authorPublished Online:16 Dec 2019https://doi.org/10.1089/crispr.2019.29076.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Partnering with bioRxiv." The CRISPR Journal, 2(6), p. 342FiguresReferencesRelatedDetails Volume 2Issue 6Dec 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.Partnering with bioRxiv.The CRISPR Journal.Dec 2019.342-342.http://doi.org/10.1089/crispr.2019.29076.rbaPublished in Volume: 2 Issue 6: December 16, 2019PDF download}, number={6}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, pages={342–342} } @article{nethery_barrangou_2019, title={Predicting and visualizing features of CRISPR-Cas systems}, volume={616}, ISSN={["0076-6879"]}, DOI={10.1016/bs.mie.2018.10.016}, abstractNote={Pervasive application of CRISPR–Cas systems in genome editing has prompted an increase in both interest and necessity to further elucidate existing systems as well as discover putative novel systems. The ubiquity and power of current computational platforms have made in silico approaches to CRISPR–Cas identification and characterization accessible to a wider audience and increasingly amenable for processing extensive data sets. Here, we describe in silico methods for predicting and visualizing notable features of CRISPR–Cas systems, including Cas domain determination, CRISPR array visualization, and inference of the protospacer-adjacent motif. The efficiency of these tools enables rapid exploration of CRISPR–Cas diversity across prokaryotic genomes and supports scalable analysis of large genomic data sets.}, journal={CRISPR-CAS ENZYMES}, author={Nethery, Matthew A. and Barrangou, Rodolphe}, year={2019}, pages={1–25} } @article{davis_2019, title={Profile of Rodolphe Barrangou}, volume={116}, DOI={10.1073/pnas.1911079116}, abstractNote={CRISPR, the Instapot of genome editing tools, has its origins in a bacterial immune system that recognizes and slices the genetic material of invading phages. Rodolphe Barrangou, a professor of food science at North Carolina State University, demonstrated the original function of the characteristic repeating genetic sequences long before it became a household word. Barrangou is now turning CRISPR inward, using bacterial cells’ own machinery to edit bacteria. “Unfortunately, bacteria do not typically have good DNA repair mechanisms, so self-targeting usually turns out to be lethal,” explains Barrangou, who was elected to the National Academy of Sciences in 2018. In his Inaugural Article, Barrangou outlines how repurposing the existing type I-E CRISPR-Cas3 system of Lactobacillus crispatus and inserting repair templates can enable targeted editing of this common member of the human microbiome (1). Photograph of Rodolphe Barrangou. Image courtesy of North Carolina State University/Marc Hall. Probiotic bacterium L. acidophilus NCFM. Image courtesy of North Carolina State University/Courtney Klotz, Valerie Lapham, and Charles Mooney. Born in France in 1975, Barrangou found his appetite for science relatively late, when he decided to major in chemistry at the Universite Rene Descartes in Paris. After earning a bachelor’s degree in 1996, he pursued a master’s degree in biological engineering at the Universite de Technologie Compiegne. Barrangou could not envision spending “10 to 20 years working on 1 molecule, 1 project,” as an organic chemist, and engineering was not quite the right fit either. A microbiology class on fermentation propelled him toward a second master’s degree in food science and the field he has helped shape for the past 2 decades. “The living part of microbes was a whole different dimensionality.”}, number={32}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Davis, Tinsley H.}, year={2019}, month={Jul}, pages={15754–15756} } @article{varble_meaden_barrangou_westra_marraffini_2019, title={Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci}, volume={4}, ISSN={["2058-5276"]}, url={https://doi.org/10.1038/s41564-019-0400-2}, DOI={10.1038/s41564-019-0400-2}, abstractNote={CRISPR (clustered regularly interspaced short palindromic repeats) loci and their associated (cas) genes encode an adaptive immune system that protects prokaryotes from viral1 and plasmid2 invaders. Following viral (phage) infection, a small fraction of the prokaryotic cells are able to integrate a small sequence of the invader’s genome into the CRISPR array1. These sequences, known as spacers, are transcribed and processed into small CRISPR RNA guides3–5 that associate with Cas nucleases to specify a viral target for destruction6–9. Although CRISPR−cas loci are widely distributed throughout microbial genomes and often display hallmarks of horizontal gene transfer10–12, the drivers of CRISPR dissemination remain unclear. Here, we show that spacers can recombine with phage target sequences to mediate a form of specialized transduction of CRISPR elements. Phage targets in phage 85, ΦNM1, ΦNM4 and Φ12 can recombine with spacers in either chromosomal or plasmid-borne CRISPR loci in Staphylococcus, leading to either the transfer of CRISPR-adjacent genes or the propagation of acquired immunity to other bacteria in the population, respectively. Our data demonstrate that spacer sequences not only specify the targets of Cas nucleases but also can promote horizontal gene transfer. CRISPR spacers can recombine with phage target sequences to mediate a form of specialized transduction that can promote transfer of CRISPR elements to other bacteria in the population.}, number={6}, journal={NATURE MICROBIOLOGY}, publisher={Springer Nature}, author={Varble, Andrew and Meaden, Sean and Barrangou, Rodolphe and Westra, Edze R. and Marraffini, Luciano A.}, year={2019}, month={Jun}, pages={956–963} } @article{selle_andersen_barrangou_2019, title={Short communication: Transcriptional response to a large genomic island deletion in the dairy starter culture Streptococcus thermophilus}, volume={102}, ISSN={["1525-3198"]}, DOI={10.3168/jds.2019-16397}, abstractNote={Streptococcus thermophilus is a lactic acid bacterium widely used in the syntrophic fermentation of milk into yogurt and cheese. Streptococcus thermophilus has adapted to ferment milk primarily through reductive genome evolution but also through acquisition of genes conferring proto-cooperation with Lactobacillus bulgaricus and efficient metabolism of milk macronutrients. Genomic analysis of Strep. thermophilus strains suggests that mobile genetic elements have contributed to genomic evolution through horizontal gene transfer and genomic plasticity. We previously used the endogenous type II CRISPR-Cas [clustered regularly interspaced short palindromic repeats (CRISPR) with CRISPR-associated sequences (Cas)] system in Strep. thermophilus to isolate derivatives lacking the chromosomal mobile genetic element and expandable island that display decreased fitness under routine culturing conditions. Of note, the Lac operon and Leloir pathway genes were deleted in the largest expendable genomic island (102 kbp), rendering the strain incapable of acidifying milk. However, the removal of other open reading frames in the same island had unclear effects on the fitness and regulatory networks of Strep. thermophilus. To uncover the physiological basis for the observed phenotypic changes and underlying regulatory networks affected by deletion of the 102-kbp genomic island in Strep. thermophilus, we analyzed the transcriptome of the mutant that lacked ∼5% of its genome. In addition to the loss of transcripts encoded by the deleted material, we detected a total of 56 genes that were differentially expressed, primarily encompassing 10 select operons. Several predicted metabolic pathways were affected, including amino acid and purine metabolism, oligopeptide transport, and iron transport. Collectively, these results suggest that deletion of a 102-kb genomic island in Strep. thermophilus influences compensatory transcription of starvation stress response genes and metabolic pathways involved in important niche-related adaptation.}, number={9}, journal={JOURNAL OF DAIRY SCIENCE}, publisher={American Dairy Science Association}, author={Selle, Kurt and Andersen, Joakim M. and Barrangou, Rodolphe}, year={2019}, month={Sep}, pages={7800–7806} } @article{barrangou_2019, title={Taking CRISPR to New Heights}, volume={2}, DOI={10.1089/crispr.2019.29064.rba}, abstractNote={The CRISPR JournalVol. 2, No. 3 EditorialTaking CRISPR to New HeightsRodolphe BarrangouRodolphe BarrangouEditor-in-Chief, The CRISPR Journal.Search for more papers by this authorPublished Online:21 Jun 2019https://doi.org/10.1089/crispr.2019.29064.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Taking CRISPR to New Heights." The CRISPR Journal, 2(3), p. 133FiguresReferencesRelatedDetails Volume 2Issue 3Jun 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.Taking CRISPR to New Heights.The CRISPR Journal.Jun 2019.133-133.http://doi.org/10.1089/crispr.2019.29064.rbaPublished in Volume: 2 Issue 3: June 21, 2019PDF download}, number={3}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, month={Jun}, pages={133–133} } @article{pickar-oliver_black_lewis_mutchnick_klann_gilcrest_sitton_nelson_barrera_bartelt_et al._2019, title={Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells}, volume={37}, ISSN={["1546-1696"]}, DOI={10.1038/s41587-019-0235-7}, abstractNote={Class 2 CRISPR–Cas systems, such as Cas9 and Cas12, have been widely used to target DNA sequences in eukaryotic genomes. However, class 1 CRISPR–Cas systems, which represent about 90% of all CRISPR systems in nature, remain largely unexplored for genome engineering applications. Here, we show that class 1 CRISPR–Cas systems can be expressed in mammalian cells and used for DNA targeting and transcriptional control. We repurpose type I variants of class 1 CRISPR–Cas systems from Escherichia coli and Listeria monocytogenes, which target DNA via a multi-component RNA-guided complex termed Cascade. We validate Cascade expression, complex formation and nuclear localization in human cells, and demonstrate programmable CRISPR RNA (crRNA)-mediated targeting of specific loci in the human genome. By tethering activation and repression domains to Cascade, we modulate the expression of targeted endogenous genes in human cells. This study demonstrates the use of Cascade as a CRISPR-based technology for targeted eukaryotic gene regulation, highlighting class 1 CRISPR–Cas systems for further exploration. Type I CRISPR–Cas systems, the largest group of CRISPR systems in nature, can be repurposed for DNA targeting and gene regulation in human cells}, number={12}, journal={NATURE BIOTECHNOLOGY}, publisher={Springer Science and Business Media LLC}, author={Pickar-Oliver, Adrian and Black, Joshua B. and Lewis, Mae M. and Mutchnick, Kevin J. and Klann, Tyler S. and Gilcrest, Kylie A. and Sitton, Madeleine J. and Nelson, Christopher E. and Barrera, Alejandro and Bartelt, Luke C. and et al.}, year={2019}, month={Dec}, pages={1493-+} } @article{young_gasior_jones_wang_navarro_vickroy_barrangou_2019, title={The repurposing of type I-E CRISPR-Cascade for gene activation in plants}, url={https://doi.org/10.1038/s42003-019-0637-6}, DOI={10.1038/s42003-019-0637-6}, abstractNote={Abstract CRISPR-Cas systems are robust and facile tools for manipulating the genome, epigenome and transcriptome of eukaryotic organisms. Most groups use class 2 effectors, such as Cas9 and Cas12a, however, other CRISPR-Cas systems may provide unique opportunities for genome engineering. Indeed, the multi-subunit composition of class 1 systems offers to expand the number of domains and functionalities that may be recruited to a genomic target. Here we report DNA targeting in Zea mays using a class 1 type I-E CRISPR-Cas system from S. thermophilus . First, we engineer its Cascade complex to modulate gene expression by tethering a plant transcriptional activation domain to 3 different subunits. Next, using an immunofluorescent assay, we confirm Cascade cellular complex formation and observe enhanced gene activation when multiple subunits tagged with the transcriptional activator are combined. Finally, we examine Cascade mediated gene activation at chromosomal DNA targets by reprogramming Zea mays cells to change color.}, journal={Communications Biology}, author={Young, Joshua K. and Gasior, Stephen L. and Jones, Spencer and Wang, Lijuan and Navarro, Pedro and Vickroy, Becca and Barrangou, Rodolphe}, year={2019}, month={Oct} } @article{barrangou_2019, title={Thinking About CRISPR: The Ethics of Human Genome Editing}, volume={2}, DOI={10.1089/crispr.2019.29072.rba}, abstractNote={The CRISPR JournalVol. 2, No. 5 EditorialThinking About CRISPR: The Ethics of Human Genome EditingRodolphe BarrangouRodolphe BarrangouEditor-in-Chief, The CRISPR Journal.Search for more papers by this authorPublished Online:9 Oct 2019https://doi.org/10.1089/crispr.2019.29072.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Thinking About CRISPR: The Ethics of Human Genome Editing." The CRISPR Journal, 2(5), pp. 247–248FiguresReferencesRelatedDetailsCited byDemocratizing CRISPR? Stories, practices, and politics of science and governance on the agricultural gene editing frontier25 February 2020 | Elementa: Science of the Anthropocene, Vol. 8 Volume 2Issue 5Oct 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.Thinking About CRISPR: The Ethics of Human Genome Editing.The CRISPR Journal.Oct 2019.247-248.http://doi.org/10.1089/crispr.2019.29072.rbaPublished in Volume: 2 Issue 5: October 9, 2019PDF download}, number={5}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, month={Oct}, pages={247–248} } @article{barrangou_2019, title={Time To Let CRISPR B.E.?}, volume={2}, DOI={10.1089/crispr.2019.29055.rdb}, abstractNote={The CRISPR JournalVol. 2, No. 2 EditorialTime To Let CRISPR B.E.?Rodolphe BarrangouRodolphe BarrangouEditor-in-Chief, The CRISPR JournalSearch for more papers by this authorPublished Online:18 Apr 2019https://doi.org/10.1089/crispr.2019.29055.rdbAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Time To Let CRISPR B.E.?." The CRISPR Journal, 2(2), p. 67FiguresReferencesRelatedDetails Volume 2Issue 2Apr 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.Time To Let CRISPR B.E.?.The CRISPR Journal.Apr 2019.67-67.http://doi.org/10.1089/crispr.2019.29055.rdbPublished in Volume: 2 Issue 2: April 18, 2019PDF download}, number={2}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2019}, month={Apr}, pages={67–67} } @misc{donohoue_barrangou_may_2018, title={Advances in Industrial Biotechnology Using CRISPR-Cas Systems}, volume={36}, ISSN={["1879-3096"]}, DOI={10.1016/j.tibtech.2017.07.007}, abstractNote={The term 'clustered regularly interspaced short palindromic repeats' (CRISPR) has recently become synonymous with the genome-editing revolution. The RNA-guided endonuclease CRISPR-associated protein 9 (Cas9), in particular, has attracted attention for its promise in basic research and gene editing-based therapeutics. CRISPR-Cas systems are efficient and easily programmable nucleic acid-targeting tools, with uses reaching beyond research and therapeutic development into the precision breeding of plants and animals and the engineering of industrial microbes. CRISPR-Cas systems have potential for many microbial engineering applications, including bacterial strain typing, immunization of cultures, autoimmunity or self-targeted cell killing, and the engineering or control of metabolic pathways for improved biochemical synthesis. In this review, we explore the fundamental characteristics of CRISPR-Cas systems and highlight how these features can be used in industrial settings.}, number={2}, journal={TRENDS IN BIOTECHNOLOGY}, publisher={Elsevier BV}, author={Donohoue, Paul D. and Barrangou, Rodolphe and May, Andrew P.}, year={2018}, month={Feb}, pages={134–146} } @article{barrangou_2018, title={CRISPR Craziness: A Response to the EU Court Ruling}, volume={1}, DOI={10.1089/crispr.2018.29025.edi}, abstractNote={The CRISPR JournalVol. 1, No. 4 EditorialsCRISPR Craziness: A Response to the EU Court RulingRodolphe BarrangouRodolphe BarrangouEditor-in-Chief, The CRISPR Journal.Search for more papers by this authorPublished Online:1 Aug 2018https://doi.org/10.1089/crispr.2018.29025.ediAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"CRISPR Craziness: A Response to the EU Court Ruling." The CRISPR Journal, 1(4), pp. 251–252FiguresReferencesRelatedDetailsCited byCRISPR-Cas Genome Editing for Horticultural Crops Improvement: Advantages and Prospects30 December 2022 | Horticulturae, Vol. 9, No. 1Consumer Evaluation of Novel Plant-Breeding Technologies: A Decision-Focused Research Agenda4 January 2023CRISPR and Chromothripsis: Proceed with Caution Stephanie Mack and I. Alasdair Russell16 June 2021 | The CRISPR Journal, Vol. 4, No. 3A Field Day for Gene-Edited Brassicas and Crop Improvement Johnathan A. Napier16 June 2021 | The CRISPR Journal, Vol. 4, No. 3How should we regulate products of new breeding techniques? Opinion of surveyed experts in plant biotechnologyBiotechnology Reports, Vol. 26European Court of Justice ruling regarding new genetic engineering methods scientifically justified: a commentary on the biased reporting about the recent ruling20 December 2018 | Environmental Sciences Europe, Vol. 30, No. 1 Volume 1Issue 4Aug 2018 InformationCopyright 2018, Mary Ann Liebert, Inc.To cite this article:Rodolphe Barrangou.CRISPR Craziness: A Response to the EU Court Ruling.The CRISPR Journal.Aug 2018.251-252.http://doi.org/10.1089/crispr.2018.29025.ediPublished in Volume: 1 Issue 4: August 1, 2018PDF download}, number={4}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2018}, month={Aug}, pages={251–252} } @article{barrangou_2018, title={CRISPR Crossroads for Genome Editing}, volume={1}, DOI={10.1089/crispr.2018.29040.rba}, abstractNote={The CRISPR JournalVol. 1, No. 6 EditorialCRISPR Crossroads for Genome EditingRodolphe BarrangouRodolphe BarrangouEditor-in-Chief, The CRISPR JournalSearch for more papers by this authorPublished Online:20 Dec 2018https://doi.org/10.1089/crispr.2018.29040.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"CRISPR Crossroads for Genome Editing." The CRISPR Journal, 1(6), pp. 349–350FiguresReferencesRelatedDetailsCited byRealigning gene editing with clinical research ethics: What the “CRISPR Twins” debacle means for Chinese and international research ethics governance17 May 2019 | Accountability in Research, Vol. 26, No. 4 Volume 1Issue 6Dec 2018 InformationCopyright 2018, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.CRISPR Crossroads for Genome Editing.The CRISPR Journal.Dec 2018.349-350.http://doi.org/10.1089/crispr.2018.29040.rbaPublished in Volume: 1 Issue 6: December 20, 2018PDF download}, number={6}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2018}, pages={349–350} } @article{crawley_henriksan_barranaou_2018, title={CRISPRdisco: An Automated Pipeline for the Discovery and Analysis of CRISPR-Cas Systems}, volume={1}, ISSN={["2573-1602"]}, DOI={10.1089/crispr.2017.0022}, abstractNote={CRISPR-Cas adaptive immune systems of bacteria and archaea have catapulted into the scientific spotlight as genome editing tools. To aid researchers in the field, we have developed an automated pipeline, named CRISPRdisco (CRISPR discovery), to identify CRISPR repeats and cas genes in genome assemblies, determine type and subtype, and describe system completeness. All six major types and 23 currently recognized subtypes and novel putative V-U types are detected. Here, we use the pipeline to identify and classify putative CRISPR-Cas systems in 2,777 complete genomes from the NCBI RefSeq database. This allows comparison to previous publications and investigation of the occurrence and size of CRISPR-Cas systems. Software available at http://github.com/crisprlab/CRISPRdisco provides reproducible, standardized, accessible, transparent, and high-throughput analysis methods available to all researchers in and beyond the CRISPR-Cas research community. This tool opens new avenues to enable classification within a complex nomenclature and provides analytical methods in a field that has evolved rapidly.}, number={2}, journal={CRISPR JOURNAL}, publisher={Mary Ann Liebert Inc}, author={Crawley, Alexandra R. and Henriksan, Jams R. and Barranaou, Rodolphe}, year={2018}, month={Apr}, pages={171–181} } @article{crawley_henriksen_stout_brandt_barrangou_2018, title={Characterizing the activity of abundant, diverse and active CRISPR-Cas systems in lactobacilli}, volume={8}, ISSN={2045-2322}, url={http://dx.doi.org/10.1038/S41598-018-29746-3}, DOI={10.1038/s41598-018-29746-3}, abstractNote={CRISPR-Cas systems provide immunity against phages and plasmids in bacteria and archaea. Despite the popularity of CRISPR-Cas9 based genome editing, few endogenous systems have been characterized to date. Here, we sampled 1,262 publically available lactobacilli genomes found them to be enriched with CRISPR-Cas adaptive immunity. While CRISPR-Cas is ubiquitous in some Lactobacillus species, CRISPR-Cas content varies at the strain level in most Lactobacillus species. We identified that Type II is the most abundant type across the genus, with II-A being the most dominant sub-type. We found that many Type II-A systems are actively transcribed, and encode spacers that efficiently provide resistance against plasmid uptake. Analysis of various CRISPR transcripts revealed that guide sequences are highly diverse in terms of crRNA and tracrRNA length and structure. Interference assays revealed highly diverse target PAM sequences. Lastly, we show that these systems can be readily repurposed for self-targeting by expressing an engineered single guide RNA. Our results reveal that Type II-A systems in lactobacilli are naturally active in their native host in terms of expression and efficiently targeting invasive and genomic DNA. Together, these systems increase the possible Cas9 targeting space and provide multiplexing potential in native hosts and heterologous genome editing purpose.}, number={1}, journal={Scientific Reports}, publisher={Springer Science and Business Media LLC}, author={Crawley, Alexandra B. and Henriksen, Emily D. and Stout, Emily and Brandt, Katelyn and Barrangou, Rodolphe}, year={2018}, month={Aug} } @article{crawley_barrangou_2018, title={Conserved Genome Organization and Core Transcriptome of the Lactobacillus acidophilus Complex}, volume={9}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2018.01834}, abstractNote={The Lactobacillus genus encompasses a genetically and functionally diverse group of species, and contains many strains widely formulated in the human food supply chain as probiotics and starter cultures. Within this genetically expansive group, there are several distinct clades that have high levels of homology, one of which is the Lactobacillus acidophilus group. Of the uniting features, small genomes, low GC content, adaptation to dairy environments, and fastidious growth requirements, are some of the most defining characteristics of this group. To better understand what truly links and defines this clade, we sought to characterize the genomic organization and content of the genomes of several members of this group. Through core genome analysis we explored the synteny and intrinsic genetic underpinnings of the L. acidophilus clade, and observed key features related to the evolution and adaptation of these organisms. While genetic content is able to provide a large map of the potential of each organism, it does not always reflect their functionality. Through transcriptomic data we inferred the core transcriptome of the L. acidophilus complex to better define the true metabolic capabilities that unite this clade. Using this approach we have identified seven small ORFs that are both highly conserved and transcribed in diverse members of this clade and could be potential novel small peptide or untranslated RNA regulators. Overall, our results reveal the core features of the L. acidophilus complex and open new avenues for the enhancement and formulation and of next generation probiotics and starter cultures.}, journal={FRONTIERS IN MICROBIOLOGY}, publisher={Frontiers Media SA}, author={Crawley, Alexandra B. and Barrangou, Rodolphe}, year={2018}, month={Aug} } @article{barrangou_2018, title={Cultivating CRISPR}, volume={1}, DOI={10.1089/crispr.2018.29011.rba}, abstractNote={The CRISPR JournalVol. 1, No. 2 EditorialCultivating CRISPRRodolphe BarrangouRodolphe BarrangouSearch for more papers by this authorPublished Online:1 Apr 2018https://doi.org/10.1089/crispr.2018.29011.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Cultivating CRISPR." The CRISPR Journal, 1(2), pp. 99–100FiguresReferencesRelatedDetails Volume 1Issue 2Apr 2018 InformationCopyright 2018, Mary Ann Liebert, Inc.To cite this article:Rodolphe Barrangou.Cultivating CRISPR.The CRISPR Journal.Apr 2018.99-100.http://doi.org/10.1089/crispr.2018.29011.rbaPublished in Volume: 1 Issue 2: April 1, 2018PDF download}, number={2}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2018}, month={Apr}, pages={99–100} } @article{stout_sanozky-dawes_goh_crawley_klaenhammer_barrangou_2018, title={Deletion-based escape of CRISPR-Cas9 targeting in Lactobacillus gasseri}, volume={164}, ISSN={["1465-2080"]}, DOI={10.1099/mic.0.000689}, abstractNote={Lactobacillus gasseri is a human commensal which carries CRISPR-Cas, an adaptive immune system that protects the cell from invasive mobile genetic elements (MGEs). However, MGEs occasionally escape CRISPR targeting due to DNA mutations that occur in sequences involved in CRISPR interference. To better understand CRISPR escape processes, a plasmid interference assay was used to screen for mutants that escape CRISPR-Cas targeting. Plasmids containing a target sequence and a protospacer adjacent motif (PAM) were transformed for targeting by the native CRISPR-Cas system. Although the primary outcome of the assay was efficient interference, a small proportion of the transformed population overcame targeting. Mutants containing plasmids that had escaped were recovered to investigate the genetic routes of escape and their relative frequencies. Deletion of the targeting spacer in the native CRISPR array was the dominant pattern of escape, accounting for 52-70 % of the mutants from two L. gasseri strains. We repeatedly observed internal deletions in the chromosomal CRISPR array, characterized by polarized excisions from the leader end that spanned 1-15 spacers, and systematically included the leader-proximal targeting spacer. This study shows that deletions of spacers within CRISPR arrays constitute a key escape mechanism to evade CRISPR targeting, while preserving the functionality of the CRISPR-Cas system. This mechanism enables cells to maintain an active immune system, but allows the uptake of potentially beneficial plasmids. Our study revealed the co-occurrence of other genomic mutations associated with various phenotypes, showing how this selection process uncovers population diversification.}, number={9}, journal={MICROBIOLOGY-SGM}, publisher={Microbiology Society}, author={Stout, Emily A. and Sanozky-Dawes, Rosemary and Goh, Yong Jun and Crawley, Alexandra B. and Klaenhammer, Todd R. and Barrangou, Rodolphe}, year={2018}, month={Sep}, pages={1098–1111} } @article{lamanna_barrangou_2018, title={Enabling the Rise of a CRISPR World}, volume={1}, DOI={10.1089/crispr.2018.0022}, abstractNote={CRISPR technology has dramatically changed scientists' ability to conduct research in medicine, biotechnology, and agriculture through faster, more efficient genome editing. A key driver of the technology's adoption is the easy, fast, and inexpensive access to vectors and the resulting next-generation tools by the nonprofit plasmid repository Addgene. Since 2013, Addgene has shipped over 100,000 CRISPR plasmids to more than 75 countries worldwide. This pipeline of new technologies is enabling cutting-edge research to address the grand challenges of mankind.}, number={3}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={LaManna, Caroline M. and Barrangou, Rodolphe}, year={2018}, month={Jun}, pages={205–208} } @misc{klotz_barrangou_2018, title={Engineering Components of the Lactobacillus S-Layer for Biotherapeutic Applications}, volume={9}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2018.02264}, abstractNote={Lactic acid bacteria (LAB) are frequently harnessed for the delivery of biomolecules to mucosal tissues. Several species of Lactobacillus are commonly employed for this task, of which a subset are known to possess surface-layers (S-layers). The S-layer is a two-dimensional crystalline array of repeating proteinaceous subunits that forms the outermost coating of many prokaryotic cell envelopes. Its periodicity and abundance have made it a target for numerous biotechnological applications, including delivery of therapeutic proteins and vaccine antigens. In the following review, we examine the multi-faceted S-layer protein (Slp), and its use in both heterologous protein expression and mucosal vaccine delivery, through its diverse genetic components: the strong native promoter, capable of synthesizing as many as 500 Slp subunits per second; the signal peptide that stimulates robust secretion of target proteins; and the structural domains, which can be harnessed for both cell surface display of a foreign peptide or adhesion enhancement of a host bacterium. Although numerous studies have established vaccine platforms based on one or more components of the Lactobacillus S-layer, this area of research remains largely in its infancy, thus this review not only highlights past works, but also advocates for the future use of Slps in mucosal vaccine research.}, journal={FRONTIERS IN MICROBIOLOGY}, publisher={Frontiers Media SA}, author={Klotz, Courtney and Barrangou, Rodolphe}, year={2018}, month={Oct} } @article{barrangou_2018, title={Expanding the CRISPR Landscape on a cas by cas Basis}, volume={1}, DOI={10.1089/crispr.2018.29035.rba}, abstractNote={The CRISPR JournalVol. 1, No. 5 EditorialExpanding the CRISPR Landscape on a cas by cas BasisRodolphe BarrangouRodolphe BarrangouEditor-in-Chief, The CRISPR Journal.Search for more papers by this authorPublished Online:17 Oct 2018https://doi.org/10.1089/crispr.2018.29035.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Expanding the CRISPR Landscape on a cas by cas Basis." The CRISPR Journal, 1(5), p. 303FiguresReferencesRelatedDetails Volume 1Issue 5Oct 2018 InformationCopyright 2018, Mary Ann Liebert, Inc., publishersTo cite this article:Rodolphe Barrangou.Expanding the CRISPR Landscape on a cas by cas Basis.The CRISPR Journal.Oct 2018.303-303.http://doi.org/10.1089/crispr.2018.29035.rbaPublished in Volume: 1 Issue 5: October 17, 2018PDF download}, number={5}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2018}, month={Oct}, pages={303–303} } @article{weissman_holmes_barrangou_moineau_fagan_levin_johnson_2018, title={Immune loss as a driver of coexistence during host-phage coevolution}, volume={12}, ISSN={["1751-7370"]}, DOI={10.1038/ismej.2017.194}, abstractNote={Bacteria and their viral pathogens face constant pressure for augmented immune and infective capabilities, respectively. Under this reciprocally imposed selective regime, we expect to see a runaway evolutionary arms race, ultimately leading to the extinction of one species. Despite this prediction, in many systems host and pathogen coexist with minimal coevolution even when well-mixed. Previous work explained this puzzling phenomenon by invoking fitness tradeoffs, which can diminish an arms race dynamic. Here we propose that the regular loss of immunity by the bacterial host can also produce host-phage coexistence. We pair a general model of immunity with an experimental and theoretical case study of the CRISPR-Cas immune system to contrast the behavior of tradeoff and loss mechanisms in well-mixed systems. We find that, while both mechanisms can produce stable coexistence, only immune loss does so robustly within realistic parameter ranges.}, number={2}, journal={ISME JOURNAL}, publisher={Springer Science and Business Media LLC}, author={Weissman, Jake L. and Holmes, Rayshawn and Barrangou, Rodolphe and Moineau, Sylvain and Fagan, William F. and Levin, Bruce and Johnson, Philip L. F.}, year={2018}, month={Feb}, pages={585–597} } @misc{hidalgo-cantabrana_sanozky-dawes_barrangou_2018, title={Insights into the Human Virome Using CRISPR Spacers from Microbiomes}, volume={10}, ISSN={["1999-4915"]}, url={https://doi.org/10.3390/v10090479}, DOI={10.3390/v10090479}, abstractNote={Due to recent advances in next-generation sequencing over the past decade, our understanding of the human microbiome and its relationship to health and disease has increased dramatically. Yet, our insights into the human virome, and its interplay with important microbes that impact human health, is relatively limited. Prokaryotic and eukaryotic viruses are present throughout the human body, comprising a large and diverse population which influences several niches and impacts our health at various body sites. The presence of prokaryotic viruses like phages, has been documented at many different body sites, with the human gut being the richest ecological niche. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and associated proteins constitute the adaptive immune system of bacteria, which prevents attack by invasive nucleic acid. CRISPR-Cas systems function by uptake and integration of foreign genetic element sequences into the CRISPR array, which constitutes a genomic archive of iterative vaccination events. Consequently, CRISPR spacers can be investigated to reconstruct interplay between viruses and bacteria, and metagenomic sequencing data can be exploited to provide insights into host-phage interactions within a niche. Here, we show how the CRISPR spacer content of commensal and pathogenic bacteria can be used to determine the evidence of their phage exposure. This framework opens new opportunities for investigating host-virus dynamics in metagenomic data, and highlights the need to dedicate more efforts for virome sampling and sequencing.}, number={9}, journal={VIRUSES-BASEL}, author={Hidalgo-Cantabrana, Claudio and Sanozky-Dawes, Rosemary and Barrangou, Rodolphe}, year={2018}, month={Sep} } @article{barrangou_2018, title={Keep Calm and CRISPR On}, volume={1}, ISSN={["2573-1602"]}, DOI={10.1089/crispr.2017.29000.rba}, abstractNote={The CRISPR JournalVol. 1, No. 1 EditorialKeep Calm and CRISPR OnRodolphe BarrangouRodolphe BarrangouSearch for more papers by this authorPublished Online:1 Feb 2018https://doi.org/10.1089/crispr.2017.29000.rbaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byDevelopment of CNN Model for Prediction of CRISPR/Cas12 Guide RNA Activity20 November 2019Breaking the germline barrier in a moral vacuum26 July 2019 | Accountability in Research, Vol. 26, No. 6Collateral damage and CRISPR genome editing14 March 2019 | PLOS Genetics, Vol. 15, No. 3How to talk about genome editing25 April 2018 | British Medical Bulletin, Vol. 126, No. 1 Volume 1Issue 1Feb 2018 InformationCopyright 2018, Mary Ann Liebert, Inc.To cite this article:Rodolphe Barrangou.Keep Calm and CRISPR On.The CRISPR Journal.Feb 2018.1-3.http://doi.org/10.1089/crispr.2017.29000.rbaPublished in Volume: 1 Issue 1: February 1, 2018Online Ahead of Print:January 8, 2018PDF download}, number={1}, journal={CRISPR JOURNAL}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2018}, month={Feb}, pages={1–3} } @article{anderson_mcclelland_maksimova_strezoska_basila_briner_barrangou_smith_2018, title={Lactobacillus gasseri CRISPR-Cas9 characterization In Vitro reveals a flexible mode of protospacer-adjacent motif recognition}, volume={13}, ISSN={["1932-6203"]}, DOI={10.1371/journal.pone.0192181}, abstractNote={While the CRISPR-Cas9 system from S. pyogenes is a powerful genome engineering tool, additional programmed nucleases would enable added flexibility in targeting space and multiplexing. Here, we characterized a CRISPR-Cas9 system from L. gasseri and found that it has modest activity in a cell-free lysate assay but no activity in mammalian cells even when altering promoter, position of tag sequences and NLS, and length of crRNA:tracrRNA. In the lysate assay we tested over 400 sequential crRNA target sequences and found that the Lga Cas9 PAM is NNGA/NDRA, different than NTAA predicted from the native bacterial host. In addition, we found multiple instances of consecutive crRNA target sites, indicating flexibility in either PAM sequence or distance from the crRNA target site. This work highlights the need for characterization of new CRISPR systems and highlights the non-triviality of porting them into eukaryotes as gene editing tools.}, number={2}, journal={PLOS ONE}, publisher={Public Library of Science (PLoS)}, author={Anderson, Emily M. and McClelland, Shawn and Maksimova, Elena and Strezoska, Zaklina and Basila, Megan and Briner, Alexandra E. and Barrangou, Rodolphe and Smith, Anja van Brabant}, editor={Xu, Shuang-yongEditor}, year={2018}, month={Feb} } @article{davies_barrangou_2018, title={MasterChef at Work: An Interview with Rodolphe Barrangou}, volume={1}, DOI={10.1089/crispr.2018.29015.int}, abstractNote={The CRISPR JournalVol. 1, No. 3 InterviewMasterChef at Work: An Interview with Rodolphe BarrangouKevin Davies and Rodolphe BarrangouKevin DaviesSearch for more papers by this author and Rodolphe BarrangouSearch for more papers by this authorPublished Online:1 Jun 2018https://doi.org/10.1089/crispr.2018.29015.intAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 1Issue 3Jun 2018 InformationCopyright 2018, Mary Ann Liebert, Inc.To cite this article:Kevin Davies and Rodolphe Barrangou.MasterChef at Work: An Interview with Rodolphe Barrangou.The CRISPR Journal.Jun 2018.219-222.http://doi.org/10.1089/crispr.2018.29015.intPublished in Volume: 1 Issue 3: June 1, 2018PDF download}, number={3}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Davies, Kevin and Barrangou, Rodolphe}, year={2018}, month={Jun}, pages={219–222} } @article{barrangou_oost_2018, title={Mining for novel bacterial defence systems}, volume={3}, ISSN={["2058-5276"]}, DOI={10.1038/s41564-018-0149-z}, abstractNote={Bacteria encode many strategies to prevent or escape infection. Through the analysis of metagenomic dark matter, several novel defence systems were identified, some of which were engineered and characterized in vivo, showing that they provide resistance against viruses and plasmids.}, number={5}, journal={NATURE MICROBIOLOGY}, publisher={Springer Science and Business Media LLC}, author={Barrangou, Rodolphe and Oost, John}, year={2018}, month={May}, pages={535–536} } @article{daughtry_johanningsmeier_sanozky-dawes_klaenhammer_barrangou_2018, title={Phenotypic and genotypic diversity of Lactobacillus buchneri strains isolated from spoiled, fermented cucumber}, volume={280}, ISSN={["1879-3460"]}, DOI={10.1016/j.ijfoodmicro.2018.04.044}, abstractNote={Lactobacillus buchneri is a Gram-positive, obligate heterofermentative, facultative anaerobe commonly affiliated with spoilage of food products. Notably, L. buchneri is able to metabolize lactic acid into acetic acid and 1,2-propanediol. Although beneficial to the silage industry, this metabolic capability is detrimental to preservation of cucumbers by fermentation. The objective of this study was to characterize isolates of L. buchneri purified from both industrial and experimental fermented cucumber after the onset of secondary fermentation. Genotypic and phenotypic characterization included 16S rRNA sequencing, DiversiLab® rep-PCR, colony morphology, API 50 CH carbohydrate analysis, and ability to degrade lactic acid in modified MRS and fermented cucumber media. Distinct groups of isolates were identified with differing colony morphologies that varied in color (translucent white to opaque yellow), diameter (1 mm–11 mm), and shape (umbonate, flat, circular or irregular). Growth rates in MRS revealed strain differences, and a wide spectrum of carbon source utilization was observed. Some strains were able to ferment as many as 21 of 49 tested carbon sources, including inulin, fucose, gentiobiose, lactose, mannitol, potassium ketogluconate, saccharose, raffinose, galactose, and xylose, while others metabolized as few as eight carbohydrates as the sole source of carbon. All isolates degraded lactic acid in both fermented cucumber medium and modified MRS, but exhibited differences in the rate and extent of lactate degradation. Isolates clustered into eight distinct groups based on rep-PCR fingerprints with 20 of 36 of the isolates exhibiting >97% similarity. Although isolated from similar environmental niches, significant phenotypic and genotypic diversity was found among the L. buchneri cultures. A collection of unique L. buchneri strains was identified and characterized, providing the basis for further analysis of metabolic and genomic capabilities of this species to enable control of lactic acid degradation in fermented plant materials.}, journal={INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY}, publisher={Elsevier BV}, author={Daughtry, Katheryne V and Johanningsmeier, Suzanne D. and Sanozky-Dawes, Rosemary and Klaenhammer, Todd R. and Barrangou, Rodolphe}, year={2018}, month={Sep}, pages={46–56} } @article{curchoe_barrangou_2018, title={Pomp and Circumstance: Making the Case for CRISPR}, volume={1}, DOI={10.1089/crispr.2018.29030.oxf}, abstractNote={The CRISPR JournalVol. 1, No. 4 EditorialsPomp and Circumstance: Making the Case for CRISPRCarol Lynn Curchoe and Rodolphe BarrangouCarol Lynn CurchoeSan Diego Fertility Center and 32ATPs, San Diego, CaliforniaSearch for more papers by this author and Rodolphe BarrangouEditor-in-Chief, The CRISPR Journal.Search for more papers by this authorPublished Online:1 Aug 2018https://doi.org/10.1089/crispr.2018.29030.oxfAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Pomp and Circumstance: Making the Case for CRISPR." The CRISPR Journal, 1(4), pp. 253–254FiguresReferencesRelatedDetails Volume 1Issue 4Aug 2018 InformationCopyright 2018, Mary Ann Liebert, Inc.To cite this article:Carol Lynn Curchoe and Rodolphe Barrangou.Pomp and Circumstance: Making the Case for CRISPR.The CRISPR Journal.Aug 2018.253-254.http://doi.org/10.1089/crispr.2018.29030.oxfPublished in Volume: 1 Issue 4: August 1, 2018PDF download}, number={4}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Curchoe, Carol Lynn and Barrangou, Rodolphe}, year={2018}, month={Aug}, pages={253–254} } @article{gersbach_barrangou_2018, title={Pulling the genome in opposite directions to dissect gene networks}, volume={19}, DOI={10.1186/s13059-018-1425-1}, abstractNote={Orthogonal CRISPR-Cas systems have been integrated into combinatorial screens to decipher complex genetic relationships in two recent studies.}, number={1}, journal={Genome Biology}, publisher={Springer Science and Business Media LLC}, author={Gersbach, Charles A. and Barrangou, Rodolphe}, year={2018}, month={Mar} } @article{gersbach_barrangou_2018, title={Pulling the genome in opposite directions to dissect gene networks}, volume={19}, journal={Genome Biology}, author={Gersbach, C. A. and Barrangou, R.}, year={2018} } @article{barrangou_2018, title={The Democratization of CRISPR}, volume={1}, DOI={10.1089/crispr.2018.29019.rba}, abstractNote={The CRISPR JournalVol. 1, No. 3 EditorialFree AccessThe Democratization of CRISPRRodolphe BarrangouRodolphe BarrangouSearch for more papers by this authorPublished Online:1 Jun 2018https://doi.org/10.1089/crispr.2018.29019.rbaAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail By many measures, CRISPR*-based technologies and their applications have taken over the world in the past few years, and the CRISPR era is upon us. Much like cloning and PCR in prior decades, CRISPR stands to become a generation-defining technology. Indeed, as illustrated on the cover of this issue and discussed in the Perspective by LaManna and Barrangou on page 205, researchers continue to advance, develop, and implement a wide array of CRISPR tools, which are now being circulated globally in real time by Addgene. Embraced by commercial entities and fueled by motivated investors, the commercialization of CRISPR is next.The goal of making CRISPR openly available, regardless of location, political, or regulatory consideration, epitomizes the mission of Addgene, a nonprofit organization aimed at empowering academic laboratories by granting access to cutting-edge technologies and advance science. This is a noteworthy departure from ongoing intellectual-property disputes—and a refreshing digression from some perplexing steep licensing fees charged by not-for-profit academic institutions that hold rights to CRISPR tools.The numbers alone reflect the Addgene-enabled pervasiveness of CRISPR, not just in North America, Europe, and Asia, but also in many third world countries. CRISPR is no longer an exclusive technology but rather universal—internationally, culturally, and socially. For example, new applications of CRISPR in a diagnostic context offer great potential in territories at risk of disease outbreaks with limited resources (see the First Cut article by Karl Petri and Vikram Pattanayak, page 209). Naturally, governments and the public are actively evaluating how this technology should be managed; their opinions and actions will have widespread impact on both science and society.Public opinion has proven to be a powerful modulator of scientific progress, leading to long-lasting repercussions for many countries. As always, one hopes that scientifically informed decisions will be made, but history and recent events remind us that this is not always the case, given the public perception about science, use of misguided terms such as “frankenfood” and “designer babies” by the media, and historical shortcomings displayed by the agriculture (Ag) industry with regard to public relations, communications, and stewardship. Yet, there is hope. While much focus has been on the science, we should be mindful of the people driving these efforts. Indeed, scientists spend decades training and preparing for such opportunities and dedicate most of their lives to solving problems and creating solutions. The recent “Unite to Cure” conference at the Vatican signaled a new chapter for CRISPR acceptance and stewardship (see the First Cut by Davies on page 213) and extends a crucial dialogue about ethical implications and societal engagement.Already, CRISPR is transcending not just scientific and economic boundaries for medicine and agriculture, but also religious, ethical, and societal frontiers. Besides the well-documented therapeutic implications, notwithstanding recent Food and Drug Administration clarification requests, many signs already point to tremendous benefits pending in agriculture (see the First Cut by Willmann on page 211). Arguably, agriculture is poised to win the CRISPR race: teams of scientists in academia and industry, including “big Ag” and several new start-up companies, are harnessing next-generation breeding of crops and livestock to help feed the world. The benefits comprise classical targets such as increased yield, pest management, and drought resistance to address the food gap for our rapidly expanding population. Efforts increasingly encompass sustainability, with improved water usage and efficient land management receiving critical attention. We need more food, but also a safer and healthier supply chain, globally.Our ability to bring CRISPR to the people hinges on both supportive adjudication by regulatory agencies and legislators as well as public acceptance of science and technology. The challenges are formidable given skepticism of “big Ag” along with confusion and uncertainty over what CRISPR actually entails. Actually, there is an opportunity for both sides to discuss how to best regulate genome editing to encourage support rather than constrain the advancement and exploitation of these beneficial technologies.A major milestone was the March 2018 announcement by the U.S. Department of Agriculture stating that it will not regulate genetically edited plants that recapitulate traditional breeding results is encouraging, but this is only the beginning. Concerted efforts by multiple communities and stakeholders are underway to formalize the regulatory landscape with input from academics and PR experts. Those addressing the food gap and harnessing CRISPR-based technologies to ensure a healthier and more sustainable food supply must better convey how critical, impactful, and noble their efforts are. Unity, caution, transparency, and engagement constitute the path forward. A series of recent and forthcoming meetings will define the ability of CRISPR to make progress in the short term.For CRISPR to realize its obvious potential, the scientific community must strive to share its progress with all stakeholders: we all need to do a better job at communicating about science in general and telling and spreading the CRISPR story in particular. It is unclear if and how quickly we will get there.* Clustered Regularly Interspaced Short Palindromic Repeats.FiguresReferencesRelatedDetails Volume 1Issue 3Jun 2018 InformationCopyright 2018, Mary Ann Liebert, Inc.To cite this article:Rodolphe Barrangou.The Democratization of CRISPR.The CRISPR Journal.Jun 2018.203-204.http://doi.org/10.1089/crispr.2018.29019.rbaPublished in Volume: 1 Issue 3: June 1, 2018PDF download}, number={3}, journal={The CRISPR Journal}, publisher={Mary Ann Liebert Inc}, author={Barrangou, Rodolphe}, year={2018}, month={Jun}, pages={203–204} } @article{o'flaherty_crawley_theriot_barrangou_2018, title={The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation}, volume={3}, ISSN={["2379-5042"]}, url={https://doi.org/10.1128/mSphere.00140-18}, DOI={10.1128/msphere.00140-18}, abstractNote={Various Lactobacillus species have been reported to deconjugate bile acids in the gastrointestinal tract (GIT) through the action of bile salt hydrolase (BSH) proteins. This function contributes to altering the gut microbiota composition and bile metabolism and detoxification and to lowering cholesterol levels. Here, we investigated the Lactobacillus BSH repertoire across 170 sequenced species. We used hidden Markov models to distinguish between BSH and closely related penicillin-V acylase (PVA) proteins. Even though BSH and PVA proteins have very different target substrates, they share high sequence similarity and are often misannotated. We determined that 82/170 (48.24%) species encoded PVA proteins, 39/170 (22.94%) species encoded BSH proteins, and 8/170 (4.71%) species encoded both BSH and PVA proteins, while 57/170 (33.53%) species encoded neither. Mapping the occurrence of BSH-encoding species onto a phylogenetic tree revealed that BSH-encoding lactobacilli primarily adopt the vertebrate-adapted lifestyle but not the environmental or plant-associated subsets. Phylogenetic analysis of the BSH sequences revealed two distinct clades, several conserved motifs, and the presence of six previously reported active-site residues. These data will guide future mechanistic studies of BSH activity and contribute to the development and selection of BSH-encoding Lactobacillus strains with therapeutic potential.IMPORTANCE Bile acids play an integral role in shaping the gut microbiota and host physiology by regulating metabolic signaling, weight gain, and serum cholesterol and liver triglyceride levels. Given these important roles of bile acids, we investigated the presence of bile salt hydrolase (BSH) in Lactobacillus genomes representing 170 different species, determined strain- and species-specific patterns of occurrences, and expanded on the diversity of the BSH repertoire in this genus. While our data showed that 28% of Lactobacillus species encode BSH proteins, these species are associated mainly with vertebrate-adapted niches, demonstrating selective pressure on lactobacilli to evolve to adapt to specific environments. These new data will allow targeted selection of specific strains of lactobacilli and BSH proteins for future mechanistic studies to explore their therapeutic potential for treating metabolic disorders.}, number={3}, journal={MSPHERE}, publisher={American Society for Microbiology}, author={O'Flaherty, Sarah and Crawley, Alexandra Briner and Theriot, Casey M. and Barrangou, Rodolphe}, editor={Ellermeier, Craig D.Editor}, year={2018} } @article{morovic_roos_zabel_hidalgo-cantabrana_kiefer_barrangou_2018, title={Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline}, volume={84}, ISSN={["1098-5336"]}, url={https://doi.org/10.1128/AEM.01999-18}, DOI={10.1128/AEM.01999-18}, abstractNote={Commercial probiotic bacteria must be tested for acquired antibiotic resistance elements to avoid potential transfer to pathogens. The European Food Safety Authority recommends testing resistance using microdilution culture techniques previously used to establish inhibitory thresholds for the Bifidobacterium genus. Many Bifidobacterium animalis subsp. lactis strains exhibit increased resistance to tetracycline, historically attributed to the ribosomal protection gene tet(W). However, some strains that harbor genetically identical tet(W) genes show various inhibition levels, suggesting that other genetic elements also contribute to observed differences. Here, we adapted several molecular assays to confirm the inhibition of B. animalis subsp. lactis strains Bl-04 and HN019 and employed RNA sequencing to assess the transcriptional differences related to genomic polymorphisms. We detected specific stress responses to the antibiotic by correlating ATP concentration to number of viable genome copies from droplet digital PCR and found that the bacteria were still metabolically active in high drug concentrations. Transcriptional analyses revealed that several polymorphic regions, particularly a novel multidrug efflux transporter, were differentially expressed between the strains in each experimental condition, likely having phenotypic effects. We also found that the tet(W) gene was upregulated only during subinhibitory tetracycline concentrations, while two novel tetracycline resistance genes were upregulated at high concentrations. Furthermore, many genes involved in amino acid metabolism and transporter function were upregulated, while genes for complex carbohydrate utilization, protein metabolism, and clustered regularly interspaced short palindromic repeat(s) (CRISPR)-Cas systems were downregulated. These results provide high-throughput means for assessing antibiotic resistances of two highly related probiotic strains and determine the genetic network that contributes to the global tetracycline response.IMPORTANCEBifidobacterium animalis subsp. lactis is widely used in human food and dietary supplements. Although well documented to be safe, B. animalis subsp. lactis strains must not contain transferable antibiotic resistance elements. Many B. animalis subsp. lactis strains have different resistance measurements despite being genetically similar, and the reasons for this are not well understood. In the current study, we sought to examine how genomic differences between two closely related industrial B. animalis subsp. lactis strains contribute to different resistance levels. This will lead to a better understanding of resistance, identify future targets for analysis of transferability, and expand our understanding of tetracycline resistance in bacteria.}, number={23}, journal={APPLIED AND ENVIRONMENTAL MICROBIOLOGY}, publisher={American Society for Microbiology}, author={Morovic, Wesley and Roos, Paige and Zabel, Bryan and Hidalgo-Cantabrana, Claudio and Kiefer, Anthony and Barrangou, Rodolphe}, editor={Müller, VolkerEditor}, year={2018}, month={Dec} } @article{brandt_barrangou_2018, title={Using glycolysis enzyme sequences to inform Lactobacillus phylogeny}, volume={4}, DOI={10.1099/mgen.0.000187}, abstractNote={The genus Lactobacillus encompasses a diversity of species that occur widely in nature and encode a plethora of metabolic pathways reflecting their adaptation to various ecological niches, including humans, animals, plants and food products. Accordingly, their functional attributes have been exploited industrially and several strains are commonly formulated as probiotics or starter cultures in the food industry. Although divergent evolutionary processes have yielded the acquisition and evolution of specialized functionalities, all Lactobacillus species share a small set of core metabolic properties, including the glycolysis pathway. Thus, the sequences of glycolytic enzymes afford a means to establish phylogenetic groups with the potential to discern species that are too closely related from a 16S rRNA standpoint. Here, we identified and extracted glycolysis enzyme sequences from 52 species, and carried out individual and concatenated phylogenetic analyses. We show that a glycolysis-based phylogenetic tree can robustly segregate lactobacilli into distinct clusters and discern very closely related species. We also compare and contrast evolutionary patterns with genome-wide features and transcriptomic patterns, reflecting genomic drift trends. Overall, results suggest that glycolytic enzymes provide valuable phylogenetic insights and may constitute practical targets for evolutionary studies.}, number={6}, journal={Microbial Genomics}, publisher={Microbiology Society}, author={Brandt, Katelyn and Barrangou, Rodolphe}, year={2018}, month={Jun} } @article{barrangou_horvath_2017, title={A decade of discovery: CRISPR functions and applications}, volume={2}, ISSN={["2058-5276"]}, DOI={10.1038/nmicrobiol.2017.92}, abstractNote={This year marks the tenth anniversary of the identification of the biological function of CRISPR–Cas as adaptive immune systems in bacteria. In just a decade, the characterization of CRISPR–Cas systems has established a novel means of adaptive immunity in bacteria and archaea and deepened our understanding of the interplay between prokaryotes and their environment, and CRISPR-based molecular machines have been repurposed to enable a genome editing revolution. Here, we look back on the historical milestones that have paved the way for the discovery of CRISPR and its function, and discuss the related technological applications that have emerged, with a focus on microbiology. Lastly, we provide a perspective on the impacts the field has had on science and beyond. In this Review Article, Horvath and Barrangou describe the discovery of CRISPR–Cas systems as mechanisms of adaptive immunity in prokaryotes and explore the technological applications that have emerged from studying these molecular machines.}, number={7}, journal={NATURE MICROBIOLOGY}, publisher={Springer Nature}, author={Barrangou, Rodolphe and Horvath, Philippe}, year={2017}, month={Jul} } @article{stout_klaenhammer_barrangou_2017, title={CRISPR-Cas Technologies and Applications in Food Bacteria}, volume={8}, ISSN={["1941-1421"]}, DOI={10.1146/annurev-food-072816-024723}, abstractNote={Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins form adaptive immune systems that occur in many bacteria and most archaea. In addition to protecting bacteria from phages and other invasive mobile genetic elements, CRISPR-Cas molecular machines can be repurposed as tool kits for applications relevant to the food industry. A primary concern of the food industry has long been the proper management of food-related bacteria, with a focus on both enhancing the outcomes of beneficial microorganisms such as starter cultures and probiotics and limiting the presence of detrimental organisms such as pathogens and spoilage microorganisms. This review introduces CRISPR-Cas as a novel set of technologies to manage food bacteria and offers insights into CRISPR-Cas biology. It primarily focuses on the applications of CRISPR-Cas systems and tools in starter cultures and probiotics, encompassing strain-typing, phage resistance, plasmid vaccination, genome editing, and antimicrobial activity.}, number={1}, journal={ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 8}, publisher={Annual Reviews}, author={Stout, Emily and Klaenhammer, Todd and Barrangou, Rodolphe}, year={2017}, pages={413–437} } @misc{hidalgo-cantabrana_o'flaherty_barrangou_2017, title={CRISPR-based engineering of next-generation lactic acid bacteria}, volume={37}, ISSN={["1879-0364"]}, DOI={10.1016/j.mib.2017.05.015}, abstractNote={The advent of CRISPR-based technologies has opened new avenues for the development of next-generation food microorganisms and probiotics with enhanced functionalities. Building off two decades of functional genomics studies unraveling the genetic basis for food fermentations and host–probiotic interactions, CRISPR technologies offer a wide range of opportunities to engineer commercially-relevant Lactobacillus and Bifidobacteria. Endogenous CRISPR–Cas systems can be repurposed to enhance gene expression or provide new features to improve host colonization and promote human health. Alternatively, engineered CRISPR–Cas systems can be harnessed to genetically modify probiotics and enhance their therapeutic potential to deliver vaccines or modulate the host immune response.}, journal={CURRENT OPINION IN MICROBIOLOGY}, publisher={Elsevier BV}, author={Hidalgo-Cantabrana, Claudio and O'Flaherty, Sarah and Barrangou, Rodolphe}, year={2017}, month={Jun}, pages={79–87} } @article{hidalgo-cantabrana_crawley_sanchez_barrangou_2017, title={Characterization and Exploitation of CRISPR Loci in Bifidobacterium longum}, volume={8}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2017.01851}, abstractNote={Diverse CRISPR-Cas systems provide adaptive immunity in many bacteria and most archaea, via a DNA-encoded, RNA-mediated, nucleic-acid targeting mechanism. Over time, CRISPR loci expand via iterative uptake of invasive DNA sequences into the CRISPR array during the adaptation process. These genetic vaccination cards thus provide insights into the exposure of strains to phages and plasmids in space and time, revealing the historical predatory exposure of a strain. These genetic loci thus constitute a unique basis for genotyping of strains, with potential of resolution at the strain-level. Here, we investigate the occurrence and diversity of CRISPR-Cas systems in the genomes of various}, journal={FRONTIERS IN MICROBIOLOGY}, publisher={Frontiers Media SA}, author={Hidalgo-Cantabrana, Claudio and Crawley, Alexandra B. and Sanchez, Borja and Barrangou, Rodolphe}, year={2017}, month={Sep} } @article{selle_goh_johnson_sarah_andersen_barrangou_klaenhammer_2017, title={Deletion of Lipoteichoic Acid Synthase Impacts Expression of Genes Encoding Cell Surface Proteins in Lactobacillus acidophilus}, volume={8}, DOI={10.3389/fmicb.2017.00553}, abstractNote={Lactobacillus acidophilus NCFM is a well-characterized probiotic microorganism, supported by a decade of genomic and functional phenotypic investigations. L. acidophilus deficient in lipoteichoic acid (LTA), a major immunostimulant in Gram-positive bacteria, has been shown to shift immune system responses in animal disease models. However, the pleiotropic effects of removing LTA from the cell surface in lactobacilli are unknown. In this study, we surveyed the global transcriptional and extracellular protein profiles of two strains of L. acidophilus deficient in LTA. Twenty-four differentially expressed genes specific to the LTA-deficient strains were identified, including a predicted heavy metal resistance operon and several putative peptidoglycan hydrolases. Cell morphology and manganese sensitivity phenotypes were assessed in relation to the putative functions of differentially expressed genes. LTA-deficient L. acidophilus exhibited elongated cellular morphology and their growth was severely inhibited by elevated manganese concentrations. Exoproteomic surveys revealed distinct changes in the composition and relative abundances of several extracellular proteins and showed a bias of intracellular proteins in LTA-deficient strains of L. acidophilus. Taken together, these results elucidate the impact of ltaS deletion on the transcriptome and extracellular proteins of L. acidophilus, suggesting roles of LTA in cell morphology and ion homeostasis as a structural component of the Gram positive cell wall.}, journal={Frontiers in Microbiology}, publisher={Frontiers Media SA}, author={Selle, Kurt and Goh, Yong J. and Johnson, Brant R. and Sarah, O’Flaherty and Andersen, Joakim M. and Barrangou, Rodolphe and Klaenhammer, Todd R.}, year={2017}, month={Apr} } @article{barrangou_gersbach_2017, title={Expanding the CRISPR Toolbox: Targeting RNA with Cas13b}, volume={65}, ISSN={["1097-4164"]}, DOI={10.1016/j.molcel.2017.02.002}, abstractNote={In this issue of Molecular Cell, Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar unearth Cas13b from type VI-B CRISPR-Cas immune systems and characterize its RNA-guided, RNA-targeting activity, including regulation by the novel co-factors Csx27 and Csx28, as well as non-specific collateral RNA damage. In this issue of Molecular Cell, Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar unearth Cas13b from type VI-B CRISPR-Cas immune systems and characterize its RNA-guided, RNA-targeting activity, including regulation by the novel co-factors Csx27 and Csx28, as well as non-specific collateral RNA damage. CRISPR and associated sequences (Cas) together constitute CRISPR-Cas systems that provide adaptive immunity against invasive nucleic acids via DNA-encoded, RNA-mediated, sequence-specific targeting. Several molecular machines derived from CRISPR-Cas systems have been very successfully repurposed as technologies for editing the genome, controlling the transcriptome, and altering the epigenome (Barrangou and Doudna, 2016Barrangou R. Doudna J.A. Nat. Biotechnol. 2016; 34: 933-941Crossref PubMed Scopus (537) Google Scholar). Indeed, Cas9 has enabled the democratization of genome editing in the past 3 years, with great promise for versatile cell engineering. Despite the transformative impact of CRISPR-based technologies in recent years, only a small fraction of CRISPR-Cas systems have yet to be explored in any detail. Consequently, several recent efforts have focused on mining microbial genomes to unearth programmable Cas effector proteins able to expand the molecular biology toolkit, with recent additions such as Cpf1 (now Cas12a) (Zetsche et al., 2015Zetsche B. Gootenberg J.S. Abudayyeh O.O. Slaymaker I.M. Makarova K.S. Essletzbichler P. Volz S.E. Joung J. van der Oost J. Regev A. et al.Cell. 2015; 163: 759-771Abstract Full Text Full Text PDF PubMed Scopus (2500) Google Scholar), C2c2 (now Cas13a) (Shmakov et al., 2015Shmakov S. Abudayyeh O.O. Makarova K.S. Wolf Y.I. Gootenberg J.S. Semenova E. Minakhin L. Joung J. Konermann S. Severinov K. et al.Mol. Cell. 2015; 60: 385-397Abstract Full Text Full Text PDF PubMed Scopus (714) Google Scholar), CasX, and CasY (Burstein et al., 2016Burstein D. Harrington L.B. Strutt S.C. Probst A.J. Anantharaman K. Thomas B.C. Doudna J.A. Banfield J.F. Nature. 2016; (Published online December 22, 2016)https://doi.org/10.1038/nature21059Crossref Scopus (323) Google Scholar). The featured study by Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar reports that Cas13b (previously C2c6) from type VI-B CRISPR-Cas systems is an RNA-guided RNase with an idiosyncratic mechanism of action that could be repurposed to target RNA in a programmable manner (Figure 1). In the past decade, CRISPR-Cas systems have been established as the drivers of adaptive immunity in bacteria and repurposed as a revolutionary genome-editing technology (Barrangou and Doudna, 2016Barrangou R. Doudna J.A. Nat. Biotechnol. 2016; 34: 933-941Crossref PubMed Scopus (537) Google Scholar). Our appreciation for the natural diversity of CRISPR-Cas systems has yielded several rounds of classification and nomenclature evolution, and there are currently two major classes distinguished by single versus complexed effector proteins, which are further divided into six major types and 19 subtypes (Makarova et al., 2015Makarova K.S. Wolf Y.I. Alkhnbashi O.S. Costa F. Shah S.A. Saunders S.J. Barrangou R. Brouns S.J. Charpentier E. Haft D.H. et al.Nat. Rev. Microbiol. 2015; 13: 722-736Crossref PubMed Scopus (1462) Google Scholar, Shmakov et al., 2017Shmakov S. Smargon A. Scott D. Cox D. Pyzocha N. Yan W. Abudayyeh O.O. Gootenberg J.S. Makarova K.S. Wolf Y.I. et al.Nat. Rev. Microbiol. 2017; (Published online January 23, 2017)https://doi.org/10.1038/nrmicro.2016.184Crossref PubMed Scopus (555) Google Scholar). The most effective strategy to uncover the next Cas effector protein is to develop sophisticated and creative in silico analyses to parse through the ever-increasing numbers of sequenced microbial genomes. To find a new subtype of CRISPR-Cas systems, Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar used a computational database mining approach to search for single large effector proteins associated with CRISPR arrays that did not contain the nearly universal markers cas1 and cas2 and identified Cas13b. Two distinct classes were detected repeatedly among a total of 105 genomic loci identified and were particularly enriched in Bacteriodetes, such as Porphyromonas and Prevotella. Though Cas13b has a novel sequence, it carries two HEPN domains (RxxxxH), somewhat similar to the architecture of Cas13a, the signature RNase from the type VI-A CRISPR-Cas system (Shmakov et al., 2015Shmakov S. Abudayyeh O.O. Makarova K.S. Wolf Y.I. Gootenberg J.S. Semenova E. Minakhin L. Joung J. Konermann S. Severinov K. et al.Mol. Cell. 2015; 60: 385-397Abstract Full Text Full Text PDF PubMed Scopus (714) Google Scholar, Shmakov et al., 2017Shmakov S. Smargon A. Scott D. Cox D. Pyzocha N. Yan W. Abudayyeh O.O. Gootenberg J.S. Makarova K.S. Wolf Y.I. et al.Nat. Rev. Microbiol. 2017; (Published online January 23, 2017)https://doi.org/10.1038/nrmicro.2016.184Crossref PubMed Scopus (555) Google Scholar). Genetically, the CRISPR array is reminiscent of other class 2 systems, with a 36 nt, partially palindromic repeat sequence and spacers with homology to phage genome sequences. Mechanistically, two mature CRISPR RNA (crRNA) species were identified, a “short” 66 nt crRNA and a “long” 118 nt crRNA with an extended CRISPR repeat portion. After porting the systems into E. coli, Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar showed knockdown of essential genes when Cas13b was heterologously expressed with targeted crRNAs. By studying strongly depleted sequences, Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar revealed that heavily targeted sequences are typically flanked by a peculiar double-sided protospacer flanking sequence (PFS), akin to the protospacer-associated motif (PAM). Focusing on the Bergeyella zoohelcum BzCas13b, Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar showed sequence-specific single-stranded RNA (ssRNA) targeting. Furthermore, this activity was associated with non-specific RNA cleavage, dubbed “collateral” RNase activity, albeit only in the presence of target RNA, similar to what has been previously described for Cas13a (Abudayyeh et al., 2016Abudayyeh O.O. Gootenberg J.S. Konermann S. Joung J. Slaymaker I.M. Cox D.B. Shmakov S. Makarova K.S. Semenova E. Minakhin L. et al.Science. 2016; 353: aaf5573Crossref PubMed Scopus (1146) Google Scholar, East-Seletsky et al., 2016East-Seletsky A. O’Connell M.R. Knight S.C. Burstein D. Cate J.H. Tjian R. Doudna J.A. Nature. 2016; 538: 270-273Crossref PubMed Scopus (592) Google Scholar). HEPN-dependent interference was confirmed by resistance against lytic phage MS2, with reduced plaque formation in the presence of targeting spacers, involving conserved catalytic arginines and histidines (R116/H121 and R1177/H1182). Additionally, the study investigated other novel cas genes they found typically associated with cas13b, Csx27, and Csx28, which were determined to be a repressor and an enhancer of Cas13b activity, respectively. Mechanistically, the absence of the nearly universal CRISPR markers cas1 and cas2 is intriguing given their implication in novel spacer acquisition during the immunization process, though they could be provided in trans given the frequent occurrence of other CRISPR-Cas systems in genomes that carry cas13b. This is somewhat contradictory with the typical orthogonality of different CRISPR-Cas systems, and future studies should investigate whether Cas1 and Cas2 can interact with type VI-B CRISPR arrays and determine how acquisition occurs in this subtype. The potential for cross-reactivity of acquisition machinery across systems may help with understanding the currently mysterious mechanisms of immunization. Arguably the most novel insight provided by this new system is the discovery of the co-regulatory molecules Csx27 and Csx28. The dual control options afforded by Csx27 inhibition and Csx28 activation of Cas13b beg the question as to whether there is control of cas13b transcription prior to interference and/or post-transcriptional control by direct interaction with Cas13b (or possibly crRNA) following invasive RNA targeting. Smargon et al., 2017Smargon A. Cox D.B.T. Pyzocha N.K. Zheng K. Slaymaker I.M. Gootenberg J.S. Abudayyeh O.A. Essletzbichler P. Shmakov S. Makarova K.S. et al.Mol. Cell. 2017; 65 (this issue): 618-630Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar’s demonstration of Csx27- and Csx28-based regulation in non-native hosts from heterologous systems indicates that the latter is at least one contributing factor, but this should certainly be a necessary area of future work. The mechanism of Csx27 and Csx28 action also determines how they might interplay with the putative target phages, including potential roles in the rise of phage resistance via invader transcript destruction or possibly triggering of host death via collateral RNA targeting. The former would enable the host to thrive, whereas the latter would drive suicide of infected cells for the benefit of the rest of the population, akin to the abortive infection system. It will be important to define the role of these new regulatory control systems in determining the cellular outcome of Cas13b activity and the impact at the population levels for both hosts and phages. Additionally, similar to recent analyses of Cas9 and other Cas effector proteins, biochemical and structural studies will also be necessary, to provide critical insights into their biology, as well as a basis to enhance their functions and optimize their activity and specificity by engineering. Given the potential repurposing of these molecular machines in eukaryotes, it is intriguing to ponder how effectively and specifically RNA targeting will be for either RNA-virus eradication or promoting programmed cell death by exploiting collateral RNase activity. Actually, it is still unclear whether this system naturally targets RNA viruses and/or the RNA transcripts of DNA viruses. Although CRISPR-Cas systems are potent antivirals by nature, they could also be reprogrammed to drive the death of the host when it is desirable to do so. Indeed, an endogenous lethal self-targeting pathway could be hijacked to drive cell suicide by exploiting the collateral RNA damage mechanism, leading to systemic RNA degradation and programmed cell death. This is reminiscent of the repurposing of self-targeting CRISPR-Cas systems as antimicrobials (Gomaa et al., 2014Gomaa A.A. Klumpe H.E. Luo M.L. Selle K. Barrangou R. Beisel C.L. MBio. 2014; 5: e00928-13Crossref PubMed Scopus (245) Google Scholar). Overall, this study illustrates how mining dark matter in obscure bacterial genomes is continuing to yield novel Cas-based molecular machines that advance our understanding of the interplay between bacteria and their predators and open new avenues for the development of new tools that expand the molecular biology toolbox for genome, transcriptome, and epigenome engineering. R.B. and C.A.G. are inventors on patents related to CRISPR-Cas systems and their various uses. R.B. is a co-founder and SAB member of Intellia Therapeutics and Locus Biosciences; C.A.G. is a co-founder and SAB member of Locus Biosciences and Element Genomics. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28Smargon et al.Molecular CellJanuary 5, 2017In BriefSmargon et al. identify and characterize two class 2 type VI-B CRISPR systems lacking Cas1 and Cas2 and containing the RNA-guided RNase Cas13b, differentially regulated by Csx27 and Csx28. Through an E. coli essential gene screen they show that Cas13b RNA targeting is dependent on a double-sided PFS and RNA accessibility. Full-Text PDF Open Archive}, number={4}, journal={MOLECULAR CELL}, publisher={Elsevier BV}, author={Barrangou, Rodolphe and Gersbach, Charles A.}, year={2017}, month={Feb}, pages={582–584} } @article{pijkeren_barrangou_2017, title={Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics}, volume={5}, DOI={10.1128/microbiolspec.bad-0013-2016}, abstractNote={ABSTRACT Lactic acid bacteria have been used historically for food manufacturing mainly to ensure preservation via fermentation. More recently, lactic acid bacteria have been exploited to promote human health, and many strains serve as industrial workhorses. Recent advances in microbiology and molecular biology have contributed to understanding the genetic basis of many of their functional attributes. These include dissection of biochemical processes that drive food fermentation, and identification and characterization of health-promoting features that positively impact the composition and roles of microbiomes in human health. Recently, the advent of clustered regularly interspaced short palindromic repeat (CRISPR)-based technologies has revolutionized our ability to manipulate genomes, and we are on the cusp of a broad-scale genome editing revolution. Here, we discuss recent advances in genetic alteration of food-grade bacteria, with a focus on CRISPR-associated enzyme genome editing, single-stranded DNA recombineering, and the modification of bacteriophages. These tools open new avenues for the genesis of next-generation biotherapeutic agents with improved genotypes and enhanced health-promoting functional features.}, number={5}, journal={Microbiology Spectrum}, publisher={American Society for Microbiology}, author={Pijkeren, Jan-Peter and Barrangou, Rodolphe}, year={2017}, month={Oct} } @article{barrangou_bikard_2017, title={Guest editorial: CRISPRcas9: CRISPR-Cas systems: at the cutting edge of microbiology}, volume={37}, DOI={10.1016/j.mib.2017.09.015}, journal={Current Opinion in Microbiology}, publisher={Elsevier BV}, author={Barrangou, Rodolphe and Bikard, David}, year={2017}, month={Jun}, pages={vii-viii} } @article{weissman_holmes_barrangou_moineau_fagan_levin_johnson_2017, title={Immune Loss as a Driver of Coexistence During Host-Phage Coevolution}, url={https://doi.org/10.1101/105908}, DOI={10.1101/105908}, abstractNote={Abstract Bacteria and their viral pathogens face constant pressure for augmented immune and infective capabilities, respectively. Under this reciprocally imposed selective regime, we expect to see a runaway evolutionary arms race, ultimately leading to the extinction of one species. Despite this prediction, in many systems host and pathogen coexist with minimal coevolution even when well-mixed. Previous work explained this puzzling phenomenon by invoking fitness tradeoffs, which can diminish an arms race dynamic. Here we propose that the regular loss of immunity by the bacterial host can also produce host-phage coexistence. We pair a general model of immunity with an experimental and theoretical case study of the CRISPR-Cas immune system to contrast the behavior of tradeoff and loss mechanisms in well-mixed systems. We find that, while both mechanisms can produce stable coexistence, only immune loss does so robustly within realistic parameter ranges.}, author={Weissman, Jake L and Holmes, Rayshawn and Barrangou, Rodolphe and Moineau, Sylvain and Fagan, William F and Levin, Bruce and Johnson, Philip L F}, year={2017}, month={Feb} } @article{klotz_o'flaherty_goh_barrangou_2017, title={Investigating the Effect of Growth Phase on the Surface-Layer Associated Proteome of Lactobacillus acidophilus Using Quantitative Proteomics}, volume={8}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2017.02174}, abstractNote={Bacterial surface-layers (S-layers) are semi-porous crystalline arrays that self-assemble to form the outermost layer of some cell envelopes. S-layers have been shown to act as scaffolding structures for the display of auxiliary proteins externally. These S-layer associated proteins have recently gained attention in probiotics due to their direct physical contact with the intestinal mucosa and potential role in cell proliferation, adhesion, and immunomodulation. A number of studies have attempted to catalog the S-layer associated proteome of Lactobacillus acidophilus NCFM under a single condition. However, due to the versatility of the cell surface, we chose to employ a multiplexing-based approach with the intention of accurately contrasting multiple conditions. In this study, a previously described lithium chloride isolation protocol was used to release proteins bound to the L. acidophilus S-layer during logarithmic and early stationary growth phases. Protein quantification values were obtained via TMT (tandem mass tag) labeling combined with a triple-stage mass spectrometry (MS3) method. Results showed significant growth stage-dependent alterations to the surface-associated proteome while simultaneously highlighting the sensitivity and reproducibility of the technology. Thus, this study establishes a framework for quantifying condition-dependent changes to cell surface proteins that can easily be applied to other S-layer forming bacteria.}, journal={FRONTIERS IN MICROBIOLOGY}, publisher={Frontiers Media SA}, author={Klotz, Courtney and O'Flaherty, Sarah and Goh, Yong Jun and Barrangou, Rodolphe}, year={2017}, month={Nov} } @article{theilmann_goh_nielsen_klaenhammer_barrangou_abou hachem_2017, title={Lactobacillus acidophilus Metabolizes Dietary Plant Glucosides and Externalizes Their Bioactive Phytochemicals}, volume={8}, ISSN={["2150-7511"]}, url={https://doi.org/10.1128/mBio.01421-17}, DOI={10.1128/mbio.01421-17}, abstractNote={Therapeutically active glycosylated phytochemicals are ubiquitous in the human diet. The human gut microbiota (HGM) modulates the bioactivities of these compounds, which consequently affect host physiology and microbiota composition. Despite a significant impact on human health, the key players and the underpinning mechanisms of this interplay remain uncharacterized. Here, we demonstrate the growth of Lactobacillus acidophilus on mono- and diglucosyl dietary plant glycosides (PGs) possessing small aromatic aglycones. Transcriptional analysis revealed the upregulation of host interaction genes and identified two loci that encode phosphotransferase system (PTS) transporters and phospho-β-glucosidases, which mediate the uptake and deglucosylation of these compounds, respectively. Inactivating these transport and hydrolysis genes abolished or severely reduced growth on PG, establishing the specificity of the loci to distinct groups of PGs. Following intracellular deglucosylation, the aglycones of PGs are externalized, rendering them available for absorption by the host or for further modification by other microbiota taxa. The PG utilization loci are conserved in L. acidophilus and closely related lactobacilli, in correlation with versatile growth on these compounds. Growth on the tested PG appeared more common among human gut lactobacilli than among counterparts from other ecologic niches. The PGs that supported the growth of L. acidophilus were utilized poorly or not at all by other common HGM strains, underscoring the metabolic specialization of L. acidophilus These findings highlight the role of human gut L. acidophilus and select lactobacilli in the bioconversion of glycoconjugated phytochemicals, which is likely to have an important impact on the HGM and human host.IMPORTANCE Thousands of therapeutically active plant-derived compounds are widely present in berries, fruits, nuts, and beverages like tea and wine. The bioactivity and bioavailability of these compounds, which are typically glycosylated, are altered by microbial bioconversions in the human gut. Remarkably, little is known about the bioconversion of PGs by the gut microbial community, despite the significance of this metabolic facet to human health. Our work provides the first molecular insights into the metabolic routes of diet relevant and therapeutically active PGs by Lactobacillus acidophilus and related human gut lactobacilli. This taxonomic group is adept at metabolizing the glucoside moieties of select PG and externalizes their aglycones. The study highlights an important role of lactobacilli in the bioconversion of dietary PG and presents a framework from which to derive molecular insights into their metabolism by members of the human gut microbiota.}, number={6}, journal={MBIO}, publisher={American Society for Microbiology}, author={Theilmann, Mia C. and Goh, Yong Jun and Nielsen, Kristian Fog and Klaenhammer, Todd R. and Barrangou, Rodolphe and Abou Hachem, Maher}, editor={Martens, Eric and McFall-Ngai, Margaret J.Editors}, year={2017} } @article{bikard_barrangou_2017, title={Les systèmes CRISPR-Cas comme arme contre les bactéries pathogènes}, volume={211}, ISSN={2105-0678 2105-0686}, url={http://dx.doi.org/10.1051/JBIO/2018004}, DOI={10.1051/jbio/2018004}, abstractNote={CRISPR-Cas systems (Clustered Regularly Interspaced Short Palindromic Repeats) are the adaptive immune system of bacteria and archaea. They target foreign genetic elements thanks to small RNAs able to guide Cas nucleases to destroy them. These nucleases can be reprogrammed to target chromosomal sequences rather than invasive genetic elements. Whereas targeting the genome of eukaryotic cells enables the efficient genesis of mutations, DNA breaks induced by Cas nucleases are lethal in bacteria. This property can be used in the development of novel antimicrobial strategies. CRISPR-Cas systems can be delivered to target bacteria using bacteriophage capsids in order to specifically eliminate bacteria carrying antibiotic resistance genes or virulence factors. These technologies enable the development of novel tools based on CRISPR-Cas systems to specifically eliminate pathogenic bacteria and precisely modify the composition of various microbiomes.}, number={4}, journal={Biologie Aujourd'hui}, publisher={EDP Sciences}, author={Bikard, David and Barrangou, Rodolphe}, year={2017}, pages={265–270} } @article{toms_barrangou_2017, title={On the global CRISPR array behavior in class I systems}, volume={12}, ISSN={["1745-6150"]}, DOI={10.1186/s13062-017-0193-2}, abstractNote={Much effort is underway to build and upgrade databases and tools related to occurrence, diversity, and characterization of CRISPR-Cas systems. As microbial communities and their genome complements are unearthed, much emphasis has been placed on details of individual strains and model systems within the CRISPR-Cas classification, and that collection of information as a whole affords the opportunity to analyze CRISPR-Cas systems from a quantitative perspective to gain insight into distribution of CRISPR array sizes across the different classes, types and subtypes. CRISPR diversity, nomenclature, occurrence, and biological functions have generated a plethora of data that created a need to understand the size and distribution of these various systems to appreciate their features and complexity.By utilizing a statistical framework and visual analytic techniques, we have been able to test several hypotheses about CRISPR loci in bacterial class I systems. Quantitatively, though CRISPR loci can expand to hundreds of spacers, the mean and median sizes are 40 and 25, respectively, reflecting rather modest acquisition and/or retention overall. Histograms uncovered that CRISPR array size displayed a parametric distribution, which was confirmed by a goodness-of fit test. Mapping the frequency of CRISPR loci on a standardized chromosome plot revealed that CRISPRs have a higher probability of occurring at clustered locations along the positive or negative strand. Lastly, when multiple arrays occur in a particular system, the size of a particular CRISPR array varies with its distance from the cas operon, reflecting acquisition and expansion biases.This study establishes that bacterial Class I CRISPR array size tends to follow a geometric distribution; these CRISPRs are not randomly distributed along the chromosome; and the CRISPR array closest to the cas genes is typically larger than loci in trans. Overall, we provide an analytical framework to understand the features and behavior of CRISPR-Cas systems through a quantitative lens.This article was reviewed by Eugene Koonin (NIH-NCBI) and Uri Gophna (Tel Aviv University).}, journal={BIOLOGY DIRECT}, author={Toms, Alice and Barrangou, Rodolphe}, year={2017}, month={Aug} } @article{nair_2017, title={QnAs with Rodolphe Barrangou}, volume={114}, DOI={10.1073/pnas.1710348114}, abstractNote={The past decade in biological research might well be christened the age of CRISPR, a once-curious feature of bacterial genomes that spawned a handy tool for editing genes. Using CRISPR-based tools, researchers are making leaps in basic clinical research, and biotechnology companies are racing to launch trials of gene therapies for an array of diseases. Yet the immediate gains from this game-changing technique might spring from its application to agriculture. Hornless dairy cattle, drought-resistant wheat, and nonbrowning mushrooms are merely the harbingers of an approaching agricultural revolution, says Rodolphe Barrangou, a molecular biologist and food scientist at North Carolina State University. Barrangou’s foresight stems from his long familiarity with CRISPR. More than a decade ago, while working at the Danish food ingredient manufacturer Danisco (now DuPont), Barrangou furnished experimental proof for the notion that CRISPR confers a form of adaptive immunity that helps bacteria fend off invading viruses. For this crucial insight into the fundamental biology of CRISPR, Barrangou was honored with 2017 National Academy of Sciences Award in molecular biology. PNAS spoke to Barrangou about his wide-ranging work on CRISPR. Rodolphe Barrangou. Image courtesy of North Carolina State University (Raleigh, NC). > PNAS:CRISPR entered the spotlight when its potential as a genome editor became apparent, but your tryst with it began more than a decade ago while working with Philippe Horvath in the food industry. Those efforts led to a milestone 2007 article in Science , in which you demonstrated that bacteria use CRISPR-Cas systems as a form of adaptive immunity against viruses (1). Could you take our readers down memory lane? > Barrangou:For a long time, people didn’t really have a clue what these repeated DNA sequences—the CRISPR arrays—in …}, number={28}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Nair, Prashant}, year={2017}, month={Jul}, pages={7183–7184} } @article{barrangou_ousterout_2017, title={Repurposing CRISPR-Cas systems as DNA-based smart antimicrobials}, volume={3}, DOI={10.18609/cgti.2017.008}, number={1}, journal={Cell and Gene Therapy Insights}, publisher={BioInsights Publishing, Ltd.}, author={Barrangou, Rodolphe and Ousterout, David G}, year={2017}, month={Feb}, pages={63–72} } @article{johnson_o'flaherty_goh_carroll_barrangou_klaenhammer_2017, title={The S-layer Associated Serine Protease Homolog PrtX Impacts Cell Surface-Mediated Microbe-Host Interactions of Lactobacillus acidophilus NCFM}, volume={8}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2017.01185}, abstractNote={Health-promoting aspects attributed to probiotic microorganisms, including adhesion to intestinal epithelia and modulation of the host mucosal immune system, are mediated by proteins found on the bacterial cell surface. Notably, certain probiotic and commensal bacteria contain a surface (S-) layer as the outermost stratum of the cell wall. S-layers are non-covalently bound semi-porous, crystalline arrays of self-assembling, proteinaceous subunits called S-layer proteins (SLPs). Recent evidence has shown that multiple proteins are non-covalently co-localized within the S-layer, designated S-layer associated proteins (SLAPs). In Lactobacillus acidophilus NCFM, SLP and SLAPs have been implicated in both mucosal immunomodulation and adhesion to the host intestinal epithelium. In this study, a S-layer associated serine protease, PrtX (prtX, lba1578), was deleted from the chromosome of L. acidophilus NCFM. Compared to the parent strain, the PrtX-deficient strain (∆prtX) demonstrated increased autoaggregation, an altered cellular morphology, and pleiotropic increases in adhesion to mucin and fibronectin, in vitro. Furthermore, ∆prtX demonstrated increased in vitro immune stimulation of IL-6, IL-12, and IL-10 compared to wild-type, when exposed to mouse dendritic cells. Finally, in vivo colonization of germ-free mice with ∆prtX led to an increase in epithelial barrier integrity. The absence of PrtX within the exoproteome of a ∆prtX strain caused morphological changes, resulting in a pleiotropic increase of the organisms' immunomodulatory properties and interactions with some intestinal epithelial cell components.}, journal={FRONTIERS IN MICROBIOLOGY}, publisher={Frontiers Media SA}, author={Johnson, Brant R. and O'Flaherty, Sarah and Goh, Yong Jun and Carroll, Ian and Barrangou, Rodolphe and Klaenhammer, Todd R.}, year={2017}, month={Jun} } @misc{bikard_barrangou_2017, title={Using CRISPR-Cas systems as antimicrobials}, volume={37}, ISSN={["1879-0364"]}, DOI={10.1016/j.mib.2017.08.005}, abstractNote={Although CRISPR-Cas systems naturally evolved to provide adaptive immunity in bacteria and archaea, Cas nucleases can be co-opted to target chromosomal sequences rather than invasive genetic elements. Although genome editing is the primary outcome of self-targeting using CRISPR-based technologies in eukaryotes, self-targeting by CRISPR is typically lethal in bacteria. Here, we discuss how DNA damage introduced by Cas nucleases in bacteria can efficiently and specifically lead to plasmid curing or drive cell death. Specifically, we discuss how various CRISPR-Cas systems can be engineered and delivered using phages or phagemids as vectors. These principles establish CRISPR-Cas systems as potent and programmable antimicrobials, and open new avenues for the development of CRISPR-based tools for selective removal of bacterial pathogens and precise microbiome composition alteration.}, journal={CURRENT OPINION IN MICROBIOLOGY}, publisher={Elsevier BV}, author={Bikard, David and Barrangou, Rodolphe}, year={2017}, month={Jun}, pages={155–160} } @misc{barrangou_doudna_2016, title={Applications of CRISPR technologies in research and beyond}, volume={34}, ISSN={["1546-1696"]}, url={https://doi.org/10.1038/nbt.3659}, DOI={10.1038/nbt.3659}, abstractNote={Programmable DNA cleavage using CRISPR-Cas9 enables efficient, site-specific genome engineering in single cells and whole organisms. In the research arena, versatile CRISPR-enabled genome editing has been used in various ways, such as controlling transcription, modifying epigenomes, conducting genome-wide screens and imaging chromosomes. CRISPR systems are already being used to alleviate genetic disorders in animals and are likely to be employed soon in the clinic to treat human diseases of the eye and blood. Two clinical trials using CRISPR-Cas9 for targeted cancer therapies have been approved in China and the United States. Beyond biomedical applications, these tools are now being used to expedite crop and livestock breeding, engineer new antimicrobials and control disease-carrying insects with gene drives.}, number={9}, journal={NATURE BIOTECHNOLOGY}, publisher={Springer Nature}, author={Barrangou, Rodolphe and Doudna, Jennifer A.}, year={2016}, month={Sep}, pages={933–941} } @article{andersen_shoup_robinson_bitton_olsen_barrangou_2016, title={CRISPR Diversity and Microevolution in Clostridium difficile}, volume={8}, ISSN={["1759-6653"]}, DOI={10.1093/gbe/evw203}, abstractNote={Virulent strains of Clostridium difficile have become a global health problem associated with morbidity and mortality. Traditional typing methods do not provide ideal resolution to track outbreak strains, ascertain genetic diversity between isolates, or monitor the phylogeny of this species on a global basis. Here, we investigate the occurrence and diversity of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated genes (cas) in C. difficile to assess the potential of CRISPR-based phylogeny and high-resolution genotyping. A single Type-IB CRISPR-Cas system was identified in 217 analyzed genomes with cas gene clusters present at conserved chromosomal locations, suggesting vertical evolution of the system, assessing a total of 1,865 CRISPR arrays. The CRISPR arrays, markedly enriched (8.5 arrays/genome) compared with other species, occur both at conserved and variable locations across strains, and thus provide a basis for typing based on locus occurrence and spacer polymorphism. Clustering of strains by array composition correlated with sequence type (ST) analysis. Spacer content and polymorphism within conserved CRISPR arrays revealed phylogenetic relationship across clades and within ST. Spacer polymorphisms of conserved arrays were instrumental for differentiating closely related strains, e.g., ST1/RT027/B1 strains and pathogenicity locus encoding ST3/RT001 strains. CRISPR spacers showed sequence similarity to phage sequences, which is consistent with the native role of CRISPR-Cas as adaptive immune systems in bacteria. Overall, CRISPR-Cas sequences constitute a valuable basis for genotyping of C. difficile isolates, provide insights into the micro-evolutionary events that occur between closely related strains, and reflect the evolutionary trajectory of these genomes.}, number={9}, journal={GENOME BIOLOGY AND EVOLUTION}, publisher={Oxford University Press (OUP)}, author={Andersen, Joakim M. and Shoup, Madelyn and Robinson, Cathy and Bitton, Robert and Olsen, Katharina E. P. and Barrangou, Rodolphe}, year={2016}, month={Sep}, pages={2841–2855} } @article{barrangou_dudley_2016, title={CRISPR-Based Typing and Next-Generation Tracking Technologies}, volume={7}, DOI={10.1146/annurev-food-022814-015729}, abstractNote={Bacteria occur ubiquitously in nature and are broadly relevant throughout the food supply chain, with diverse and variable tolerance levels depending on their origin, biological role, and impact on the quality and safety of the product as well as on the health of the consumer. With increasing knowledge of and accessibility to the microbial composition of our environments, food supply, and host-associated microbiota, our understanding of and appreciation for the ratio of beneficial to undesirable bacteria are rapidly evolving. Therefore, there is a need for tools and technologies that allow definite, accurate, and high-resolution identification and typing of various groups of bacteria that include beneficial microbes such as starter cultures and probiotics, innocuous commensals, and undesirable pathogens and spoilage organisms. During the transition from the current molecular biology-based PFGE (pulsed-field gel electrophoresis) gold standard to the increasingly accessible omics-level whole-genome sequencing (WGS) N-gen standard, high-resolution technologies such as CRISPR-based genotyping constitute practical and powerful alternatives that provide valuable insights into genome microevolution and evolutionary trajectories. Indeed, several studies have shown potential for CRISPR-based typing of industrial starter cultures, health-promoting probiotic strains, animal commensal species, and problematic pathogens. Emerging CRISPR-based typing methods open new avenues for high-resolution typing of a broad range of bacteria and constitute a practical means for rapid tracking of a diversity of food-associated microbes.}, number={1}, journal={Annual Review of Food Science and Technology}, publisher={Annual Reviews}, author={Barrangou, Rodolphe and Dudley, Edward G.}, year={2016}, month={Feb}, pages={395–411} } @misc{barrangou_dudley_2016, title={CRISPR-based typing and next-generation tracking technologies}, volume={7}, journal={Annual review of food science and technology, vol 7}, author={Barrangou, R. and Dudley, E. G.}, year={2016}, pages={395–411} } @article{johnson_hymes_sanozky-dawes_henriksen_barrangou_klaenhammer_2016, title={Conserved S-Layer-Associated Proteins Revealed by Exoproteomic Survey of S-Layer-Forming Lactobacilli}, volume={82}, ISSN={["1098-5336"]}, url={https://doi.org/10.1128/AEM.01968-15}, DOI={10.1128/aem.01968-15}, abstractNote={ABSTRACT The Lactobacillus acidophilus homology group comprises Gram-positive species that include L. acidophilus , L. helveticus , L. crispatus , L. amylovorus , L. gallinarum , L. delbrueckii subsp. bulgaricus , L. gasseri , and L. johnsonii . While these bacteria are closely related, they have varied ecological lifestyles as dairy and food fermenters, allochthonous probiotics, or autochthonous commensals of the host gastrointestinal tract. Bacterial cell surface components play a critical role in the molecular dialogue between bacteria and interaction signaling with the intestinal mucosa. Notably, the L. acidophilus complex is distinguished in two clades by the presence or absence of S-layers, which are semiporous crystalline arrays of self-assembling proteinaceous subunits found as the outermost layer of the bacterial cell wall. In this study, S-layer-associated proteins (SLAPs) in the exoproteomes of various S-layer-forming Lactobacillus species were proteomically identified, genomically compared, and transcriptionally analyzed. Four gene regions encoding six putative SLAPs were conserved in the S-layer-forming Lactobacillus species but not identified in the extracts of the closely related progenitor, L. delbrueckii subsp. bulgaricus , which does not produce an S-layer. Therefore, the presence or absence of an S-layer has a clear impact on the exoproteomic composition of Lactobacillus species. This proteomic complexity and differences in the cell surface properties between S-layer- and non-S-layer-forming lactobacilli reveal the potential for SLAPs to mediate intimate probiotic interactions and signaling with the host intestinal mucosa.}, number={1}, journal={APPLIED AND ENVIRONMENTAL MICROBIOLOGY}, publisher={American Society for Microbiology}, author={Johnson, Brant R. and Hymes, Jeffrey and Sanozky-Dawes, Rosemary and Henriksen, Emily DeCrescenzo and Barrangou, Rodolphe and Klaenhammer, Todd R.}, editor={Nojiri, H.Editor}, year={2016}, month={Jan}, pages={134–145} } @misc{briner_barrangou_2016, title={Deciphering and shaping bacterial diversity through CRISPR}, volume={31}, ISSN={["1879-0364"]}, url={https://doi.org/10.1016/j.mib.2016.03.006}, DOI={10.1016/j.mib.2016.03.006}, abstractNote={Phage and bacteria have engaged in a sustainable arms race, a seemingly endless conflict, since the beginning of time. CRISPR-Cas systems shape and generate environmental diversity through evolution of both predator and prey genomes. Indeed, the gain or loss of CRISPR-mediated immunity and genome maintenance can spark speciation in bacteria. Alternatively, turning CRISPR-Cas on the host by targeting chromosomal DNA has led to the development of next-generation smart antimicrobials and genetic screening and engineering technologies. Although the ability to target and cleave DNA in a sequence-specific manner is a powerful mechanism utilized by bacteria to fend off phage, plasmids, and potentially harmful nucleic acids, it is also a promising technology for programmable targeting of undesirable bacteria in microbiome consortia.}, journal={CURRENT OPINION IN MICROBIOLOGY}, publisher={Elsevier BV}, author={Briner, Alexandra E. and Barrangou, Rodolphe}, year={2016}, month={Jun}, pages={101–108} } @misc{barrangou_pijkeren_2016, title={Exploiting CRISPR-Cas immune systems for genome editing in bacteria}, volume={37}, ISSN={["1879-0429"]}, DOI={10.1016/j.copbio.2015.10.003}, abstractNote={The CRISPR-Cas immune system is a DNA-encoded, RNA-mediated, DNA-targeting defense mechanism, which provides sequence-specific targeting of DNA. This molecular machinery can be engineered into the sgRNA:Cas9 technology, for programmable cleavage of DNA. Following the genesis of double-stranded DNA breaks, the DNA repair machinery generates mutations at the cleavage site using various pathways. This technology has revolutionized eukaryotic genome editing, and we are at the cusp of full exploitation in bacteria. Here, we discuss the potential of CRISPR-based technologies for use in bacteria, and highlight the application of single stranded DNA recombineering combined with CRISPR-Cas selection to edit the genome of a probiotic organism. We envision that CRISPR-Cas technologies will play a key role in the development of next-generation industrial bacteria.}, journal={CURRENT OPINION IN BIOTECHNOLOGY}, publisher={Elsevier BV}, author={Barrangou, Rodolphe and Pijkeren, Jan-Peter}, year={2016}, month={Feb}, pages={61–68} } @article{hymes_johnson_barrangou_klaenhammer_2016, title={Functional Analysis of an S-Layer-Associated Fibronectin-Binding Protein in Lactobacillus acidophilus NCFM}, volume={82}, ISSN={["1098-5336"]}, DOI={10.1128/aem.00024-16}, abstractNote={ABSTRACT Bacterial surface layers (S-layers) are crystalline arrays of self-assembling proteinaceous subunits called S-layer proteins (Slps) that comprise the outermost layer of the cell envelope. Many additional proteins that are associated with or embedded within the S-layer have been identified in Lactobacillus acidophilus NCFM, an S-layer-forming bacterium that is widely used in fermented dairy products and probiotic supplements. One putative S-layer-associated protein (SLAP), LBA0191, was predicted to mediate adhesion to fibronectin based on the in silico detection of a fibronectin-binding domain. Fibronectin is a major component of the extracellular matrix (ECM) of intestinal epithelial cells. Adhesion to intestinal epithelial cells is considered an important trait for probiotic microorganisms during transit and potential association with the intestinal mucosa. To investigate the functional role of LBA0191 (designated FbpB) in L. acidophilus NCFM, an fbpB -deficient strain was constructed. The L. acidophilus mutant with a deletion of fbpB lost the ability to adhere to mucin and fibronectin in vitro . Homologues of fbpB were identified in five additional putative S-layer-forming species, but no homologues were detected in species outside the L. acidophilus homology group.}, number={9}, journal={APPLIED AND ENVIRONMENTAL MICROBIOLOGY}, publisher={American Society for Microbiology}, author={Hymes, Jeffrey P. and Johnson, Brant R. and Barrangou, Rodolphe and Klaenhammer, Todd R.}, editor={Dudley, E. G.Editor}, year={2016}, month={May}, pages={2676–2685} } @article{morovic_hibberd_zabel_barrangou_stahl_2016, title={Genotyping by PCR and High-Throughput Sequencing of Commercial Probiotic Products Reveals Composition Biases}, volume={7}, ISSN={["1664-302X"]}, DOI={10.3389/fmicb.2016.01747}, abstractNote={Recent advances in microbiome research have brought renewed focus on beneficial bacteria, many of which are available in food and dietary supplements. Although probiotics have historically been defined as microorganisms that convey health benefits when ingested in sufficient viable amounts, this description now includes the stipulation "well defined strains," encompassing definitive taxonomy for consumer consideration and regulatory oversight. Here, we evaluated 52 commercial dietary supplements covering a range of labeled species, and determined their content using plate counting, targeted genotyping. Additionally, strain identities were assessed using methods recently published by the United States Pharmacopeial Convention. We also determined the relative abundance of individual bacteria by high-throughput sequencing (HTS) of the 16S rRNA sequence using paired-end 2x250bp Illumina MiSeq technology. Using multiple methods, we tested the hypothesis that products do contain the quantitative amount of labeled bacteria, and qualitative list of labeled microbial species. We found that 17 samples (33%) were below label claim for CFU prior to their expiration dates. A multiplexed-PCR scheme showed that only 30/52 (58%) of the products contained a correctly labeled classification, with issues encompassing incorrect taxonomy, missing species and un-labeled species. The HTS revealed that many blended products consisted predominantly of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis. These results highlight the need for reliable methods to qualitatively determine the correct taxonomy and quantitatively ascertain the relative amounts of mixed microbial populations in commercial probiotic products.}, journal={FRONTIERS IN MICROBIOLOGY}, publisher={Frontiers Media SA}, author={Morovic, Wesley and Hibberd, Ashley A. and Zabel, Bryan and Barrangou, Rodolphe and Stahl, Buffy}, year={2016}, month={Nov} } @article{briner_barrangou_2016, title={Guide RNAs: A Glimpse at the Sequences that Drive CRISPR–Cas Systems}, volume={2016}, DOI={10.1101/pdb.top090902}, abstractNote={CRISPR–Cas systems provide adaptive immunity in bacteria and archaea. Although there are two main classes of CRISPR–Cas systems defined by gene content, interfering RNA biogenesis, and effector proteins, Type II systems have recently been exploited on a broad scale to develop next-generation genetic engineering and genome-editing tools. Conveniently, Type II systems are streamlined and rely on a single protein, Cas9, and a guide RNA molecule, comprised of a CRISPR RNA (crRNA) and trans -acting CRISPR RNA (tracrRNA), to achieve effective and programmable nucleic acid targeting and cleavage. Currently, most commercially available Cas9-based genome-editing tools use the CRISPR–Cas system from Streptococcus pyogenes (SpyCas9), although many orthogonal Type II systems are available for diverse and multiplexable genome engineering applications. Here, we discuss the biological significance of Type II CRISPR–Cas elements, including the tracrRNA, crRNA, Cas9, and protospacer-adjacent motif (PAM), and look at the native function of these elements to understand how they can be engineered, enhanced, and optimized for genome editing applications. Additionally, we discuss the basis for orthogonal Cas9 and guide RNA systems that would allow researchers to concurrently use multiple Cas9-based systems for different purposes. Understanding the native function of endogenous Type II CRISPR–Cas systems can lead to new Cas9 tool development to expand the genetic manipulation toolbox.}, number={7}, journal={Cold Spring Harbor Protocols}, publisher={Cold Spring Harbor Laboratory}, author={Briner, Alexandra E. and Barrangou, Rodolphe}, year={2016}, month={Jul}, pages={pdb.top090902} } @article{leenay_maksimchuk_slotkowski_agrawal_gomaa_briner_barrangou_beisel_2016, title={Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems}, volume={62}, ISSN={["1097-4164"]}, DOI={10.1016/j.molcel.2016.02.031}, abstractNote={